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Prefaces to First Edition
Book One
The time that statistical analyses, including analysis of variance and regression
analyses, were analyzed by statistical analysts has gone for good, thanks to the
availability of user-friendly statistical software. The teaching department, the
educations committee, and the scientific committee of the Albert Schweitzer
Hospital, Dordrecht, the Netherlands, are pleased to announce that since November
2009, the entire staff and personnel are able to perform statistical analyses with the
help of SPSS Statistical Software in their offices through the institution’s intranet.
It is our experience as master’s and doctorate class teachers of the European
College of Pharmaceutical Medicine (EC Socrates Project) that students are eager
to master adequate command of statistical software for carrying out their own
statistical analyses. However, students often lack adequate knowledge of basic
principles, and this carries the risk of fallacies. Computers cannot think and can
only execute commands as given. As an example, regression analysis usually
applies independent and dependent variables, often interpreted as causal factors
and outcome factors. For example, gender and age may determine the type of
operation or the type of surgeon. The type of surgeon does not determine the age
and gender. Yet, software programs have no difficulty to use nonsense determi-
nants, and the investigator in charge of the analysis has to decide what is caused by
what, because a computer cannot do a thing like that, although it is essential to the
analysis.
It is our experience that a pocket calculator is very helpful for the purpose of
studying the basic principles. Also, a number of statistical methods can be
performed more easily on a pocket calculator, than using a software program.
Advantages of the pocket calculator method include the following:
1. You better understand what you are doing. The statistical software program is
kind of a black box program.
2. The pocket calculator works faster, because far less steps have to be taken.
v
3. The pocket calculator works faster, because averages can be used.
4. With statistical software all individual data have to be included separately, a
time-consuming activity in case of large data files.
Also, some analytical methods, for example, power calculations and required
sample size calculations, are difficult on a statistical software program and easy on
a pocket calculator. This book reviews the pocket calculator methods together with
practical examples, both hypothesized and real patient data. The book was pro-
duced together with the similarly sized book SPSS for Starters from the same
authors (edited by Springer, Dordrecht 2010). The two books complement one
another. However, they can be studied separately as well.
Lyon, France Ton J. Cleophas
December 2010 Aeilko H. Zwinderman
Book Two
The small book Statistical Analysis of Clinical Data on a Pocket Calculator edited
in 2011 presented 20 chapters of cookbook-like step-by-step analyses of clinical
data and was written for clinical investigators and medical students as a basic
approach to the understanding and carrying out of medical statistics. It addressed
subjects like the following:
1. Statistical tests for continuous/binary data
2. Power and sample size assessments
3. Calculation of confidence intervals
4. Calculating variabilities
5. Adjustments for multiple testing
6. Reliability assessments of qualitative and quantitative diagnostic tests
This book is a logical continuation and reviews additional pocket calculator
methods that are important to data analysis:
1. Logarithmic and invert logarithmic transformations
2. Binary partitioning
3. Propensity score matching
4. Mean and hot deck imputations
5. Precision assessments of diagnostic tests
6. Robust variabilities
These methods are, generally, difficult on a statistical software program and easy
on a pocket calculator. We should add that pocket calculators work faster, because
summary statistics are used. Also you better understand what you are doing. Pocket
calculators are wonderful: they enable you to test instantly without the need to
download a statistical software program.
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The methods can also help you make use of methodologies for which there is
little software, like Bhattacharya modeling, fuzzy models, Markov models, binary
partitioning, etc.
We do hope that Statistical Analysis of Clinical Data on a Pocket Calculator 1
and 2 will enhance your understanding and carrying out of medical statistics and
help you dig deeper into the fascinating world of statistical data analysis. We
recommend to those completing the current books to study, as a next step, the
two books entitled SPSS for Starters 1 and 2 from the same authors.
Lyon, France Ton J. Cleophas
March 2012 Aeilko H. Zwinderman
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Preface to Second Edition
We as authors were, initially, pretty unsure, whether, in the current era of
computer analyses, a work based on pocket calculator analyses of clinical data
would be appreciated by medical and health professionals and students. However,
within the first two years of publication, over thirty thousand e-copies were sold.
From readers’ comments we came to realize that statistical software programs had
been experienced as black box programs producing lots of p-values, but little
answers to scientific questions, and that many readers had not been happy with
that situation.
The pocket calculator analyses appeared to be, particularly, appreciated, because
they enabled readers for the first time to understand the scientific methods of
statistical reasoning and hypothesis testing. So much so that it started something
like a new dimension in their professional world.
The reason for a rewrite was to give updated and upgraded versions of the
forty chapters from the first editions, including the valuable comments of readers.
Like in the textbook complementary to the current work, entitled SPSS for
Starters and 2nd Levelers (Springer Heidelberg 2015, from the same authors),
an improved structure of the chapters was produced, including background, main
purpose, scientific question, schematic overview of data files, and reference
sections. In addition, for the analysis of more complex data, twenty novel
chapters were written. We will show that, also here, a pocket calculator can be
very helpful.
For convenience the chapters have been reclassified according to the most basic
difference in data characteristics: continuous outcome data (34 chapters) and binary
outcome data (26 chapters). Both hypothesized and real data examples are used to
explain the sixty pocket calculator methods described. The arithmetic is of a no-
more-than high-school level.
Lyon, France Ton J. Cleophas




Part I Continuous Outcome Data
1 Data Spread, Standard Deviations . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 3
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
5 Calculate Standard Deviations . . . . . . . . . . . . . . . . . . . . . . . . . . 4
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2 Data Summaries, Histograms, Wide and Narrow
Gaussian Curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 7
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
4 Hypothesized Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
5 Importance of SEM-Graphs in Statistics . . . . . . . . . . . . . . . . . . . 10
6 Drawing a Gaussian Curve without a Computer . . . . . . . . . . . . . . 10
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3 Null-Hypothesis Testing with Graphs . . . . . . . . . . . . . . . . . . . . . . . 13
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 14
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
5 Examples of a Negative Trial and a Trial
with Borderline Result . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
xi
4 Null-Hypothesis Testing with the T-Table . . . . . . . . . . . . . . . . . . . . 19
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 20
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
5 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
5 One-Sample Continuous Data (One-Sample T-Test,
One-Sample Wilcoxon Test) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 25
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
4 Data Example, One-Sample T-test . . . . . . . . . . . . . . . . . . . . . . . 26
5 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
6 Data Example, One-Sample Wilcoxon Test . . . . . . . . . . . . . . . . . 28
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
6 Paired Continuous Data (Paired T-Test, Wilcoxon
Signed Rank Test) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 31
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
5 Analysis: Paired T-Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
6 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
7 Alternative Analysis: Wilcoxon Signed Rank Test . . . . . . . . . . . . 34
8 Wilcoxon Test Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
9 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
10 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
7 Unpaired Continuous Data (Unpaired T-Test, Mann-Whitney) . . . 37
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 37
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
5 Unpaired T-Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
6 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
7 Mann-Whitney test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
8 Mann-Whitney Table P< 0.01 . . . . . . . . . . . . . . . . . . . . . . . . . . 42
9 Mann-Whitney Table P< 0.05 . . . . . . . . . . . . . . . . . . . . . . . . . . 43
10 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
11 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
xii Contents
8 Linear Regression (Regression Coefficient, Correlation
Coefficient and Their Standard Errors) . . . . . . . . . . . . . . . . . . . . . 45
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 46
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
5 Analysis: Linear Regression . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
6 Electronic Calculator for Linear Regression . . . . . . . . . . . . . . . . 48
7 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
9 Kendall-Tau Regression for Ordinal Data . . . . . . . . . . . . . . . . . . . . 51
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 51
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
5 Rank Correlation Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
6 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
10 Paired Continuous Data, Analysis with Help
of Correlation Coefficients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 57
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
5 Unpaired T-Test of Paired Data, the Wrong Analysis . . . . . . . . . . 58
6 Paired T-Test of Paired Data . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
7 Linear Regression for Adjustment of Erroneous
T-Value from Sect. 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
8 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
9 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
10 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
11 Power Equations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 65
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4 Power Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
5 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
6 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Contents xiii
12 Sample Size Calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 71
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4 Data Example, Continuous Data, Power 50 % . . . . . . . . . . . . . . . 72
5 Data Example, Continuous Data, Power 80 % . . . . . . . . . . . . . . . 73
6 Data Example, Continuous Data, Power 80 %,
Two Groups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
13 Confidence Intervals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 75
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4 Data Example, Continuous Outcome Data . . . . . . . . . . . . . . . . . . 76
5 T-Table and 95% Confidence Intervals . . . . . . . . . . . . . . . . . . . . 77
6 Data Example, Binary Outcome Data . . . . . . . . . . . . . . . . . . . . . 78
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
14 Equivalence Testing Instead of Null-Hypothesis Testing . . . . . . . . . 79
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 80
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
15 Noninferiority Testing Instead of Null-Hypothesis Testing . . . . . . . 83
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 84
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5 Step 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
6 Step 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
7 Step 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
16 Superiority Testing Instead of Null-Hypothesis Testing . . . . . . . . . 87
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 87
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
5 T-Table . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
xiv Contents
17 Missing Data Imputation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 93
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
18 Bonferroni Adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 99
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4 Bonferroni T-Test, Data Example . . . . . . . . . . . . . . . . . . . . . . . . 100
5 Bonferroni T-Test Over-conservative . . . . . . . . . . . . . . . . . . . . . 101
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
19 Unpaired Analysis of Variance . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 103
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4 Variations Expressed as the Sums of Squares . . . . . . . . . . . . . . . 104
5 Real Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
20 Paired Analysis of Variance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 107
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
4 Variations Expressed as the Sums of Squares . . . . . . . . . . . . . . . 108
5 Real Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
21 Variability Analysis for One or Two Samples . . . . . . . . . . . . . . . . . 113
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 113
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
4 One Sample Variability Analysis . . . . . . . . . . . . . . . . . . . . . . . . 114
5 Two Sample Variability Test . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
22 Variability Analysis for Three or More Samples . . . . . . . . . . . . . . . 121
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 121
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
Contents xv
4 Data Example (Bartlett’s Test) . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
23 Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 126
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
4 Confounding Assessed with Subclassification . . . . . . . . . . . . . . . 126
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
24 Propensity Scores and Propensity Score Matching
for Assessing Multiple Confounders . . . . . . . . . . . . . . . . . . . . . . . . 131
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 131
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
4 Propensity Scores . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
5 Propensity Score Matching . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
25 Interaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 140
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
4 Data Example of Interaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
26 Accuracy and Reliability Assessments . . . . . . . . . . . . . . . . . . . . . . . 145
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 145
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
4 Testing Accuracy with R2-Values . . . . . . . . . . . . . . . . . . . . . . . . 146
5 Testing Reliability with Duplicate Standard Deviations . . . . . . . . 147
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
27 Robust Tests for Imperfect Data . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 151
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
5 T-Test for Medians and Median Absolute
Deviations (MADs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
6 T-Test for Winsorized Variances . . . . . . . . . . . . . . . . . . . . . . . . 155
xvi Contents
7 Mood’s Test (One Sample Wilcoxon’s Test) . . . . . . . . . . . . . . . . 155
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
28 Non-linear Modeling on a Pocket Calculator . . . . . . . . . . . . . . . . . . 159
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 159
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
5 Calculation of Linear Regression Parameters
from a Pocket Calculator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
29 Fuzzy Modeling for Imprecise and Incomplete Data . . . . . . . . . . . . 163
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 163
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4 Fuzzy Terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4.1 Universal Space . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4.2 Fuzzy Memberships . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4.3 Linguistic Membership Names . . . . . . . . . . . . . . . . . . . . . . 164
4.4 Triangular Fuzzy Sets . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4.5 Fuzzy Plots . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
4.6 Linguistic Rules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
5 Data Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
6 Data Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
30 Bhattacharya Modeling for Unmasking Hidden
Gaussian Curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 171
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
31 Item Response Modeling Instead of Classical
Linear Analysis of Questionnaires . . . . . . . . . . . . . . . . . . . . . . . . . . 175
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 175
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
4 Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
Contents xvii
32 Meta-analysis of Continuous Data . . . . . . . . . . . . . . . . . . . . . . . . . . 181
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 181
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
4 Data Example, Pooling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
5 Data Example, Assessing Heterogeneity . . . . . . . . . . . . . . . . . . . 183
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
33 Goodness of Fit Tests for Identifying Nonnormal Data . . . . . . . . . . 185
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 185
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 186
4 Chi-Square Goodness of Fit Test, Data Example . . . . . . . . . . . . . 186
5 Kolmogorov-Smirnov Goodness of Fit Test, Data Example . . . . . . . 189
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
34 Non-parametric Tests for Three or More Samples
(Friedman and Kruskal-Wallis) . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 193
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
4 Friedman Test for Paired Observations . . . . . . . . . . . . . . . . . . . . 194
5 Kruskal-Wallis Test for Unpaired Observations . . . . . . . . . . . . . . 196
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
Part II Binary Outcome Data
35 Data Spread: Standard Deviations, One Sample Z-Test,
One Sample Binomial Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 201
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
4 The Computation of the Proportion of Responders
and Its Standard Deviation (SD) . . . . . . . . . . . . . . . . . . . . . . . . . 202
5 One Sample Z-Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202
6 Computing the 95 % Confidence Intervals of a Data Set . . . . . . . 204
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
36 Z-Test for Cross-Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 207
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
4 Data Example, Two Group Z-Test . . . . . . . . . . . . . . . . . . . . . . . 208
5 Single Group Z-Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
xviii Contents
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
37 Phi Tests for Nominal Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 212
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 212
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
38 Chi-square Tests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 215
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
4 Data Example I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
5 Data Example II . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
6 Example for Practicing 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
7 Example for Practicing 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
39 Fisher Exact Tests Convenient for Small Samples . . . . . . . . . . . . . . 221
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 221
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
40 Confounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225
2 Schematic Overview of Type of Data . . . . . . . . . . . . . . . . . . . . . 225
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
4 Data Example, Demonstrating Confounding . . . . . . . . . . . . . . . . 226
5 Testing Confounding with a Z-Test . . . . . . . . . . . . . . . . . . . . . . . 228
6 Testing Confounding with a Mantel-Haenszl Test . . . . . . . . . . . . 229
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
41 Interaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
2 Schematic Overview of Type of Data . . . . . . . . . . . . . . . . . . . . . 231
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
4 Interaction, Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
5 Interaction, Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 234
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Contents xix
42 Chi-Square Tests for Large Cross-Tabs . . . . . . . . . . . . . . . . . . . . . 237
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 237
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
4 Data Example One: 3 2 Cross-Tab . . . . . . . . . . . . . . . . . . . . . . 238
5 Data Example Two: Theoretical Distribution . . . . . . . . . . . . . . . . 240
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
43 Logarithmic Transformations, a Great Help
to Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 243
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
4 Theory and Basic Steps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
5 Example, Markov Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
6 Example, Odds Ratios . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
44 Odds Ratios, a Short-Cut for Analyzing Cross-Tabs . . . . . . . . . . . . 249
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 249
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
4 Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
5 Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
45 Logodds, the Basis of Logistic Regression . . . . . . . . . . . . . . . . . . . . 253
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253
2 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254
3 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254
4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
5 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256
46 Log Likelihood Ratio Tests for the Best Precision . . . . . . . . . . . . . . 257
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 257
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258
4 Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258
5 Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
6 Example 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262
xx Contents
47 Hierarchical Loglinear Models for Higher Order
Cross-Tabs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 263
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 264
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 264
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265
4.1 First Order Effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265
4.2 Second Order Effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268
48 McNemar’s Tests for Paired Cross-Tabs . . . . . . . . . . . . . . . . . . . . . 269
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 269
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 269
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 270
4 Data Example, Chi-Square McNemar’s Test . . . . . . . . . . . . . . . . 270
5 Data Example, McNemar’s Z-Test . . . . . . . . . . . . . . . . . . . . . . . 271
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
49 McNemar’s Odds Ratios . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 275
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
50 Power Equations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 279
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 282
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 282
51 Sample Size Calculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 283
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 283
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 283
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284
4 Data Example, Binary Data, Power 80 % . . . . . . . . . . . . . . . . . . 284
5 Data Example, Binary Data, Power 80 %, Two Groups . . . . . . . . 284
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285
Contents xxi
52 Accuracy Assessments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 287
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
4 Estimating Uncertainty of Sensitivity and Specificity . . . . . . . . . . 288
5 Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
6 Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 289
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290
53 Reliability Assessments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 291
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 292
4 Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 292
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293
54 Unmasking Fudged Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 295
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 298
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 298
55 Markov modeling for Predicting Outside the Range
of Observations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 299
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300
4 Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300
5 Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
6 Example 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 301
7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302
8 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302
56 Binary Partitioning for CART (Classification
and Regression Tree) Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 304
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304
4 Binary Partitioning, the Analysis . . . . . . . . . . . . . . . . . . . . . . . . 305
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
xxii Contents
57 Meta-analysis of Binary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 307
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
4 Data Example, Pooling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
5 Data Example, Assessing Heterogeneity . . . . . . . . . . . . . . . . . . . 310
6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 310
7 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311
58 Physicians’ Daily Life and the Scientific Method . . . . . . . . . . . . . . . 313
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 314
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314
4 Example 1, Falling Out of Bed . . . . . . . . . . . . . . . . . . . . . . . . . . 314
5 Example 2, Evaluation of Fundic Gland Polyps . . . . . . . . . . . . . . 316
6 Example 3, Physicians with a Burn-Out . . . . . . . . . . . . . . . . . . . 316
7 Example 4, Patients’ Letters of Complaints . . . . . . . . . . . . . . . . . 317
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 318
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 318
59 Incident Analysis and the Scientific Method . . . . . . . . . . . . . . . . . . 319
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 319
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
4 Data Example, Test 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
5 Data Example, Test 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 322
6 Data Example, Test 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 323
7 Data Example, Test 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324
8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 324
9 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 325
60 Cochran Q-Test for Large Paired Cross-Tabs . . . . . . . . . . . . . . . . . 327
1 General Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 327
2 Schematic Overview of Type of Data File . . . . . . . . . . . . . . . . . . 327
3 Primary Scientific Question . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328
4 Cochran Q-Test for a Study with Three Paired Binary
Observations per Patient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 328
5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330
6 Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 330





Data Spread, Standard Deviations
1 General Purpose
Repeated measures have a central tendency (averages, two averages, regression lines),
and a tendency to depart from the expected central values. In order to estimate the
magnitude of the departures from the averages an index is needed. Why not simply
add-updepartures?However, thisdoesnotwork,becausegenerally thevalueshigher and
lower than the averages tend to even out, and the results would be zero. A pragmatic
solution was taken by statisticians around the world. They decided to square the depar-
tures first, and then add-up. The add-up sum of the squared departures is called the
variance. The square root of the variance is called the standard deviation. This chapter
shows how pocket calculators can be used for computation of standard deviations.
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3 Primary Scientific Question
Is the standard deviation an adequate index for spread in the data?
4 Data Example
Standard deviations (SDs) are often used for summarizing the spread of the data
from a sample. If the spread in the data is small, then the same will be true for the




















SD¼ . . .. . .. . .. . . ¼> . . ... / (n-1) ¼> √. . ..¼> 1.407885953
5 Calculate Standard Deviations
Each scientific pocket calculator has a mode for data-analysis. It is helpful to
calculate in a few minutes the mean and standard deviation of a sample.
Calculate standard deviation: mean ¼ 53.375 SD ¼ 1.407885953
4 1 Data Spread, Standard Deviations
The next steps are required:
Casio fx-825 scientific
On . . . .mode....shift.. . .AC.. . .55.. . .M+.. . .54.. . .M+.. . .51.. . .M+.. . .55.. . .




On.. . .55.. . .Σ+.. . .54.. . .Σ+.. . .51.. . .Σ+.. . .55.. . . Σ+. . ..53.. . .Σ+.. . .53.. . .Σ
+....54.. . . Σ+.. . .52.. . .Σ+.. . .2nd.. . .x.. . .2nd.. . .σxn-1
----------------------------------------------------------------
Sigma AK 222 and Commodoor
On . . . 2ndf . . . on . . . 55 . . . M+ . . . 54 . . . M+ . . . 51 . . . M+ . . . 55 . . . M+ . . . 53 . . . M+
. . . 53 . . . M+ . . . 54 . . . M+ . . . 52 . . . M+ . . . x¼>M . . . MR
----------------------------------------------------------------
Calculator: Electronic Calculator
On.. . .mode.. . .2.. . .55.. . .M+.. . .54.. . .M+.. . .51.. . .M+.. . .55.. . .M+.. . .53.. . .M
+.. . .53....M+.. . .54.. . .M+.. . .52.. . .M+.. . .Shift.. . .S-var.. . .1.. . .¼.. . .
(mean).. . .Shift.. . .S-var.. . . 3.. . .(sd)
6 Conclusion
Repeated measures have a central tendency and tendency to depart from the
expected central values. In order to estimate the magnitude of the departures from
the averages an index is needed. The add-up sum of the squared departures is used
for the purpose, and is called the variance. The square root of the variance is called
the standard deviation. This chapter shows how pocket calculators can be used for
computation of standard deviations. Sometimes, data files are skewed, and mean
values do not mean too much. Instead the modus (the frequentest value) or the
median (the value in the middle) are more meaningful (see Chap. 27).
Example:











More background, theoretical and mathematical information of means, variances,
standard deviations, and standard errors (of the mean) is given in Statistics applied
to clinical studies 5th edition, Chap. 1, Springer Heidelberg Germany, 2012, from
the same authors.
6 1 Data Spread, Standard Deviations
Chapter 2
Data Summaries, Histograms, Wide
and Narrow Gaussian Curves
1 General Purpose
In order to summarize continuous data, either histograms can be plotted or Gaussian
curves can be drawn. This chapter is to assess how to summarize your data with the
help of a pocket calculator.











3 Primary Scientific Question
How can histograms, otherwise called frequency distributions, and wide and narrow
Gaussian curves be used for summarizing continuous data?
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4 Hypothesized Data Example
Based on the same data, but with different meaning. The wide one summarizes the
data of our trial. The narrow one summarizes the mean of many trials similar to our
trial. It can be mathematically proven that this is so.
Continuous data can be plotted in the form of a histogram (upper graph). The
upper graph is assumed to present individual cholesterol reductions after one week
drug treatment in 1000 patients. The bar in the middle is observed most frequently.
The bars on either side grow gradually shorter. The graph, thus, pretty well exhibits
two main characteristics of your data namely the place of the mean and the
distribution of the individual data against the mean. On the x-axis, frequently called
z-axis in statistics, it has individual data. On the y-axis it has “how often”. This
graph adequately represents the data. It is, however, not adequate for statistical
analyses. The lower graph pictures a Gaussian curve, otherwise called normal
(distribution) curve. On the x-axis we have, again, the individual data, expressed
either in absolute data or in SDs (standard deviations) distant from the mean. See
Chap. 1 for calculation information of SDs. On the y-axis the bars have been
replaced with a continuous line. It is now impossible to determine from the graph
how many patients had a particular outcome. Instead, important inferences can be
made. For example, the total area under the curve (AUC) represents:
100 % of the data,
AUC left from mean represents 50 % of the data,
left from 1 SDs it has 15.9 % of the data,
left from 2 SDs it has 2.5 % of the data,
between +2 SDs and 2 SDs we have 95 % of the data
(the 95 % confidence interval of the data).
It is remarkable that the patterns of Gaussian curves from biological data are
countless, but that all of them, nonetheless, display the above percentages. This is
something like a present from heaven, and it enables to make use of the Gaussian
curves for making predictions from your data about future data. However, in order
to statistically test your data, we will have to go one step further.
8 2 Data Summaries, Histograms, Wide and Narrow Gaussian Curves
95 % of all means
95 % of all data












The figure underneath gives two Gaussian curves, a narrow and a wide one. Both
are based on the same data, but with different meaning. The wide one summarizes the
data of our trial. The narrow one summarizes the mean of many trials similar to our
trial. It can be mathematically proven that this is so. However this is beyond scope of
the current text. Still, it is easy to conceive that the distribution of all means of many
similar trials is narrower and has fewer outliers than the distribution of the actual data
from our trial, and that it will center around the mean of our trial, because our trial is
assumed to be representative for the entire population. Now why should the mean of
many trials be equal to the mean of our trial. The truth is, we have no certainty, but
neither do we have any argument to have the overall mean on the left of right side of
the measured mean of our data. You may find it hard to believe, but the narrow curve
with standard errors of the mean (SEMs), or, simply, SEs on the x-axis can be
effectively used for testing important statistical hypotheses, like
1. no difference between new and standard treatment,
2. a real difference,
3. the new treatment is better than the standard treatment,
4. the two treatments are equivalent.
thus, mean 2 SDs (or more precisely 1.96 SDs) represents 95 % of the AUC of
the wide distribution, otherwise called the 95 % confidence interval of the data,
which means that 95 % of the data of the sample are within. The SEM-curve
(narrow one) is narrower than the SD-curve (wide one), because SEM ¼ SD= ffiffiffinp
with n¼ sample size. Mean 2 SEMs (or more precisely 1.96 SEMs) represents
95 % of the means of many trials similar to our trial.
SEM¼ SD = ffiffiffinp
4 Hypothesized Data Example 9
5 Importance of SEM-Graphs in Statistics
Why is this SEM approach so important in statistics. Statistics makes use of mean
values and their standard error to test the null hypotheses of finding no difference
from zero in your sample. When we reject a null hypothesis at p< 0.05, it literally
means that there is <5 % chance that the mean value of our sample crosses the area
of the null hypothesis where we say there is no difference. It does not mean that
many individual data may not go beyond that boundary. Actually, it is just a matter
of agreement. But it works well.
6 Drawing a Gaussian Curve without a Computer
The mathematical equation of a Gaussian curve is (e¼Euler’s constant¼ 2.718)
y¼ e-1/2 (x^2)
x¼ (individual values) / (standard deviation)
x^2¼ x2
at x¼ 0! y¼ 1
at x¼ 1! y¼ 0.607
at x¼ 2! y¼ 0.135
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probability distribution
SDs
With the help of the above equation, various y-values can, thus, be computed,
and in this way a standard Gaussian curve can be drawn.
10 2 Data Summaries, Histograms, Wide and Narrow Gaussian Curves
7 Conclusion
In order to summarize continuous data, either histograms can be plotted or Gaussian
curves can be drawn. Gaussian curves can be drawn with the help of the Gaussian
curve equation y¼ e-1/2 (x ^2).. The above procedure is only entirely correct with
larger samples like 100 or so. With small samples data tend to produce somewhat
larger spread, and normal distributions turn into t-distributions (see the Chap. 8).
But as a first step, before any analysis, histograms and Gaussian curves are
convenient even with small samples.
8 Note
More background, theoretical and mathematical information of histograms and
Gaussian curves is given in Statistics applied to clinical studies 5th edition,
Chap. 1, Springer Heidelberg Germany, 2012, from the same authors.
8 Note 11
Chapter 3
Null-Hypothesis Testing with Graphs
1 General Purpose
Because biological processes are full of variations, statistics will give no certainties
only chances. What chances? Chances that hypotheses are true/untrue. What
hypotheses? For example:
1. our mean effect is not different from a 0 effect,
2. it is really different from a 0 effect,
3. it is worse than a 0 effect,
where 0 effect means that your new treatment or any other intervention doesnot
work. Statistics is about estimating such chances/testing such hypotheses. Please
note that trials often calculate differences between a test treatment and a control
treatment, and, subsequently, test whether this difference is larger than 0. A simple
way to reduce a study of two groups of data, and, thus, two means to a single mean
and single distribution of data, is to take the difference between the two means and
compare it with 0.
In the Chap.2 we explained that the data of a trial can be described in the form of
a normal distribution graph with SEMs on the x-axis, and that this method is
adequate for testing various statistical hypotheses. We will now focus on a very
important hypothesis, the null-hypothesis. What it literally means is: no difference
from a 0 effect: the mean value of our sample is not different from the value 0. We
will try and make a graph of this null-hypothesis, and then assess whether our result
is significantly different from the null-hypothesis.
© Springer International Publishing Switzerland 2016
T.J. Cleophas, A.H. Zwinderman, Clinical Data Analysis on a Pocket Calculator,
DOI 10.1007/978-3-319-27104-0_3
13











3 Primary Scientific Question
Is the result of our study significant different from the null-hypothesis?
4 Data Example
Let us assume that 1000 patients will be treated with a cholesterol lowering agent.
After one week of treatment all cholesterol reductions are summarized with a mean
reduction and its standard error. In order to make a graph of our result as compared
to the null-hypothesis, our results have to be standardized first.
Mean Standard Error
is divided by its own standard error
Mean/Standard Error Standard Error/Standard Error ¼
Mean/Standard Error 1
The unit of the standardized results is not mmol/l anymore, but something else.
We will call it SEM units (otherwise often called z-values or t-values).
In our example the result is given:
Mean Standard Error ¼
3 1 SEM units
The mathematical equation of the Gaussian curve of our data is obtained from
the equation (see also Chap. 2, e¼Euler’s constant¼ 2.718).
y ¼ e1=2 x2ð Þ
14 3 Null-Hypothesis Testing with Graphs
x¼Mean/Standard Error
x^2¼ x2
at x¼ 0! y¼ 1
at x¼ 1! y¼ 0.607
at x¼ 2! y¼ 0.135
at x¼ 3! y¼ 0.011
The above values can be plotted, and the underneath Gaussian curve H0
(hypothesis 0) will be obtained. It is, actually, a graph of the null-hypothesis.






It is now easy to, subsequently, draw a curve of the null-hypothesis H1 (hypoth-
esis 1). It is equally wide and high as the H0 curve, but with an overall mean value
of 3 instead of 0. This null-hypothesis is now used to test whether your result is
significantly different from zero, meaning that your cholesterol treatment is
efficaceous. The following statistical reasoning is used.
As explained in the Chap.2, the Gaussian curve H1 with SEMs on the x-axis
is not only a kind of summary of your data, it is also the summary of many trials
similar to our trial.
H1 ¼ graph based on the data of our trial with SEMs on the x-axis.
H0 ¼ the same graph with mean 0.
Now we will make a giant leap from our data to the entire population (we can do
so, because our data are representative).
H1 ¼ also the summary of many trials similar to ours.
H0 ¼ summary of many trials similar to ours but with an overall mean effect
of zero.
4 Data Example 15
We can’t prove anything, but we can calculate chances/probabilities. A mean
result of 3 is far distant from 0: suppose it belongs to H0. Only 5 % of the H0 trials
are >2 SEMs distant from 0. Our mean result is, indeed, > 2 SEMs distant from
0, namely 3 SEMs. This means, that the chance that our result belongs to the H0
trials is<5 %, because the AUC (area under the curve)>2 SEMs and<2 SEMs is
only 5 % of the entire AUC (Chap. 2). We conclude that we have< 5 % of finding
this result, and decide that we will reject this small chance.
Any study result larger than 2 SEMs or smaller than – 2 SEMs is in the small tails
of the H0 curve, and, if your treatment does not work, you will have less than 5 %
chance of being in the tails. Our result is, obviously, in the tails, and, so, we may
conclude that we can reject the null-hypothesis of no difference from zero with a
probability of< 5 %. By doing so you are committing an error. Your mean result is
in the AUC of H0. Yet you conclude that it is significantly different from H0. But
your error is only 5 %, and, at the same time, you have 95 % chance that you did not
commit an error. Worldwide statisticians have agreed that this level of error is
acceptable. The small AUCs in the right and left end tails, covering 5 % of the entire
AUC of the H0, is, usually, called alpha (α). It is also called the type I error, or the
chance of finding a difference where there is none.






In the above graph the mean of the trial is 0.9 SEMs distant from 0. This result is not
on right side of 2 SEMs. The null-hypothesis H0 can, therefore, not be rejected. The
AUC (area under the curve) right from 0.9¼ not 5 %, but rather 35 % or so of the
entire AUC. And so p¼ 0.35 (35 %).
16 3 Null-Hypothesis Testing with Graphs





In the above graph the mean is 2 SEMs distant from 0. Alpha level of
rejection¼ 2. The AUC right from 2 is only 5 % of the entire AUC. We will reject
H0 at p¼ 0.05 or 5 %. A p-value of 5 % is, however, a borderline result. We will
have, at least, 5 % chance that our conclusion is untrue, and 50 % chance of a type II
error (see Chap. 11).
6 Conclusion
Because biological processes are full of variations, statistics will give no certainties,
only chances. What chances? Chances that hypotheses are true/untrue. What
hypotheses?: e.g.:
our mean effect is not different from a 0 effect,
a test treatment and a control treatment differ more than zero.
This chapter shows that it is pretty easy to draw a curve of your data and the
corresponding null-hypothesis H0. This null-hypothesis can, then, be used to test,
whether your result is significantly different from zero, meaning that, e.g., your
cholesterol treatment was efficaceous.
6 Conclusion 17
7 Note
More background, theoretical and mathematical information of null-hypothesis
testing is given in Statistics applied to clinical studies 5th edition, Chaps. 1–3,
Springer Heidelberg Germany, 2012, from the same authors.
18 3 Null-Hypothesis Testing with Graphs
Chapter 4
Null-Hypothesis Testing with the T-Table
1 General Purpose
In the previous chapter we discussed that the patterns of Gaussian curve from
biological data have a constant frequency distribution and that this phenomenon
is used for making predictions from your data to future data. However, this is only
entirely true with large samples like samples> 100. In practice many studies
involve rather small samples and in order for your data from small samples to
adequately fit a theoretical frequency distribution we have to replace the Gaussian
normal distribution with multiple Gaussian t-distributions which are a little bit
wider.
In the twenties the USA government employed wives of workless citizens in the
Work Project Administration US. With the help of Monte Carlo Models, and a
pocket calculator not yet available at that time, the numerical characteristics of the
best fit Gaussian curves for any sample size was calculated. These characteristics
were summarized in the famous t-table, which is still the basis of any statistical
software program. This chapter is to assess how the t-table can be used for null-
hypothesis testing.
© Springer International Publishing Switzerland 2016
T.J. Cleophas, A.H. Zwinderman, Clinical Data Analysis on a Pocket Calculator,
DOI 10.1007/978-3-319-27104-0_4
19












The above graph shows members of the family of t-distributions: with n¼ 5 the
distribution is wide, with n¼ 10 and n¼ 100 this is increasingly less so. This
chapter is to show how the t-table can be used for testing null-hypotheses of no
effects in your data.











20 4 Null-Hypothesis Testing with the T-Table
3 Primary Scientific Question
Is the result of our study significant different from the null-hypothesis? At what
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DISTRIBUTION
The above graph gives an example of experimental data is given with sample size
(n)¼ 19 and mean result¼ 2.9 SEMs (SEM-units), and a t-distributed instead of
normal frequency distribution. Any result larger than approximately 2 SEMs is
statistically significantly different from 0 SEMs at p< 0.05. However, our mean of
2.9 SEMs is pretty far away in the <5 % tail, and, so, the chance of being so far
away may be a lot smaller than 5 %. Our p-values may be a lot smaller than 0.05.
The t-table can be more precise regarding the level of significance, and is given
underneath.
4 Data Example 21
5 T-Table
The t-table has a left-end column giving degrees of freedom (sample sizes), and
two top rows with p-values (areas under the curve¼ p-values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with 1 degrees
of freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with nature.
A t-value of 2.9 with 18 of freedom (19 patients and 1 group means we have
19–1¼ 18 of freedom) indicates that we will need the row no. 18 of the table. The
t-value 2.9 is left from 3.197 and right from 2.878. Now look right up to the second
22 4 Null-Hypothesis Testing with the T-Table
of the two upper rows: we are right from 0.01 and left from 0.005. The p-value
equals <0.01.
6 Conclusion
In the previous chapter we discussed that the patterns of Gaussian curves from
biological data have a constant frequency distribution and that this phenomenon is
used for making predictions from your data to future data. However, this is only
entirely true with large samples, like samples >100. In practice, many studies
involve rather small samples, and in order for your data from small samples to
adequately fit a theoretical frequency distribution we have to replace the Gaussian
normal distribution with multiple Gaussian-like t-distributions which are a little bit
wider. The t-table summarizes the numerical characteristics of these frequency
distributions of any size. It helps us to predict precisely the chance and level of a
statistically significant effect. E.g., a p value< 0.002 means that we have less than
0.2 % of finding such a result if there would be no effect in your data. In clinical
term this indicates that your treatment was very efficaceous, and that the chance that
this conclusion is erroneous will be less than 0.2 %, at least, if your null-hypothesis
is true.
7 Note
More background, theoretical and mathematical information of null-hypothesis
testing is given Statistics applied to clinical studies 5th edition, Chaps. 1–3,
Springer Heidelberg Germany, 2012, from the same authors.
7 Note 23
Chapter 5
One-Sample Continuous Data (One-Sample
T-Test, One-Sample Wilcoxon Test)
1 General Purpose
Studies where a single outcome per patient is compared to zero may be analyzed
with the one-sample t-test (see also Chap. 4). The t-test is only adequate, if the data
can be assumed to follow a Gaussian-like frequency distribution. For non-
Gaussian-like data the one-sample Wilcoxon test will be appropriate.
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3 Primary Scientific Question
Are the one-sample t-test and one-sample Wilcoxon test adequate for testing
whether the result of a one-sample study is significantly different from a zero
result?
4 Data Example, One-Sample T-test
In 10 patients the mean blood pressure reduction after treatment is calculated with
the accompanying p-value. A p-value< 0.05 indicates, that there is less than 5 %
probability that such a decrease will be observed purely by the play of chance.
There is, thus,> 95 % chance that the decrease is the result of a real blood pressure
lowering effect of the treatment. We call such a decrease statistically significant.











Is this decrease statistically significant?
Mean decrease ¼ 1.6 mm Hg
SD ¼ 2.4129 mm Hg
From the standard deviation (SD) the standard error (SE) can be calculated using
the equation
SE ¼ SD/√ n (n¼ sample size)
SE ¼ 2.4129/√ 10¼ 0.7636
De t-value (t) is the test-statistic of the t-test, and is calculated as follows:
t ¼ 1:6 = 0:7636 ¼ 2:095
Because the sample size is 10, the test has here 10–1¼ 9 of freedom.
The t-table underneath shows that with 9 of freedom the t-value should
be> 2.262 in order to obtain a two-tail result significantly different from zero at
p< 0.05. With a t-value of 2.095 the level equals: 0.05< p< 0.10. This result is
close to statistically significant, and is called a trend to significance.
26 5 One-Sample Continuous Data (One-Sample T-Test, One-Sample Wilcoxon Test)
5 T-Table
The underneath t-table has a left-end column giving degrees of freedom ( sample
sizes), and two top rows with p-values (areas under the curve¼ p-values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simulataneously. The t-table is, furthermore, full of t-values, that, with
1 degrees of freedom, are equal to z-values (Chap.36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, but
in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom
(large samples) the curve will be a little bit narrower, and more in agreement with
nature.
5 T-Table 27
6 Data Example, One-Sample Wilcoxon Test
Patient number mm Hg Decrease Smaller one of two add-up sums
1 3 6.5
2 4 9.5
3 2 3.5 3.5
4 3 6.5
5 1 1.5





The example of the previous section will be applied once more for a Wilcoxon
analysis. We will first put the differences from zero in ascending order. The patients
5 and 10 are equal (1 mm Hg different from zero), we will give them rank number
1.5 instead of 1 and 2. Patient 3 and 9 are equal (have equal distances from zero),
and will be given rank number 3.5 instead of 3 and 4.
The patients 1, 4, 6, and 8 are again equal and will be given rank number 6.5
instead of 5, 6, 7, 8. When each patient has been given an appropriate rank number,
all of the positive and all of the negative rank numbers will be added up, and the
smaller number of the two will be used for estimating the level of statistical
significance. Our add-up sum of negative outcome values is the smaller number,
and adds the values of the patients 3 and 6, and equals 3.5 + 6.5¼ 10. According to
the underneath Wilcoxon table with 10 number of paires the add-up value of
10 indicates that our p-value equals< 0.10. This result is very similar to the result
of the above t-test. Again a trend to significance is observed at 0.05< P< 0.10.
Wilcoxon Test Table
Number of pairs P< 0.10 P< 0.05 P< 0.01
7 3 2 0
8 5 2 0
9 8 6 2
10 10 8 3
11 13 11 5
12 17 14 7
13 20 17 10
14 25 21 13
15 30 25 16
16 35 30 19
The first column in the above Wilcoxon test table gives the numbers of patients
in your file. Rank numbers of positive and negative differences from zero are
28 5 One-Sample Continuous Data (One-Sample T-Test, One-Sample Wilcoxon Test)
separately added up. The second, third, and fourth columns give the smaller one of
the two add-up sums required for statistical significance of increasing levels.
7 Conclusion
Studies where one outcome in one patient is compared with zero can be analyzed
with the one-sample t-test. The t-test is adequate, if the data can be assumed to
follow a Gaussian-like frequency distribution. For non-Gaussian-like data the
one-sample Wilcoxon test is appropriate. The example given shows that levels of
statistical significance of the two tests are very similar.
8 Note
More background, theoretical and mathematical information of testing null-
hypothesis testing with t-tests and Wilcoxon tests is given in Statistics applied to




Paired Continuous Data (Paired T-Test,
Wilcoxon Signed Rank Test)
1 General Purpose
Studies where two outcomes in one patient are compared with one another, are
often called crossover studies, and the observations are called paired observations.
As paired observations are usually more similar than unpaired observations,
special tests are required in order to adjust for a positive correlation between the
paired observations.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is the first outcome significantly different from second one.
4 Data Example
The underneath study assesses whether some sleeping pill is more efficacious than a
placebo. The hours of sleep is the outcome value.
Patient number Outcome 1 Outcome 2 Individual Differences
1 6.0 5.1 0.9
2 7.1 8.0 0.9
3 8.1 3.8 4.3
4 7.5 4.7 3.1
5 6.4 5.2 1.2
6 7.9 5.4 2.5
7 6.8 4.3 2.5
8 6.6 6.0 0.6
9 7.3 3.7 3.8
10 5.6 6.2 0.6
Outcome¼ hours of sleep after treatment
5 Analysis: Paired T-Test
Rows may be more convenient than columns, if you use a pocket calculator,
because you read the data like you read the lines of a textbook. Two rows of
observations in 10 persons are given underneath:
Observations 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
Observations 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Individual differences:
0.9, 0.9, 4.3, 3.1, 1.2, 2.5, 2.5, 0.6, 3.8, 0.6
A. not significant
B. 0.05< p< 0.10
C. P< 0.05
D. P< 0.01
32 6 Paired Continuous Data (Paired T-Test, Wilcoxon Signed Rank Test)
Is there a significant difference between the observations 1 and 2, and which
level of significance is correct (P¼ p-value, SD¼ standard deviation) ?
Mean difference ¼ 1.59
SDs are calculated as demonstrated in the Chap. 1.
SD of mean difference ¼ √ (SD12 + SD22)
¼ 1.789 (SD¼ standard deviation)
SE¼ SD/√10 ¼ 0.567 (SE¼ standard error)
t¼ 1.59/0.567 ¼ 2.81
We have here (10–1)¼ 9 degrees of freedom, because we have 10 patients and
1 group of patients. According to the underneath t-table the p-value equals< 0.05,
and we can conclude that a significant difference between the two observations is in
the data: the values of row 1 are significantly higher than those of row 2. The answer
C is correct.
6 T-Table
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p-values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees
of freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing
your mean result by its own standard error. With many degrees of freedom
(large samples) the curve will be a little bit narrower, and more in agreement
with nature.
6 T-Table 33
A t-value of 2.81 with 9 degrees of freedom indicates, that we will need the 9th
row of the t-values. The upper row of the table gives the area under the curve of the
Gaussian-like t-distribution. The t-value 2.81 is left from 3.250, and right from
2.262. Now look right up at the upper row: we are right from 0.05. The p-value
is< 0.05.
7 Alternative Analysis: Wilcoxon Signed Rank Test
The t-tests as reviewed in the previous section are suitable for studies with
Gaussian-like data distributions. However, if there are outliers, then the t-tests
will not be adequately sensitive, and non-parametric tests will have to be applied.
We should add that non-parametric tests are also adequate for testing normally
distributed data. And, so, these tests are, actually, universal, and are, therefore,
absolutely recommended.
34 6 Paired Continuous Data (Paired T-Test, Wilcoxon Signed Rank Test)
Calculate the p-value using the Wilcoxon signed rank test.
Observations 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
Observations 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Individual differences:
0.9, 0.9, 4.3, 3.1, 1.2, 2.5, 2.5, 0.6, 3.6, 0.6
Rank numbers:
3.5, 3.5, 10, 7, 5, 8, 6, 2, 9, 1
A. not significant
B. 0.05< p< 0.10
C. p< 0.05
D. p< 0.01
Is there a significant difference between observations 1 and 2? Which signifi-
cance level is correct?
The individual differences are given a rank number dependent on their magnitude
of difference. If two differences are identical, and if they have for example the rank
numbers 3 and 4, then an average rank number is given to both of them, which means
3.5 and 3.5. Next, all positive and all negative rank numbers have to be added up
separately. We will find 4.5 and 50.5. According to the Wilcoxon table underneath,
with 10 numbers of pairs, the smaller one of the two add-up numbers must be smaller
than 8 in order to be able to speak of a p-value< 0.05. This is true in our example.
8 Wilcoxon Test Table
Wilcoxon Test Table











8 Wilcoxon Test Table 35
The first column gives the numbers of pairs in your paired data file. Rank
numbers of positive and negative differences are separately added up. The second
and third columns give the smaller one of the two add-up sums required for
statistical significance.
As demonstrated in the above table, also according to the non-parametric
Wilcoxon’s test the outcome one is significantly larger than the outcome two.
The p-value of difference here equals p< 0.05. We should add that
non-parametric tests take into account more than the t-test, namely, that Non-
gaussian-like data are accounted for. If you account more, then you will prove
less. That’s why the p-value may be somewhat larger.
9 Conclusion
The significant effects indicate that the null-hypothesis of no difference between the
two outcome can be rejected. The treatment 1 performs better than the treatment
2. It may be prudent to use the non-parametric tests, if normality is doubtful like in
the current small data example given. Paired t-tests and Wilcoxon signed rank tests
need, just like multivariate data, more than a single outcome variable. However,
they cannot assess the effect of predictors on the outcomes, because they do not
allow for predictor variables. They can only test the significance of difference
between the outcomes.
10 Note
The theories of null-hypotheses and frequency distributions and additional exam-
ples of paired t-tests and Wilcoxon signed rank tests are reviewed in Statistics
applied to clinical studies 5th edition, Chaps. 1 and 2, Springer Heidelberg Ger-
many, 2012, from the same authors.
36 6 Paired Continuous Data (Paired T-Test, Wilcoxon Signed Rank Test)
Chapter 7
Unpaired Continuous Data (Unpaired T-Test,
Mann-Whitney)
1 General Purpose
For the study of two outcomes often two parallel groups of similar age, gender and
other characteristics are applied, and the studies are called parallel-group studies,
and the two groups are called independent of one another. This study gives
examples of parallel-group analyses.
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3 Primary Scientific Question
Are unpaired t-tests or Mann-Whitney tests appropriate for testing, whether the
outcome of the first group is significantly different from that of the second group?
4 Data Example
The underneath study assesses in 20 patients whether some sleeping pill (parallel-
group 1) is more efficacious than a placebo (parallel-group 2). The hours of sleep is
the outcome value.
Outcome Outcome











Outcome¼ hours of sleep after treatment
5 Unpaired T-Test
Two age- and gender- matched parallel-groups are compared with one another. For
the calculation of SDs see the Chap. 1.
group 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
group 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Mean group 1 ¼ 6.93 SD ¼ 0.806 SE ¼ SD/√10 ¼ 0.255
Mean Group 2 ¼ 5.21 SD ¼ 1.299 SE ¼ SD/√10 ¼ 0.411
38 7 Unpaired Continuous Data (Unpaired T-Test, Mann-Whitney)
A. not significant
B. 0.05 < p < 0.10
C. p < 0.05
D. p < 0.01
Is there a significant difference between the two groups, which level of significance
is correct?
Mean standard deviation (SD)
6.93 0.806
5.21 - 1.299 pepe
1.72






The t-value¼ (6.93 5.21) / 0.483¼ 3.56.
20–2¼ 18 degrees of freedom, because we have 20 patients and 2 groups.
According to the t-table of page 16 the p-value is< 0.01, and we can conclude
that that a very significant difference exists between the two groups. The values of
group 1 are higher than those of group 2. The answer D is correct.
6 T-Table
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p - values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees
of freedom, are equal to z-values (Chap.36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with
nature.
6 T-Table 39
A t-value of 3.56 with 18 degrees of freedom indicates, that we will need the
18th row of t-values. The upper row of the table gives the area under the curve of
the Gaussian-like t-distribution. The t-value 3.56 is left from 4.297, right from
3.250. Now look right up at the upper row: we are right from 0.01. The p-value
equals <0.01. The hours of sleep during the sleeping pill are significantly better
than those during placebo.
40 7 Unpaired Continuous Data (Unpaired T-Test, Mann-Whitney)
7 Mann-Whitney test
Like the Wilcoxon test, being the non-parametric alternative for the paired t-test,
the Mann-Whitney test is the non-parametric alternative for the unpaired t-test.
Also this test is applicable for all kinds of data, and, therefore, particularly, to be
recommended for investigators with little affection to medical statistics.
Calculate the p-value of the difference between two groups of 10 patients with
the help of this test.
group 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6,
group 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
A. not significant
B. 0.05 < p < 0.10
C. p < 0.05
D. p < 0.01
Is there a significant difference between the two groups? What significance level
is correct?
All values are ranked together in ascending order of magnitude. The values from
group 1 are printed thin, those from group 2 are printed fat. Add a rank number to
each value. If there are identical values, for example, the rank numbers 9 and
10, then replace those rank numbers with average rank numbers, 9.5 and 9.5.
Subsequently, all fat printed rank numbers are added up, and so are the thin printed
rank numbers. We will find the values 142.5 for fat print, and 67.5 for thin print.
According to the underneath Mann-Whitney table. the difference should be
larger than 71 in order for the significance level of difference to be <0.05. We
find a difference of 75, which means that there is a p-value <0.05 and that the






















The Mann-Whitney test tables are given underneath. The values are the minimal
differences that are statistically significant with a p-value <0.01 (upper table), and
p< 0.05 (lower table). The upper row gives the size of Group 1, the left column the
size of Group 2.
8 Mann-Whitney Table P< 0.01
P< 0.01 levels
42 7 Unpaired Continuous Data (Unpaired T-Test, Mann-Whitney)
9 Mann-Whitney Table P< 0.05
P< 0.05 levels
10 Conclusion
For the study of two outcomes two parallel groups of similar age, gender and other
characteristics are often applied, and the studies are called parallel-group studies,
and the two groups are called independent of one another. Unpaired tests, like the
unpaired t-test and Mann-Whitney test are appropriate for analysis.
11 Note
The theories of null-hypotheses and frequency distributions and additional exam-
ples of unpaired t-tests and Mann-Whitney tests are reviewed in Statistics applied to
clinical studies 5th edition, Chaps. 1 and 2, entitled “Hypotheses data stratification”
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Similarly to unpaired t-tests and Mann-Whitney tests (Chap. 7), linear regression
can be used to test whether there is a significant difference between two unpaired
treatment modalities. To see how it works, picture the above linear regression of
cholesterol levels and diameters of coronary arteries. It shows that the higher the
cholesterol, the narrower the coronary arteries. Cholesterol levels are drawn on the
x-axis, coronary diameters on the y-axis, and the best fit regression line about the
data can be calculated. If coronary artery risk is measured on the y-axis instead of
coronary artery diameter, then a positive correlation will be observed (right graph).
Instead of a continuous variable on the x-axis, a binary variable can be adequately
used, such as two treatment modalities, e.g. a worse and better treatment. With
hours of sleep on the y-axis, a nice linear regression analysis can be performed: the
better the sleeping treatment, the larger the numbers of sleeping hours. The treat-
ment modality is called the x-variable. Other terms for the x-variable are indepen-
dent variable, exposure variable, and predictor variable. The hours of sleep is called
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the y-variable, otherwise called the dependent or outcome variable. This chapter is
to show how a linear simple linear analysis works.











3 Primary Scientific Question
Can linear regression be applied to demonstrate, whether, in an unpaired two group
study, one treatment is significantly more efficaceous than the other treatment.
4 Data Example
In a parallel-group study of 20 patients 10 are treated with a sleeping pill, 10 with a
placebo. The data file is given underneath.






















The group variable has 1 for sleeping pill group, 2 for the placebo.
The outcome variable is hours of sleep after treatment.
5 Analysis: Linear Regression
The equation of a linear regression model is given by
y ¼ a þ bx;
with y named the dependent variable and x the independent variable.
The line drawn from this linear function provides the best fit line for the data
given, where y¼ socalled dependent, and x¼ independent variable, b¼ regression
coefficient, a ¼ intercept:
a and b from the equation y ¼ a+bx can be calculated.
b ¼ regression coefficient ¼
X
x-xð Þ y-yð ÞX
x-xð Þ2
a ¼ intercept ¼ y-bx
r ¼ correlation coefficient ¼ another important determinant and looks a lot like b.
r ¼
X





r¼measure for the strength of association between the y and x-data. The stronger
the association, the better y predicts x, with +1 and -1 as respectively maximal and
minimal r-values.
If b and r are statistically significantly larger than 0, then x is a significant
predictor of y, and in the example given, this would mean, that there is a significant
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difference between the groups 1 and 2. One group performs better than the other,
and, so, one treatment is better than the other.
6 Electronic Calculator for Linear Regression
We will use Electronic Calculator (see Chap. 1) for computations. First, we will
calculate the b and r values.
Command:
click ON....click MODE....press 3....press 1....press SHIFT, MODE,
and again 1....press ¼....start entering the data. . .. [1, 6,0]. . ..[1,
7,1]. . ..[1, 8,1] etc.. . .
In order to obtain the b value, press: shift, S-VAR,►,►, 2, ¼ .
In order to obtain the r value, press: shift, S-VAR,►,►, 3, ¼ .
The b value equals 1.70, the r value equals -0.643.
We wish to assess whether these two values are significantly larger than 0.
The standard error of r ¼ (1 r2) / √ (n 2)
The r-value is a kind of summary-value of data, and follows a t-distribution, and
can, thus, be tested with a t-test.
t¼ | r / (its standard error) |
t¼ 0.643 5.539
t¼ 3.56
This value is much larger than 1.96, and, thus, r is significantly larger / smaller
than 0. The t-value of b can be demonstrated to be equally 3.56.
7 T-Table
In the above study we have 20 outcome values and 2 groups. According to the
underneath t-table, with 20-2 degrees of freedom (see 18th row of t-values), a
t-value of 3.56 will be close to 3.610. This means, that the treatment 1 is better than
the treatment 0 at a p-value close to 0.002. The t-table is briefly explained in the
legends underneath the t-table. It is more fully explained in the Chaps. 4, 5, 6 and 7.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve ¼ p - values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simulataneously. The t-table is, furthermore, full of t-values, that, with
1 degrees of freedom, are equal to z-values (Chap. 36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, but
in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom




We can conclude that the correlation and regression coefficients, r and b, are very
significant with p-values close to 0.002. This demonstrates that the sleeping scores
after active treatment are generally larger than after placebo treatment. The signif-
icant correlation between the treatment modality and the numbers of sleeping hours
can be interpreted as a significant difference in treatment efficacy of the two
treatment modalities. An interesting thing about linear regression is that the linear
regression equation can be used for estimating from future x-values the best fit
predictions of y-values. In our example we only have two x-values, but if you have
more of them, the size of your dependent variable can pretty well be predicted from
measured x-values, particularly, if your level of statistical significance is very high
(r values close to +1 or -1). R values > 95 % are, actually, applied for validating
quantitative diagnostic tests (see also Chap. 25).
9 Note
More examples of linear regression analyses are given in Statistics applied to
clinical studies 5th edition, Chaps. 14 and 15, Springer Heidelberg Germany,
2012, from the same authors.
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Chapter 9
Kendall-Tau Regression for Ordinal Data
1 General Purpose
Linear regressions (Chaps. 8 and 10) are adequate for outcomes with continuous
data, otherwise called scale data. Continuous data have a stepping pattern, where
the steps have equal intervals. If, in a regression model, the outcome data have a
stepping pattern, but the intervals are not equal, then the term ordinal data is more
appropriate for such data, and regression testing of ranks is more appropriate. The
data need to be tested according to the magnitude of their rank numbers. This
chapter is to assess how rank testing of regression models performs as compared to
traditional linear regression.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is rank testing of linear by linear data adequately sensitive for testing linear data
where the order of data may be more important than the magnitude itself. The latter
type of data is usually called ordinal data.
4 Data Example
In a short stay hospital the numbers hospitalization days were used to predict the
numbers of medical complications. It was assumed, that, the longer the stay, the
more risk of multiple complications.
Patient no. 1 2 3 4 5 6 7 8
Days in hospital 8 9 10 2 3 4 5 16
Numbers if complications 5 20 16 2 1 3 6 12
A traditional linear regression of the above data will produce a correlation
coefficient of 0.695 with a p-value of 0.056, which is not statistically significant.
From the above 8 patients the underneath rank numbers different in magnitude
can be obtained:
Rank numbers of days in hospital 5 6 7 1 2 3 4 8
Rank numbers of complications 4 8 7 2 1 3 5 6
Rank numbers of days in hospital in ascending order 1 2 3 4 5 6 7 8
Corresponding rank numbers of complications 2 1 3 5 4 8 7 6










1 2 3 4 5 6 7 8
The above graph (with days in hospital on the x-axis and numbers of complica-
tions on the y-axis), shows, that, although the numbers of complications tend to
increase with the numbers of hospital days their relationship is far from linear.
However, the data are not continuous, but ranks, and rank testing is the appropriate
analysis.
5 Rank Correlation Testing
We wish to know, whether the rank correlation between days in hospital and
numbers of complication is statistically significant.
1 2 3 4 5 6 7 8
2 1 3 5 4 8 7 6
In the above second row right from 2 we have 6 values larger than 2,
right from 1 we have also 6 values larger than 1,
right from 3 we have also 5 values larger than 3,
....
....
If we add-up all these values, we will end up with a value of 23.
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In the above second row right from 2 we have 1 value smaller than 2,
right from 1 we have also 0 values smaller than 1,
right from 3 we have also 0 values smaller than 3,
....
....
If we add-up all these values, we will end up with a value of 5.
The rank correlation coefficient Tau ¼ (23–5) / [½ n (n 1)]
¼ 0.64.
As Tau runs from 0 to 1 (or rather 1 to 1), a value of 0, 64 indicates a pretty
strong correlation coefficient. However, in order to test whether this correlation
coefficient is significantly different from 0, we need to test it against its standard
error, using a z-test (see also Chap. 37).
z ¼ (|Tau| 1) / √ [n (n 1) (2n + 5) / 18]
z ¼17 / 8.08
z ¼2.10
Z-values are equal to t-values with1 degrees of freedom, and can be found in
the bottom row of the t-table.
6 T-Table
Our above z-value, 2.10. is >1.960. According to the underneath t-table (bottom
row) a z-value>1.960, corresponding with a two-tail p-value of <0.05 (look right
up at the 2nd upper area under the curve row), indicates, that a significant correla-
tion between the x- and y-variable. The days in hospital is closer to numbers of
complications than could happen by chance at p-value slightly <0.05, and the
association between the two variables is, thus, statistically significant.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values (Chap. 36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms,
but in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom




The Kendall-Tau regression assesses just like the traditional linear regression the
level of linear relationships between two variables. However, Kendall-Tau provides
a slightly less sensitive result. The traditional linear model (as described in the
Chaps. 8 and 10) of the rank data produces an r-value of 0.857 and a p-value of
0.007. Why so? Unlike traditional linear regression, Kendall-Tau takes into account
that the intervals between the rank values may not be identical. Also, just like in the
non-parametric tests for comparing treatment groups and treatment modalities
(Chaps. 6, 7, and 34), if an analysis method takes into account more, it will usually
produce less spectacular _results. More in general, if you account more, you will
prove less.
8 Note
More background, theoretical and mathematical information of rank testing are
given in the Chaps 5, 6, and 7 of this work, and in the Chaps. 1, 2, 4, 9, 13, SPSS for
starters and 2nd levelers 2nd edition, Springer Heidelberg Germany, 2015, from the
same authors.
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Chapter 10
Paired Continuous Data, Analysis with Help
of Correlation Coefficients
1 General Purpose
The t-value obtained from an unpaired analysis of paired data produces biased
results. This is, because the level of correlation between unpaired data is assumed to
be zero, and this may not be true for paired observations. Particularly, repeated
measurements in one subject produces usually results more similar than those from
single measurements in separate subjects. Repeated measurements, thus, tends to
produce a positive correlation. However, this is not always true. Negative correla-
tions will be observed, if completely different treatment effects are examined in one
subject. This is, because the responders to one treatment are more at risk of being
non-responder to the other treatment and vice versa. Indeed, correlations is a very
basic phenomenon in statistical analyses, and it almost entirely determines the
results of regression analyses.
This chapter is to examine the performance of correlation coefficients (r-values
or R-values) for testing paired data, alternative to the traditional paired t-test and
Wilcoxon test. The advantage is, that correlation coefficients unmask, how the level
of correlation between repeated measures affect the overall uncertainty in crossover
study, and other repeated measures studies.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Can analysis with help of correlation coefficients be used to test in a crossover study
whether the first outcome significantly different from second one?
4 Data Example
In a crossover study 10 patients are treated with a sleeping pill and a placebo. The
first 11 patients of the 20 patient data file is given underneath.











Outcome¼ hours of sleep after treatment
5 Unpaired T-Test of Paired Data, the Wrong Analysis
outcome 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
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outcome 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Mean group 1¼ 6.93 SD¼ 0.806 SE¼ SD/√10¼ 0.255
Mean Group 2¼ 5.21 SD¼ 1.299 SE¼ SD/√10¼ 0.411
Is there a significant difference between the two groups, which level of signif-
icance is correct (SD¼ standard deviation, SE¼ standard error of the mean)?











The t-value¼ (6.93 5.21) / 0.483¼ 3.56.
6 Paired T-Test of Paired Data
Observations 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
Observations 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Individual differences:
0.9, -0.9, 4.3, 3.1, 1.2, 2.5, 2.5, 0.6, 3.8, -0.6
A. not significant
B. 0.05< p< 0.10
C. P< 0.05
D. P< 0.01
Is there a significant difference between the observations 1 and 2, and which
level of significance is correct?
Mean difference ¼ 1.59
SD of mean difference ¼ 1.789 (SD¼ standard deviation)
SE¼ SD/√10 ¼ 0.566 (SE¼ standard error)
t¼ 1,59 / 0,566 ¼ 2.81
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This t-value of 2.81 is a lot smaller than the one from the above unpaired t-test
(3.56). Obviously, the correlation between the first and second observations is
negative. We will first calculate the level of correlation, r, and then use the
underneath 2nd equation for adjustment of the overestimated t-value instead of
the first equation.
Standard error unpaired differences ¼ √ SD1
2þSD22ð Þ
n
Standard error paired differences ¼ √ SD1
2þSD22 2 r SD1:SD2ð Þ
n
7 Linear Regression for Adjustment of Erroneous T-Value
from Sect. 5
The equation of a linear regression model is given by
y ¼ a þ bx;
with y named the dependent variable and x the independent variable.
The line drawn from this linear function provides the best fit for the data given,
where y¼ so-called dependent, and x¼ independent variable, b¼ regression
coefficient, a¼ intercept:
a and b from the equation y¼ a + bx can be calculated.
b¼ regression coefficient ¼
X
x xð Þ y yð ÞX
x xð Þ2
a¼ intercept ¼ y bx
r¼ correlation coefficient¼ another important determinant and looks a lot like b.
r ¼
X





r¼measure for the strength of association between y and x-data. The stronger the
association, the better y predicts x, with +1 and 1 as maximal and minimal
r-values.
We will use the Electronic Calculator (see Chap. 1).
Command:
click ON....click MODE....press 3....press 1....press SHIFT, MODE,
and again 1....press¼....start entering the data. . .. [1, 6,0]. . ..[1,
7,1]. . ..[1, 8,1] etc.. . .
In order to obtain the b value, press: shift, S-VAR,►,►, 2, ¼ .
In order to obtain the r value, press: shift, S-VAR,►,►, 3, ¼ .
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The b value equals 1.70, the r value equals 0.643.
Standard error paired differences (* is symbol of multiplication)
¼ √ SD12þSD22 2 r SD1:SD2ð Þ
√ n
¼ √ 0:8062þ 1:2992þ 1, 286 * 0:806 * 1:299ð Þ
√10
¼ 0.607
Adjusted t-value ¼ 1.72 / 0.607
¼2.83
This adjusted t-value is approximately equal to the t-value obtained from the
paired t-test in above Sect. 6. The small difference is due to shortening of the final
digits during calculations.
8 T-Table
According to 9th row of the underneath t-table (10 subjects in one group means
9 degrees of freedom), with t¼ 2.83, the t-value is between 2.821 and 3.250. The
corresponding p-values can be observed in the second top row. It is between 0.02
and 0.01, and, thus, < 0.02.
The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p-values), one-tail mean-
ing that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees of
freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with nature.
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9 Conclusion
The t-value obtained from an unpaired analysis of paired data produces biased
results. This is, because the level of correlation between unpaired data is assumed to
be zero, and repeated measurements tend to produce a positive correlation. How-
ever, negative correlations may sometimes also be observed, if the responders to
one treatment are more at risk of being non-responder to a subsequent treatment and
vice versa. This chapter examines the use of correlation coefficients for testing
paired data, as an alternative to the traditional paired t-test and Wilcoxon test
(Chap. 5). The advantage of is that this method unmasks, how the level of corre-
lation between repeated measures affects the overall uncertainty in a study.
62 10 Paired Continuous Data, Analysis with Help of Correlation Coefficients
Correlations is a phenomenon of major importance in statistical analyses, and must
always taken into account.
10 Note
More examples of t-tests and linear regression analyses are given in Statistics
applied to clinical studies 5th edition, Chaps. 1, 2, 14 and 15, Springer Heidelberg





Power can be described as statistical conclusive force. It can be defined as the
chance of finding a difference where there is one. Other chances are the chance of
finding no difference where there is one (type II error) and the chance of finding a
difference where there is none (type I) error (Chap. 3). A study result is often
expressed in the form of the mean result and its standard deviation (SD) or standard
error (SE). With the mean result getting larger and the standard error getting
smaller, the study will obtain increasing power. This chapter is to show how to
compute from a study’s mean and standard error its statistical power.
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3 Primary Scientific Question
What is the power of a study with its mean study result and its standard error given.
4 Power Assessment
Important hypotheses are hypothesis 0 (H0, no difference from a 0 effect), and
hypothesis 1 (H1, real difference from a 0 effect). For the purpose of power
assessment, we will, particularly, emphasize hypothesis 1. The underneath figure
shows graphs of H0 and H1.





H1 is a graph based on a 2-group trial with a sample size of 20. Mean SEMs
are on the x-axis (commonly called z-axis here). H0 is the same graph with mean
0. H1 is also the summary of the means many trials similar to ours. H0 is also the
summary of the means many trials similar to ours, but with an overall mean effect
of 0. If the hypothesis 0 is true, then the mean of our study is part of H0, if the
hypothesis 1 is true, then the mean of our study is part of H1. So, the mean of our
study may be part of H0, or of H1. We can’t prove anything, but we can calculate
the chance of either of these possibilities.
A mean result of 2.9 is far distant from 0. Suppose, it belongs to H0. Only 5 % of
the H0 trials> 2.1 SEMs distant from 0. The chance, that it belongs to H0 is, thus,<
5 %. Reject this small possibility. Now, suppose the result belongs to H1.
Up to 30 % of the H1 trials are< 2.1 SEMs distant from 0. These 30 % cannot
reject null hypothesis of no effect. The trials right from 2.1 SEMs (corresponding
with 70 % of the area under the curve (AUC)) can do so.
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We can conclude from all of the above considerations: if H0 is true, we will
have< 5 % chance to find it; if H1 is true, we will have 70 % chance to find it. And
so, we will decide to reject the null hypothesis of no effect at p< 0.05, and to do so
with a power of 70 %.
5 Data Example
A blood pressure study shows a mean decrease in blood pressure of 10.8 mm Hg
with a standard error of 3.0 mm Hg. Results from study samples are often given in
grams, liters, Euros, mm Hg etc. For the calculation of power we have to first
standardize our study result, which means that the mean result has to be divided by
its own standard error (SE or SEM):
Mean SE ¼
mean /SE SE/SE ¼
t-value 1.
All of the t-values, as found in the t-table, can be looked at as the standardized
mean results of all kinds of studies. In our blood pressure study the t-value¼ 10.8 /
3.0¼ 3.6. The unit of the t-value is not mm Hg, but rather SE-units or SEM-units.
The question is: what power will the study have, if we assume a type I error
(alpha)¼ 5 % and a sample size of n¼ 20.
The question is: what will the power of this study be, if we assume a type I error
(alpha) of 5 %, and a sample size of n¼ 20.
A. 90 %< power< 95 %,
B. power> 80 %,
C. power< 75 %,
D. power> 75 %.
n¼ 20 indicates 20–2¼ 18 degrees of freedom in the case of 2 groups of
10 patients.
We will use the following power equation (prob¼ probability, z¼ value on the
z-line (the x-axis of the t-distribution)
Power ¼ 1 prob z < t t1 
t ¼ the t-value of your results,
t1 ¼ the t –value, that matches a p-value of 0.05¼ 2.1;
t ¼ 3.6; t1¼ 2.1; t-t1¼ 1.5;
prob (z< t t1) ¼ beta¼ type II error¼ between 0.05 and 0.1
1-beta¼ power ¼ between 0.9 and 0.95¼ between 90 and 95 %.
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So, there is a very good power here. Explanation of the above calculation is
given in the next few lines.
6 T-Table
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p-values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with 1 degrees
of freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with nature.
The current chapter shows how the t-table can also be applied for computing
statistical power.
With a t-value of 3.6 as shown in the previous section, and 18 degrees of
freedom, the term (t t1) equals 1.5. This value is between 1.330 and 1.734.
Look right up at the upper top row for finding beta (type II error¼ the chance of
finding no difference where there is one). We have two top rows here, one for
one-tail testing one for two-tail testing. Power is always tested one-tail. We are
between 0.1 and 0.05 (10 and 5 %). This is an adequate estimate of the type II error.
The power, thus, equals (100 % beta)¼ between 90 and 95 % in our example.
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7 Conclusion
Power can be defined as the chance of finding an effect (or a difference from zero),
where there is one. It is equal to 1 minus the type II error (¼1 β). A study result is
often expressed in the form of the mean result and its standard deviation (SD) or
standard error (SE or SEM). With the mean result getting larger and the standard
error getting smaller, the study will obtain increasing power. This chapter shows,
how to compute a study’s statistical power from its mean and standard error.
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8 Note
More background, theoretical and mathematical information of power assessments
is given in Statistics applied to clinical studies 5th edition, Chap. 6, Springer
Heidelberg Germany, 2012, from the same authors.




When writing a study protocol, just pulling the sample size out of a hat gives rise to
(1) ethical, (2) scientific, and (3) financial problems, because
1. too many patients may be given a potentially inferior treatment,
2. negative studies require repetition of the research,
3. costs are involved in too large or too small studies.
An essential part of preparing clinical studies is the question, how many subjects
need to be studied in order to answer the studies’ objectives. This chapter provides
equations that can be used for the purpose.
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3 Primary Scientific Question
What sample size do we need in order to produce a study with a statistically
significant result?
4 Data Example, Continuous Data, Power 50 %
An essential part of clinical studies is the question, how many subject need to be
studied in order to answer the studies’ objectives. As an example, we will use an
intended study that has an expected mean effect of 5, and a standard deviation
(SD) of 15.
What required sample size do we need in order to obtain a significant result, or,





A suitable equation to assess this question can be constructed as follows. With a
study’s t-value of 2.0 SEM-units (SEM¼ standard error of the mean), a significant
p-value of 0.05 will be obtained. This should not be difficult for you to understand,
when you think of the 95 % confidence interval of the mean of a study being
between – 2 and + 2 SEM-units (Chap. 13).
We assume
t-value ¼ 2 SEMs
¼ (mean study result) / (standard error)
¼ (mean study result) / (standard deviation /√n)
(n¼ study’s sample size)
From the above equation it can be derived that
√n ¼ 2  standard deviation (SD) / (mean study result)
n ¼ required sample size
¼ 4  (SD/(mean study result))2
¼ 4  (15 / 5) 2¼ 36
Answer B is correct.
You are testing here whether a result of 5 is significantly different from a result
of 0. Often two groups of data are compared and the standard deviations of the two
groups have to be pooled (see Chap. 7). As stated above, with a t-value of 2.0 SEMs
a significant result of p¼ 0.05 will be obtained. However, the power of this study is
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only 50 %, indicating, that you will have a power of only 50 % (¼ the chance of an
insignificant result the next time you perform a similar study).
5 Data Example, Continuous Data, Power 80 %
What is the required sample size of a study with an expected mean result of 5, and
SD of 15, and, that should have a p-value of at least 0.05 and a power of at least





An adequate equation is the following.
Required sample size ¼ power index  (SD/mean)2
¼ 7.8  (15 / 5) 2¼ 70
If you wish to have a power in your study of 80 % instead of 50 %, you will need
a larger sample size. With a power of only 50 % your required sample size was only
36.
6 Data Example, Continuous Data, Power 80 %,
Two Groups
What is the required sample size of a study with two groups and a mean difference
of 5 and SDs of 15 per Group, and that will have a p-value of at least 0.05 and a





The suitable equation is given underneath.
Required sample size ¼ power index  (pooled SD)2 / (mean difference)2.
(pooled SD)2 ¼ SD12 + SD22.
Required sample size ¼ 7.8  (152+ 152) / 52¼ 140.
The required sample size is 140 patients per group. And so, with two groups you
will need considerably larger samples than you will with 1 group.
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7 Conclusion
When writing a study protocol, just pulling the sample size out of a hat gives rise to
(1) ethical, (2) scientific, and (3) financial problems. An essential part of preparing
clinical studies is the question, how many subject need to be studied in order to
answer the studies’ objectives. Equations are provided, that can be used for the
purpose.
8 Note
More background, theoretical and mathematical information of sample size require-
ments is given in Statistics applied to clinical studies 5th edition, Chap. 6, Springer
Heidelberg Germany, 2012, from the same authors.




The 95% confidence interval of a study represents an interval covering 95% of the
means of many studies similar to that of our study. It tells you something about what
you can expect from future data: if you repeat the study, you will be 95% sure that
your mean outcome will be within the 95% confidence interval. The chapter shows
how it can be calculated.
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3 Primary Scientific Question
Can the 95% confidence intervals be used as an alternative to statistical significance
testing? What are the advantages?
4 Data Example, Continuous Outcome Data
The 95% confidence interval of a study represents an interval covering 95% of the
means of many studies similar to that of our study. It tells you something about what
you can expect from future data: if you repeat the study, you will be 95% sure that
the outcome will be within the 95% confidence interval. The 95% confidence of a
study is found by the equation
95% confidence interval ¼ mean 2 x standard error (SE)
The SE is equal to the standard deviation (SD) / √n, where n¼ the sample size of
your study. The SD can be calculated from the procedure reviewed in the Chap. 2.
With an SD of 1.407885953 and a sample size of n¼ 8,
your SE ¼ 1.407885953 / √ 8
¼ 0.4977,
with a mean value of your study of 53.375,
with a 95% confidence interval ¼ 53.375 2 0.4977
¼ between 52.3796 and 54.3704.
The mean study results are often reported together with 95% confidence inter-
vals. They are also the basis for equivalence studies and noninferiority studies,
which will be reviewed in the Chaps. 14 and 15. Also for study results expressed in
the form of numbers of events, proportion of deaths, odds ratios of events, etc.,
95 % confidence intervals can be readily calculated.
We should add that the equation
95% confidence interval ¼ mean 2 standard error (SE),
is a pretty rough approximation, and that a more precise estimate would be the
equation
95% confidence interval ¼ mean t1 standard error (SE),
where t1¼ the critical t-value corresponding to a two-sided p-value of 0.05.
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5 T-Table and 95% Confidence Intervals
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p-values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with 1 degrees
of freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with nature.
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In the fifth column of t-values of the above t-table all of the t1-values are given.
For example, with a sample of 120 the t1-value equals 1.980, with a sample size of
close to 8 the t1-value rise to 2.306.
6 Data Example, Binary Outcome Data
What is the standard error (SE) of a study with events in 10% of the patients, and a
sample size of 100 (n). Ten % events means a proportion of events of 0.1. The
standard deviation (SD) of this proportion is defined by the equation
√ [proportion (1 proportion)] ¼ √ (0.1 0.9)¼ √ 0.09¼ 0.3,
the standard error ¼ standard deviation/√n,
¼ 0.3/10¼ 0.03,
the 95 % confidence interval is given by
proportion given 1.960 0.03 ¼ 0.1 1.960 0.03,
¼ 0.1 0.06,
¼ between 0.04 and 0.16.
7 Conclusion
The 95% confidence interval of a study represents an interval covering 95% of the
means of many studies similar to that of our study. It tells you something about what
you can expect from future data: if you repeat the study, you will be 95% sure that
your mean outcome will be within the 95% confidence interval. The 95% confi-
dence interval can be used as an alternative to statistical significance testing. The
advantages are that the intervals picture expected mean results of future data, and
that they can be applied for studying therapeutic equivalence and noninferiority
(Chaps. 14 and 15).
8 Note
More background, theoretical and mathematical information of confidence inter-
vals are given in the Chaps. 14 and 15 of this volume.
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Chapter 14
Equivalence Testing Instead of Null-
Hypothesis Testing
1 General Purpose
A negative study is not equal to an equivalent study. The former can not reject the
null-hypothesis of no effect, while the latter assesses whether its 95 % confidence
interval is between prior boundaries, defining an area of undisputed clinical rele-
vance. Equivalence testing is important, if you expect a new treatment to be equally
efficaceous as the standard treatment. This new treatment may still be better suitable
for practice, if it has fewer adverse effects or other ancillary advantages. For the
purpose of equivalence testing we need to set boundaries of equivalence prior to the
study. After the study we check whether the 95 % confidence interval of the study is
1. entirely within the boundaries (equivalence is demonstrated),
2. partly within (equivalence is unsure),
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The above figure gives between brackets both the 95 % confidence intervals of
8 studies, and the defined boundaries of equivalence (D and +D boundary):
The studies 1–8:
1 and 7 are completely without the boundaries (no equivalence),
2, 6 and 8 are partly without the boundaries (equivalence is unsure),
3–5 are entirely within the boundaries (equivalence is demonstrated).
Particularly, the studies 3 and 5 are remarkable, because they show simulta-
neously the presence of clinical equivalence and of a statistically significant
difference from a zero effect.











3 Primary Scientific Question
How can 95 % confidence intervals be adequately used to assess studies for
therapeutic equivalence.
4 Data Example
As a data example, in a blood pressure study a difference between the new and
standard treatment between 25 and +25 mm Hg is assumed to be smaller than
clinically relevant. The boundary of equivalence is, thus, set between 25 and
+25 mm Hg. This boundary should be a priori defined in the study protocol.
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Then, the study is carried out, and the new and the standard treatment produce a
mean reduction in blood pressure of 9.9 and 8.4 mm Hg (parallel-group study of
20 patients) with standard errors of 7.0 and 6.9 mm Hg.
The mean difference ¼ 9.9 minus 8.4 mm Hg
¼1.5 mm Hg
The standard errors of the mean differences are 7.0 and 6.9 mm Hg
The pooled standard error ¼ √ (7.02 + 6.92) mm Hg
¼ √ 96.61 mm Hg
¼ 9.83 mm Hg
The 95 % confidence interval of this study ¼ 1.5 2.0  9.83 mm Hg
¼ between 18.16 and +21.16 mm
Hg
This result is entirely within the a priori defined boundary of equivalence, which
means that equivalence is demonstrated in this study.
5 Conclusion
A negative study is not equal to an equivalent study. The former assesses the null-
hypothesis of no effect, while the latter assesses, whether its 95 % confidence
interval is between a priori defined boundaries, defining an area of undisputed
clinical relevance. Equivalence testing is important, if you expect a new treatment
to be equally efficaceous as the standard treatment. This new treatment may still be
better suitable for practice, if it has fewer adverse effects or other ancillary
advantages. For the purpose of equivalence testing we need to set boundaries of
equivalence prior to the study. The boundaries of equivalence must be in the
protocol, and equivalence after the study has been completed is impossible. In an
equivalence study, after the study has been completed, you should check, whether
the 95 % confidence interval of the study is entirely within the a priori defined
boundaries of equivalence. The boundaries have been defined on clinical, not
statistical grounds.
In the current chapter, a study with continuous outcome data is used as an
example. When studying binary outcome data, the result is often expressed as the
proportion responders, e.g., 0.4 or 40 % responders. The calculation of the standard
error with binary outcomes is explained in the Chap. 37. Briefly, with a proportion
of 0.4 responders and a study sample size of 100, the standard error equals
SE ¼ √[(0.4x0.6)/100]¼ 0.049
The confidence interval of this study ¼ 0.4 1.960  0.049
¼ between 0.304 and 0.496
5 Conclusion 81
If the prior boundaries of equivalence were defined as being a proportion of
responders between 0.25 and 0.50, then this study demonstrates the presence of
equivalence.
6 Note
More background, theoretical and mathematical information of equivalence testing
is given in Statistics applied to clinical studies 5th edition, Chap. 5, Springer
Heidelberg Germany, from the same authors.





Just like equivalence studies (Chap. 14), noninferiority studies are very popular in
modern clinical research, with many treatments at hand, and with new compounds
being mostly only slightly different from the old ones. Unlike equivalence studies,
noninferiority studies have, instead of two boundaries with an interval of equiva-
lence in between, a single boundary. Noninferiority studies have been criticized for
their wide margin of inferiority, making it, virtually, impossible to reject
noninferiority.
The underneath graph shows the possible results in the form of confidence
intervals of three noninferiority trials that have the same boundary or margin of
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3 Primary Scientific Question
Is a novel treatment, if not significantly better than a standard treatment, significantly
noninferior as compared to the standard treatment.
4 Data Example
As an example, two parallel-groups of patients with rheumatoid arthritis are treated
with either a standard or a new nonsteroidal anti-inflammatory drug (NSAID). The
reduction of gamma globuline levels (g/l) after treatment is used as the primary
estimate of treatment success. The underneath three steps constitute an adequate
procedure for noninferiority analysis.
5 Step 1
(1) the Margin of Noninferiority,
(2) the Required Sample Size,
(3) the Expected P-Value and Power
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(1)
The left boundaries of the 95 % confidence intervals of previously published
studies of the standard NSAID versus various alternative NSAIDS were never
lower than –8 g/l. And, so, the margin was set at 8 g/l.
(2)
Based on a pilot-study with the novel compound the expected mean difference
was 0 g/l with an expected standard deviation of 32 g/l. This would mean a
required sample size of
n¼ power index  (SD/(marginmean))2
n¼ 7.8  (32/(80))2¼ 125 patients per group.
A power index of 7.8 takes care that noninferiority is demonstrated with a power
of about 80% in this study (see also Chap. 11).
(3)
The mean difference between the new and standard NSAID was calculated to be
3.0 g/l with a standard error (SE) of 4.6 g/l. This means that the t-value of the
study equaled t¼ (marginmean)/SE¼ (8 3)/4.6¼2.39 SE-units or
SEM-units.
This t-value corresponds with a p-value of <0.05 (see Chap. 4). Non-inferiority
is, thus, demonstrated at p< 0.05.
6 Step 2
Testing the Significance of Difference Between the New and the Standard
Treatment
The mean difference between the new and standard treatment equaled 3.0 g/l
with an SE of 4.6 g/l. The 95% confidence of this result is 3.0 2*4.6, and is
between -6.2 and 12.2 g/l (*¼ sign of multiplication). This interval does cross the
zero value on the z-axis, which means no significant difference from zero
(p> 0.05).
7 Step 3
Testing the Significance of Difference Between the New Treatment And a Placebo
A similarly sized published trial of the standard treatment versus placebo
produced a t-value of 2.83, and, thus a p-value of 0.0047. The t-value of the current
trial equals 3.0/4.6¼ 0.65 SE-units. The add-up sum 2.83 + 0.65¼ 3.48 is an
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adequate estimate of the t-value for the comparison of the new treatment versus
placebo. A t-value of 3.48 corresponds with a p-value of< 0.001 (see Chap. 4). This
would mean that the new treatment is significantly better than placebo at p< 0.001.
8 Conclusion
We can now conclude that
(1) noninferiority is demonstrated at p< 0.05,
(2) a significant difference between the new and standard treatment is rejected at
p> 0.05,
(3) the new treatment is significantly better than placebo at p< 0.001.
Non-inferiority has, thus, been unequivocally demonstrated in this study.
Also studies with binary outcomes have 95% confidence intervals (as shown
in the Chap. 13), and can, thus, be tested for noninferiority.
9 Note
More background, theoretical and mathematical information of noninferiority
testing is given in Statistics applied to clinical studies 5th edition, Chap. 63,
Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 16
Superiority Testing Instead of Null-
Hypothesis Testing
1 General Purpose
For this chapter some knowledge of power equations is required. This is given in the
Chaps. 11 and 50. Superiority testing of a study means testing whether the study
meets its a priori defined expected power. Many therapeutic studies may be able to
reject their null-hypotheses, and, are, thus, statistically significant, but they do not
meet their expected power. Although p-values are widely reported, power is rarely
given in the report. This may be a problem in practice, since lack of power indicates
that the treatments are less efficaceous than expected. Superiority testing assesses
whether the eventual power of a study is in agreement with the power as stated in
the protocol of the study. This chapter shows how superiority can be assessed.
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3 Primary Scientific Question
Is the expected power level as assessed prior to a study in agreement with the power
level obtained.
4 Data Example
The expected power of a study of a 10 patient crossover study is 90 %. The results
of the study are given underneath:
observation 1:
6.0, 7.1, 8.1, 7.5, 6.4, 7.9, 6.8, 6.6, 7.3, 5.6
observation 2:
5.1, 8.0, 3.8, 4.4, 5.2, 5.4, 4.3, 6.0, 3.7, 6.2
Individual differences
0.9, -0.9, 4.3, 3.1, 1.2, 2.5, 2.5, 0.6, 3.8, -0.6
Is there a significant difference between the observation 1 and 2, and which level
of significance is correct?
Mean difference ¼ 1.59
SD of mean difference ¼ 1.789
SE¼ SD/√10 ¼ 0.566
t¼ 1.59/0.566 ¼ 2.809
10 – 1¼ 9 degrees of freedom (10 patients and 1 group of patients).
Look at the underneath t-table to find the p-value, and assess the presence of
superiority.
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5 T-Table
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p – values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with 1 degrees
of freedom, are equal to z-values (Chap. 36). The t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, but in so-called
SEM-units (Standard error of the mean units), that are obtained by dividing your
mean result by its own standard error. With many degrees of freedom (large
samples) the curve will be a little bit narrower, and more in agreement with nature.
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The ninth row of t-values shows that our t-value is between 2.262 and 2.821.
This would mean a p-value between 0.05 and 0.02. There is, thus, a significant
difference between observation 1 and 2. However, is the expected power obtained
or is this study underpowered. The t-table is helpful to calculate the t-value required
for a power of 90 %: it mean a beta-value (type II error value) of 10 % (¼ 0.1). Look
at the upper row of the t-table.
If
beta ¼ 0.1, then
zbeta for 9 degrees of freedom
¼ 1.383.
The t-value required for a power of 90 %
¼ 1.383 + t1, where t1 is the 0.05
¼ 1.383 + 2.262
¼ 3.645.
The required t-value is much larger than the obtained t-value of 2.809, and, so,
the study does not meet its expected power. The treatment is less efficaceous than
expected.
If the investigators had required a power of 60 %, then the superiority testing
would be as follows.
beta ¼ 0.40
z ¼ 0.261
The t-value required for a power of 60 %
¼ 0.261 + t1, where t1 is the 0.05
¼ 0.261 + 2.262
¼ 2.523.
This t-value is smaller than the obtained t-value of 2.809, and, so, the study
would have met an expected power of 60 %.
6 Conclusion
Superiority testing of a study means testing whether the study meets its a priori
defined expected power. Many therapeutic studies may be able to reject their null-
hypotheses, and, are, thus, statistically significant, but they do not meet their
expected power. Superiority testing assesses whether the eventual power of a
study is in agreement with the power as stated in the sample size calculation of
the study. This chapter shows that with the help of the t-table the presence of
superiority can be readily assessed.
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We should note that the terms z-value and t-values are often used interchange-
ably, but strictly the z-value is the test statistic of the z-test, and the t-value is the
test statistic of the t-test. The bottom row of the t-able is equal to the z-table.
7 Note
More background, theoretical and mathematical information, and alternative
approaches to superiority testing is given in Statistics applied to clinical studies





Missing data in clinical research data is often a real problem. As an example, a
35 patient data file of 3 variables consists of 3  35¼ 105 values if the data are
complete. With only 5 values missing (1 value missing per patient) 5 patients will
not have complete data, and are rather useless for the analysis. This is not 5 % but
15 % of this small study population of 35 patients. An analysis of the remaining
85 % patients is likely not to be powerful to demonstrate the effects we wished to
assess. This illustrates the necessity of data imputation.
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3 Primary Scientific Question
Is mean and hot deck imputation capable of improving sensitivity of testing data
files by increasing their fit to some analytical model.
4 Data Example
Four methods of data imputation are available; (1) mean imputation, (2) hot deck
imputation, (3) regression imputation, (4) multiple imputations. In the current
chapter the methods (1) and (2) will be given. The methods (3) and (4) are described
in Statistics applied to clinical studies 5th edition, Chap. 22, Springer Heidelberg
Germany, 2012, from the same authors as the current work. A condition for any
type of data imputation is that the missing data are not clustered but randomly
distributed in the data file. A data example a 35 patient study crossover study of the
effects of age and traditional laxative efficacy (numbers of stools per month) on the
performance of a novel laxative is in the underneath table.
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Five values of the above table are missing. The underneath table gives the results
of mean imputation of these data. The missing values are imputed by the mean
values of the different variables.
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The underneath table gives the results of the second method, hot deck imputa-
tion. The missing data are imputed by those of the closest neighbour observed: the
missing value is imputed with the value of an individual whose non-missing data
are closest to those of the patient with the missing value.
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Imputed data are of course not real data, but constructed values that should increase
the sensitivity of testing. Regression imputation is more sensitive than mean and hot
deck imputation, but it often overstates sensitivity. Probably, the best method for
data imputation is multiple imputations (4), because this method works as a device
for representing missing data uncertainty. However, a pocket calculator is unable to
perform the analysis, and a statistical software package like SPSS statistical soft-
ware is required.
6 Note
More background, theoretical and mathematical information of missing data and
data imputations is given in Statistics applied to clinical studies 5th edition,





The unpaired t-test can be used to test the hypothesis that the means of two parallel-
group are not different (Chap. 7). When the experimental design involves multiple
groups, and, thus, multiple tests, it will increase the chance of finding differences.
This is, simply, due to the play of chance, rather than a real effect. Multiple testing
without any adjustment for this increased chance is called data dredging, and is the
source of multiple type I errors (chances of finding a difference where there is
none). The Bonferroni adjusted t-test (and many other methods) are appropriate for
adjusting the increased risk of type I errors. This chapter will assess how it works.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
In a parallel-group study of three or more treatments, does Bonferroni t-test
adequately adjust the increased risk of type I errors?
4 Bonferroni T-Test, Data Example
The underneath example studies three groups of patients treated with different
hemoglobin improving compounds. The mean increases of hemoglobin are given.
Sample size Mean hemoglobin Standard deviation
mmol/l mmol/l
Group1 16 8.725 0.8445
Group 2 10 10.6300 1.2841
Group 3 15 12.3000 0.9419
An overall analysis of variance test produced a p-value of< 0.01. The conclu-
sion is that we have a significant difference in the data, but we will need additional
testing to find out, exactly where the difference is:
between group 1 and 2,
between group 1 and 3, or
between group 2 and 3.
The easiest way is to perform a t-test for each comparison. It produces a highly
significant difference at p< 0.01 between group 1 versus 3 with no significant
differences between the other comparisons. This highly significant result is, how-
ever, unadjusted for multiple comparisons. If one analyzes a set of data with three
t-tests, each using a 5 % critical value for concluding that there is a significant
difference, then there is about 3 5¼ 15 % chance of finding a significant differ-
ence at least once. This mechanism is called the Bonferroni inequality. Bonferroni
recommended a solution for the inequality, and proposed to follow in case of three
t-tests to use a smaller critical level for concluding that there is a significant
difference:
With 1t-test: critical level¼ 5 %
With 2t-tests: critical level¼ (5 %) /2¼ 2,5 %
With 3t-tests: critical level¼ (5 %) /3¼ 1.67 %.
a more general version of the equation is given underneath:
In case of k comparisons and an overall critical level (¼ null-hypothesis rejec-
tion level) of α the rejection p-value will become
α  2= k k 1ð Þð Þ
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E.g. with k¼ 3, and α¼ 0.05 (5 %)
0:05  2
3 3 1ð Þ ¼ 0:0166:
In the given example a p-value of 0.0166 is still larger than 0.01, and, so, the
difference observed remained statistically significant, but using a cut-off p-value of
0.0166, instead of 0.05, means that the difference is not highly significant anymore.
5 Bonferroni T-Test Over-conservative
With k-values not too large, this method performs well. However, if k is large
(k> 5), then this Bonferroni correction will rapidly lead to very small rejection
p-values, and is, therefore, called over-conservative. E.g., with 10 comparisons the
rejection p-value will be only 0.05 2/(10 9)¼ 0.001, which is a value hard to be
obtained in a small study. Actually, a more realistic rejection p-value may be larger,
because in most multiple test studies a positive correlation between multiple
treatment comparisons exists. It means that multiple tests in one study are much
more at risk of similar results than multiple tests in different studies (see also
Chap. 10). The chance of twice a p-value of 0.05 may, therefore, not be 0.025,
but, rather, something in between, like 0.035.
6 Conclusion
Bonferroni adjustment is adequate for adjusting the increased type I error of
multiple testing, and can easily be performed with the help of a pocket calculator.
Alternative methods include Tukey’s honestly significant difference (HSD)
method, Student-Newman-Keuls method, the method of Dunnett, and many
more. They are, however, computationally more laborious, and require specific
statistical tables. Statistical software programs like SPSS or SAS are helpful.
Bonferroni adjustments increase the risk of type II errors (β-values) of not
finding a difference which does exist. This is illustrated in the underneath figure:
with α¼ 0.05 (left vertical interrupted line), β is about 30 % of the area under the
curve. With α¼ 0.167 (adjusted for three tests as demonstrated in the above Sect. 4)
(right vertical interrupted line), β has risen to about 50 %. This rise caused loss of
power from about 70 % to about only 50 % ((1β)-values), (see also Chap. 11 for
additional explanation of power assessments). H0¼ null-hypothesis,
H1¼ alternative hypothesis, SEM¼ standard error of the mean.
6 Conclusion 101









In the current chapter only continuous outcome data are adjusted for multiple
testing. However, binary data can equally be assessed using the Bonferroni
equation.
7 Note
More background, theoretical and mathematical information of multiple compari-
sons and false positive studies are given in Statistics applied to clinical studies 5th
edition, Chaps. 8 and 9, Springer Heidelberg Germany, from the same authors.
102 18 Bonferroni Adjustments
Chapter 19
Unpaired Analysis of Variance
1 General Purpose
Unpaired t-tests are for assessing two parallel groups of similar age, gender and
other characteristics treated differently. However, if you wish to compare three
different treatments, three parallel groups are required, and unpaired t-tests can no
longer be applied. Instead, unpaired analysis of variance (ANOVA), otherwise
called one-way ANOVA must be used for analysis.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How can one-way ANOVA evaluate the difference between three treatments.
4 Variations Expressed as the Sums of Squares
With unpaired ANOVA of 3 treatment groups variations between the data are split:
Total variation
| |
Between group variation within group variation
Variations is expressed as the sums of squares (SS) and can be added up to obtain
total variation. We wish to assess whether the between-group variation is large
compared to the within-group variation. This approach may be hard to understand,
but the underneath simple example shows the essentials of it (n¼ number of
patients, SD¼ standard deviation).
Group n patients mean SD
1 n – –
2 n – –
3 n – –
Grand mean¼ (mean 1 + 2 + 3) / 3
SS beween-groups¼ n (mean1  grand mean)2 + n (mean2  grand mean)2 + . . ..
SS within-groups¼ (n1)(SD1 2) + (n1) (SD22) + . . ...
The F-test (Fisher-test) is used for testing (dfs¼ degrees of freedom):
F ¼ SS between-groups=dfs
SS within-groups=dfs
¼ SS between-groups= 3 1ð Þ
SS within-groups = 3n 3ð Þ:
The F-table gives the p-value.
We should note, that, with differently sized groups, weighted grand means are
required: weighted mean¼ (n1 mean1 + n2 mean2) / (n1 + n2).
5 Real Data Example
Effect of 3 compounds on Hb
Group n patients mean SD
1 16 8.7125 0.8445
2 16 10.6300 1.2841
3 16 12.3000 0.9419
Grand mean¼ (mean 1 + 2 + 3) / 3¼ 10.4926
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SS between-groups ¼ 16 8:7125 10:4926ð Þ2 þ 16 10:6300 10:4926ð Þ2 . . . :
SS within-groups ¼ 15 0:84452þ 15 1:28412þ . . . . . . ::
F ¼ 49:9
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This value is much larger than the critical F-value producing a p< 0.05, because,
with 2 (numerator) and 45 (denominator) degrees of freedom the critical F-value
should be between 3.32 and 3.97. The difference between the three treatment is,
thus, very significant. A table of critical F-values is given on the next page. The
internet provides, however, many critical F-value calculators, that are more precise.
We should add that, in case 2 groups, the F-value produced by ANOVA equals the
t-test squared (F¼ t2). T-statistics is, indeed, a simple form of analysis of variance.
6 Conclusion
The above examples show how one-way ANOVA can be used to test the signifi-
cance of difference between three treatments. However, it does not tell us whether
treatment 1 is better than 2, 2 better than 3, or 1 better than 3, or any combinations
of these effects. For that purpose post hoc tests are required comparing the treat-
ments one by one. Unpaired t-tests should be appropriate for the purpose.
7 Note
More background, theoretical and mathematical information of unpaired and paired
ANOVA is given Statistics applied to clinical studies 5th edition, Chap. 2, Springer
Heidelberg Germany, 2012, from the same authors.
106 19 Unpaired Analysis of Variance
Chapter 20
Paired Analysis of Variance
1 General Purpose
Paired t-tests are for assessing the effect of two treatments in a single group of
patients. However, if you wish to compare three treatments, the paired t-tests can no
longer be applied. Instead, paired analysis of variance (ANOVA), otherwise called
repeated-measures ANOVA must be used for analysis.
2 Schematic Overview of Type of Data File
Patient no
Outcome Outcome Outcome
Treatment 1 Treatment 2 Treatment 3
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
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3 Primary Scientific Question
How can repeated-measures ANOVA evaluate the different effect of three different
treatments.
4 Variations Expressed as the Sums of Squares
With paired ANOVA of three treatments every single patient is treated three times.
The data are split:
Total variation
| |
Between-subject variation Within-subject variation
| |
Between-treatment variation Residual variation (random)
Variations is expressed as the sums of squares (SS), and can be added up to obtain
the total variation in the data. We will assess, whether the between-treatment variation
is large compared to the residual variation. Repeated-measure ANOVA is sometimes
called two-way ANOVA (balanced, without replications), (SD¼ standard deviation).
Subject Treatment 1 Treatment 2 Treatment 3 SD2
1 – – – –
2 – – – –
3 – – – –
4 – – – –
Treatment mean – – –
Grand mean¼ (treatment mean 1 + 2 + 3) / 3¼ . . ...
SS within-subject¼ SD12 + SD22 + SD32
SS treatment¼ (treatment mean 1grand mean)2 + (treatment mean 2grand
mean)2 + . . ...
SS residual¼ SS within-subject  SS treatment
The F-test (Fisher-test) is used for testing (dfs¼ degrees of freedom):
F ¼ SS treatment =dfs
SS residual = dfs
¼ SS treatment = 3 1ð Þ
SS residual = 3 1ð Þ 4 1ð Þ
The F-table gives the P-value.
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5 Real Data Example
The effect of 3 treatments on vascular resistance is assessed in four persons.
Person Treatment 1 Treatment 2 Treatment 3 SD2
1 22.2 5.4 10.6 147.95
2 17.0 6.3 6.2 77.05
3 14.1 8.5 9.3 18.35
4 17.0 10.7 12.3 21.45
Treatment mean 17.58 7.73 9.60
Grand mean¼ 11.63
SS within-subject¼ 147.95 + 77.05 + ..
SS treatment¼ (17.58 11.63)2 + (7.73 11.63)2 + ..
SS residual¼ SS within-subject SS treatment.
F¼ 14.31.
This value is much larger than the critical F-value producing a p< 0.05, because
with 2 (numerator) degrees of freedom and 2 3¼ 6 (denominator) degrees of
freedom the critical F-value should be around 7.26. The difference between the
effects of the three treatments is, thus, very significant. The table of critical F-values
is given on the next page. The internet provides, however, many critical F-value
calculators, that are more precise than the table given.
We should add that, in case of 2 treatments the F-value produced by the ANOVA
equals the t-value squared (F¼ t2). T-statistics is, indeed, a simple form of analysis
of variance.
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6 Conclusion
The above examples show how repeated-measures ANOVA can be used to test the
significance of difference between three treatments in a single group of patients.
However, it does not tell us whether treatment 1 is better than 2, treatment 2 better
than 3, or treatment 1 better than 3, or any combinations of these effects. For that
purpose post hoc tests are required, comparing the treatments one by one. Paired
t-tests should be appropriate for the purpose.
7 Note
More background, theoretical and mathematical information of unpaired and paired
ANOVA is given Statistics applied to clinical studies 5th edition, Chap. 2, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 21
Variability Analysis for One or Two Samples
1 General Purpose
In some clinical studies, the spread of the data may be more relevant than the
average of the data. E.g., when we assess how a drug reaches various organs,
variability of drug concentrations is important, as in some cases too little and in
other cases dangerously high levels get through. Also, variabilities in drug response
may be important. For example, the spread of glucose levels of a slow-release-
insulin is important. This chapter assesses how to estimate the spread of one and
two data-samples.
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3 Primary Scientific Question
Is the spread in a data set larger than required, is the difference in variabilities
between two data samples statistically significant.
4 One Sample Variability Analysis
For testing whether the standard deviation (or variance) of a sample is significantly
different from the standard deviation (or variance) to be expected, the chi-square
test with multiple degrees of freedom is adequate. The test statistic (the chi-square-
value¼ χ2 –value) is calculated according to
χ2 ¼ n 1ð Þs
2
σ2
for n 1 degrees of freedom
n¼ sample size, s¼ standard deviation, s2¼ variance sample, σ¼ expected
standard deviation, σ2¼ expected variance).
For example, the aminoglycoside compound gentamicin has a small therapeutic
index. The standard deviation of 50 measurements is used as a criterion for
variability. Adequate variability will be accepted, if the standard deviation is less
than 7 μg/l. In our sample a standard deviation of 9 μg/l is observed. The test
procedure is given.
χ2 ¼ 50 1ð Þ 92=72 ¼ 81
The underneath chi-square table has an upper row with areas under the curve, a left-
end column with degrees of freedom, and a whole lot of chi-square values. It shows
that, for 50–1¼ 49 degrees of freedom (close to 50 df row), we will find that a
chi-square value 76.154 will produce a p-value< 0.01. This sample’s standard
deviation is significantly larger than that required. This means that the variability




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
(continued)
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df
Two-tailed P-value
0.10 0.05 0.01 0.001
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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5 Two Sample Variability Test
F-tests can be applied to test if the variabilities of two samples are significantly
different from one another. The division sum of the samples’ variances (larger
variance / smaller variance) is used for the analysis. For example, two formulas of
gentamicin produce the following standard deviations of plasma concentrations.





¼ 9=4 ¼ 2:25
with degrees of freedom (dfs) for
formula-A of 10 1 ¼ 9
formula-B of 15 1 ¼ 14
The table of critical F-values producing a p< 0.05 is on the next page. It shows that
with 9 and 14 degrees of freedom respectively in the numerator and denominator an
F-value around 3.12 or more is required in order to reject the null – hypothesis.
Our F-value is only 2.25, and, so, the p-value is> 0.05, and the null-hypothesis
cannot be rejected. No significant difference between the two formulas can be
demonstrated.






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In some clinical studies, the spread of the data may be more relevant than the
average of the data. For example, the spread of glucose levels of a slow-release-
insulin is important. This chapter assesses how the spread of one and two data-
samples can be estimated. In the Chap. 22 statistical tests for variability assessments
with three or more samples will be given.
7 Note
More background, theoretical and mathematical information of variability assess-
ments is given in Statistics applied to clinical studies 5th edition, Chap. 44, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 22
Variability Analysis for Three or More
Samples
1 General Purpose
In some clinical studies, the spread of the data may be more relevant than the
average of the data. E.g., when we assess how a drug reaches various organs,
variability of drug concentrations is important, as in some cases too little and in
other cases dangerously high levels get through. Also, variabilities in drug response
may be important. For example, the spread of glucose levels of a slow-release-
insulin is important. In Chap. 21, the chi-square test for one sample and the F-test
for two samples have been explained. In this chapter we will explain the Bartlett’s
test which is suitable for comparing three or more samples.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is the difference in variabilities between three or more samples statistically
significant.
4 Data Example (Bartlett’s Test)
The Bartlett’s test, appropriate for comparing multiple samples for differences in
variabilities, uses the underneath equation (χ2¼ chi-square value).
χ2 ¼ n1 þ n2 þ n3  3ð Þln s2  n1  1ð Þln s21 þ n2  1ð Þln s22 þ n3  1ð Þln s23
 
where
n1¼ size sample 1
s1
2¼ variance sample 1
s2 ¼ pooled variance ¼ n11ð Þs
2
1
þ n21ð Þs22þ n31ð Þs23
n1þn2þn33 ¼
ln¼ natural logarithm
As an example, blood glucose variabilities are assessed in a parallel-group study
of three insulin treatment regimens. For that purpose three different groups of
patients are treated with different insulin regimens. Variabilities of blood glucose
levels are estimated by group-variances (ln¼ natural logarithm):
Group size (n) Variance [(mmol/l)2]
Group 1 100 8.0
Group 2 100 14.0
Group 3 100 18.0
Pooled variance ¼ 99 8:0 þ 99 14:0 þ 99 18:0
297
¼ 13:333
χ2 ¼ 297 ln13:333 99 ln 8:0 99 ln 14:0 99 ln 18:0 ¼
297 2:58776 99 2:079 99 2:639 99 2:890 ¼
768:58 753:19 ¼
15:37
We have three separate groups, and, so, 3–1¼ 2 degrees of freedom. The under-
neath chi-square table has an upper row with areas under the curve, a left-end
column with degrees of freedom, and a whole lot of chi-square values. It shows that
with a chi-square value of 15.37 a very significant difference between the three
variances is demonstrated at p< 0.001. If the three groups are representative
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comparable samples, then we may conclude, that these three insulin regimens do
not produce the same spread of glucose levels.
Chi-squared distribution
Two-tailed P-value
df 0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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5 Conclusion
An alternative to the Bartlett’s test is the Levene’s test. The Levene’s test is less
sensitive than the Bartlett’s test to departures from normality. If there is a strong
evidence that the data do in fact come from a normal, or nearly normal, distribution,
then Bartlett’s test has a better performance. Levene’s test requires a lot of arith-
metic, and is usually performed using statistical software. E.g., it is routinely used
by SPSS when performing an unpaired t-test or one-way ANOVA (analysis of
variance) (see also Cleophas, Zwinderman, SPSS for Starters, part 1, Springer
New York, 2010, Chaps. 4 and 8).
We should add that assessing significance of differences between 3 or more
variances does not answer which of the samples produced the best outcome. Just
like with analysis of variance (Chap. 19), separate post hoc one by one analyses are
required.
6 Note
More background, theoretical and mathematical information of variability assess-
ments is given in Statistics applied to clinical studies 5th edition, Chap. 44, Springer
Heidelberg Germany, 2012, from the same authors.
















In the above study the treatment effects are better in the males than they are in the
females. This difference in efficacy does not influence the overall assessment as
long as the numbers of males and females in the treatment comparison are equally
distributed. If, however, many females received the new treatment, and many males
received the control treatment, a peculiar effect on the overall data analysis is
observed as demonstrated by the difference in magnitudes of the circles in the
above figure: the overall regression line will become close to horizontal, giving rise
to the erroneous conclusion that no difference in efficacy exists between treatment
and control. This phenomenon is called confounding, and may have a profound
effect on the outcome of the study. This chapter shows how to assess confounded
studies with continuous outcome data. Confounded studies with binary outcome
data are reviewed in the Chap. 40.
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2 Schematic Overview of Type of Data File










3 Primary Scientific Question
How can confounded studies be assessed.
4 Confounding Assessed with Subclassification
Confounding can be assessed by the method of subclassification. In the above
example an overall mean difference between the two treatment modalities is
calculated.
For treatment zero
Mean effect standard error (SE) ¼ 1.5 units 0.5 units
For treatment one
Mean effect SE ¼ 2.5 units 0.6 units
The mean difference of the two treatments
¼1.0 units pooled standard error
¼1.0 √ (0.52 + 0.62)
¼1.0 0.61
The t-value as calculated ¼ 1.0 / 0.61¼ 1.639
126 23 Confounding
With 100-2 (100 patients, 2 groups)¼ 98 degrees of freedom the p-value of
difference is calculated.
The above t-table has a left-end column giving degrees of freedom ( sample
sizes), and two top rows with p-values (areas under the curve¼ p - values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees of
freedom, are equal to z-values (Chap. 36). The t-values are to be understood as mean
results of studies, but not expressed in mmol/l, kilograms, but in so-called SEM-units
(Standard error of the mean units), that are obtained by dividing your mean result by
its own standard error. With many degrees of freedom (large samples) the curve will
be a little bit narrower, and more in agreement with nature.
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We have 98 degrees of freedom, and, so, we will need the rows between
60 and 120 to estimate the area under curve of a t-value of 1.639. A t-value larger
than 1.980 is required for an area under curve significantly different from zero
(¼ p-value< 0.05). Our area under the curve of 1.639 is much larger than 0.05. We
cannot reject the null-hypothesis of no difference in the data here.
In order to assess the possibility of confounding, a weighted mean has to be
calculated. The underneath equation is adequate for the purpose.
Weighted mean ¼ Differencemales=its SE
2 þ Differencefemales=its SE2
1=SE2males þ 1=SE2females
For the males we find means of 2.0 and 3.0 units, for the females 1.0 and 2.0 units.
The mean difference for the males and females separately are 1.0 and 1.0 as
expected from the above figure. However, the pooled standard errors are different,
for the males 0.4, and for the females 0.3 units.
According to the above equation a weighted t-value is calculated
Weighted mean ¼ 1:0=0:42 þ 1:0=0:32ð Þ
1=0:42 þ 1=0:32ð Þ
¼ 1.0
Weighted SE2 ¼ 1= 1=0:42 þ 1=0:32 
¼ 0.0576
Weighted SE ¼ 0.24
t-value ¼ 1.0/0.24 ¼ 4.16
According to the above t-table with 98 degrees of freedom a t-value of 4.16 is
much larger than the critical t-value producing a p< 0.05. Our result is very
significant: p-value¼<0.001.
The weighted mean is equal to the unweighted mean. However, its SE is much
smaller. It means that after adjustment for confounding a very significant difference
is observed.
5 Conclusion
Other methods for assessing confounding include multiple regression analysis and
propensity score assessments. Particularly, with more than a single confounder




More background, theoretical and mathematical information of confounding is
given in Statistics applied to clinical studies 5th edition, Chap. 28, Springer
Heidelberg Germany, 2012, from the same authors.
6 Note 129
Chapter 24
Propensity Scores and Propensity Score
Matching for Assessing Multiple
Confounders
1 General Purpose
In the Chap. 23 methods for assessing confounders were reviewed. Propensity score
are ideal for assessing confounding, particularly, if multiple confounders are in a
study. E.g., age and cardiovascular risk factors may not be similarly distributed in
two treatment groups of a parallel-group study. Propensity score matching is used to
make observational data look like randomized controlled trial data. This chapter
assesses propensity score and propernsity score matching.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is propensity score and propensity score matching adequate for assessing studies
with multiple confounders.
4 Propensity Scores
A propensity (prop) score for age can be defined as the risk ratio (or rather odds
ratio) of receiving treatment 1 compared to that of treatment 2 if you are old in
this study.
Treatment-1 Treatment-2 odds treatment-1 / odds
treatment-2
n¼ 100 n¼ 100 (OR)
1. Age> 65 63 76 0.54 (63/76 / 37/24)
2. Age< 65 37 24 1.85 ( ¼ OR2¼ 1/OR1)
3. Diabetes 20 33 0.51
4. Not diabetes 80 67 1.96
5. Smoker 50 80 0.25
6. Not smoker 50 20 4.00
7. Hypertension 51 65 0.65
8. Not hypertension 49 35 1.78
10. Not cholesterol 39 22 2.27
The odds ratios can be tested for statistical significance (see Chap. 2, odds
ratios), and those that are statistically significant can, then, be used for calculating
a combined propensity-score for all of the inequal characteristics by multiplying the
significant odds ratios, and, then, calculating from this product the combined
propensity-score¼ combined “risk ratio” (¼ combined OR / (1+ combined OR).
y¼ yes, n¼ no, combined OR¼OR1 x OR3 x OR5 x OR7 x OR9.
Old Diab Smoker Hypert Cholesterol Combined OR Combined
propensity
score
Patient 1 y y n y y 7.99 0.889
2 n n n y y 105.27 0.991
3 y n n y y 22.80 0.958
4 y y y y y 0.4999 0.333
5 n n y
6 y y y
7 . . ..
8 . . ..
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Each patient has his / her own propensity score based on and adjusted for the
significantly larger chance of receiving one treatment versus the other treatment.
Usually, propensity score adjustment for confounders is accomplished by divid-
ing the patients into four subgroups, but for the purpose of simplicity we here use
2 subgroups, those with high and those with low propensity scores.
Confounding is assessed by the method of subclassification. In the above
example an overall mean difference between the two treatment modalities is
calculated.
For treatment zero
Mean effect standard error (SE) ¼ 1.5 units 0.5 units
For treatment one
Mean effect SE ¼ 2.5 units 0.6 units
The mean difference of the two treatments
¼1.0 units pooled standard error
¼1.0 √ (0.52 + 0.62)
¼1.0 0.61
The t-value as calculated ¼ 1.0/0.61¼ 1.639
The underneath t-table is helpful to determine a p-value.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simulataneously. The t-table is, furthermore, full of t-values, that, with
1 degrees of freedom, are equal to z-values (Chap. 36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, but
in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom
(large samples) the curve will be a little bit narrower, and more in agreement with
nature.
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With 200–2 (200 patients, 2 groups)¼ 198 degrees of freedom, a t-value> 1.96
is required to obtain a two-sided p< 0.05. It can be observed that our
p-value> 0.05. It is even> 0.10.
In order to assess the possibility of confounding, a weighted mean has to be
calculated. The underneath equation is adequate for the purpose (prop
score¼ propensity score).
Weighted mean ¼ Differencehigh prop score = its SE
2 þ Differencelow prop score= its SE2
1= SE2high prop score þ 1= SE2low prop score
For the high prop score we find means of 2.0 and 3.0 units, for the low prop score
1.0 and 2.0 units. The mean difference separately are 1.0 and 1.0 as expected.
However, the pooled standard errors are different, for the males 0.4, and for the
females 0.3 units.
According to the above equation a weighted t-value is calculated
Weighted mean ¼ 1:0=0:42 þ 1:0=0:32 
1=0:42 þ 1=0:32 
¼ 1.0
Weighted SE2 ¼ 1/(1/0.42 + 1/0.32)
¼ 0.0576
Weighted SE ¼ 0.24
t-value ¼ 1.0/0.24¼ 4.16
With 98 degrees of freedom, and a t-value of 4.16 means a two sided
p-value< 0.001 is obtained.
The weighted mean is equal to the unweighted mean. However, its SE is much
smaller. It means that after adjustment for the prop scores a very significant
difference is observed. Instead of subclassification, also linear regression with the
propensity scores as covariate is a common way to deal with propensity scores.
However, this is hard on a pocket calculator.
5 Propensity Score Matching
In the study of 200 patients each patient has his/her own propensity score. We
select for each patient in group 1 a patient from group 2 with the same propensity
score.
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The above graph is an example of the nearest neighbor watching method for
matching patients with similar propensity scores. Each square represents one
patient. In random order the first patient from group 1 is selected. Then, he/she is
matched to the patient of group 2 with the nearest propensity score. We will
continue until there are no longer similar propensity scores. Group 1 has to be
summarized above the x-axis, group 2 below it. The patients with dissimilar
propensity scores that cannot be matched, have to be removed from the analysis.
This procedure will end up sampling two new groups that are entirely symmetric
on their subgroup variables, and can, thus, be simply analyzed as two groups in a
randomized trial. In the given example two matched groups of 71 patients were left
for comparison of the treatments. They can be analyzed for treatment differences
using unpaired t-tests (Chap. 7) or chi-square tests (Chap. 38), without the need to
further account confounding anymore.
6 Conclusion
Propensity score are for assessing studies with multiple confounding variables,
e.g., age and cardiovascular risk factors, factors that are likely not to be similarly
distributed in two treatment groups of a parallel-group study. Propensity score
136 24 Propensity Scores and Propensity Score Matching for Assessing Multiple. . .
matching is used to make observational data look like randomized controlled trial
data. This chapter assesses propensity score and propernsity score matching.
7 Note
More background, theoretical and mathematical information of propensity scores is
given in Statistics applied to clinical studies 5th edition, Chap. 29, Springer





The medical concept of interaction is synonymous to the terms heterogeneity and
synergism. Interaction must be distinguished from confounding. In a trial with
interaction effects the parallel groups have similar characteristics. However, there
are subsets of patients that have an unusually high or low response. The figure
below gives an example of a study in which males seem to respond better to the
treatment 1 than females. With confounding things are different. For whatever
reason the randomization has failed, the parallel groups have asymmetric charac-
teristics. E.g., in a placebo-controlled trial of two parallel-groups asymmetry of
age may be a confounder. The control group is significantly older than the
treatment group, and this can easily explain the treatment difference as demon-
strated in the previous chapter. This chapter uses simply t-tests for assessing
interactions.
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2 Schematic Overview of Type of Data File










3 Primary Scientific Question
Can t-tests adequately demonstrate interaction between the effect on the outcome of
two exposure variables.
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4 Data Example of Interaction
A parallel-group study of verapamil versus metoprolol for the treatment of parox-
ysmal atrial tachycardias is given below. The numbers of episodes of paroxysmal

























Overall metoprolol seems to perform better. However, this is only true only for
one subgroup (males). SD¼ standard deviation, SE¼ standard error.
Males Females
Mean verapamil (SD) 46.4 (3.23866) 36.8 (3.489667)
Mean metoprolol (SD) 30.2 (3.48966)- 37.8 (3.489667)-
Difference means (SE) 16.2 (1.50554) 1.0 (1.5606)
Difference between males and females 17.2 (SE1
2 + SE1
2¼ 2.166)
t-value¼ 17.2/2.166¼ 8. . ..
p < 0.0001
We conclude, that there is a significant difference between the males and
females, and, thus, a significant interaction between gender and treat-efficacy.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p - values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simulataneously. The t-table is, furthermore, full of t-values, that, with
1 degrees of freedom, are equal to z-values (Chap. 36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, but
in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom
(large samples) the curve will be a little bit narrower, and more in agreement with
nature.
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With 40–2¼ 38 degrees of freedom (close to 40), and a t-value¼ 17.2/
2.166¼ 8. . .. and thus larger than 3.551, the two-tail p -value is< 0.001.
5 Conclusion
T-tests can readily be applied for assessing interactions between the effects on the
outcome of two exposure variables. Interaction can also be assessed with analysis of
variance and regression modeling. These two methods are the methods of choice in
case you expect more than a single interaction in your data. They should be carried
out on a computer.
6 Note
More background, theoretical and mathematical information of interaction assess-
ments is given in Statistics applied to clinical studies 5th edition, Chap. 30, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 26
Accuracy and Reliability Assessments
1 General Purpose
Clinical research is impossible without valid diagnostic tests. The methods for
validating qualitative diagnostic tests, having binary outcomes, include sensitivity
/ specificity assessments and ROC (receiver operated characteristic) curves
(Chaps. 52 and 53). In contrast, the methods for validating quantitative diagnostic
tests, having continuous outcomes, have not been agreed upon. This chapter
assesses pocket calculator methods for the purpose.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is a new diagnostic test adequately accurate and adequately reliable.
4 Testing Accuracy with R2-Values
Linear regression is often used for that purpose. The underneath figure gives an
example. The regression equation is given by y¼ a + b x (a¼ intercept,
b¼ regression coefficient). More information of linear regression is given in the
Chap. 8. In the underneath example given, the x-axis-data, ultrasound estimates, are
a very significant predictor of the y-axis-data, the electromagnetic measurements.
However, the prediction, despite the high level of statistical significance, is very













Probably, the best accuracy assessment is to test whether the 95 % confidence
interval of the a-value (the intercept) is significantly different from 0, and whether
the 95 % confidence interval of the b-value (the regression coefficient is signifi-
cantly different from 1. However, second best and more easy on a pocket calculator
is to test the data for a squared correlation coefficient (r2)> 95 %. This method
assumes a diagnostic test with the best fit equation y¼ a + b x, rather than y¼ x. A
diagnostic test with the former best fit equation, like in the above example, is not
necessarily useless, and could be approved as a valid test, if it is precise, that means,
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if the x-data precisely predict the (ya)/b- data rather than the y-data. If we apply
such a test, then the result of the x-data will, of course, have to be transformed into
a+ b x in order to find the y-data.
We will use Electronic Calculator (see Chap. 1) for computations. First, we will
calculate the b and r values.
Command:
click ON....click MODE....press 3....press 1....press SHIFT, MODE, and again 1....
press¼ ....start entering the data. . .. [x-datum1 y-datum1]. . ..[x-datum2
y-datum2]. . ..[..........] etc.. . .
In order to obtain the r value, press: shift, S-VAR,►,►, 3, ¼ .
The r-value equals 0.6. . .
The r2 -value equals 0.36. . .
This r2-value is much smaller than 0.95. It means that this diagnostic test can not
be validated as being adequately accurate.
5 Testing Reliability with Duplicate Standard Deviations
The reliability, otherwise called reproducibility, of diagnostic tests is another
important quality criterion. A diagnostic test is very unreliable, if it is not well-
reproducible. Underneath a first data example is given.
test 1 test 2 difference (difference)2
result
1 11 10 100
10 0 10 100
2 11 9 81
12 2 10 100
11 1 10 100
1 12 11 121
mean
6.17 6.17 0 100.3
Duplicate standard deviation ¼√(1/2mean of (difference)2)
¼√ (1/2 100.3)
¼7.08
The proportional duplicate standard deviation
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An adequate reliability is obtained with a proportional duplicate standard devi-
ation of 10–20 %. In the current example, although the mean difference between the
two tests equals zero, there is, thus, a very poor reproducibility.
Underneath a second example is given. The question is, is this test well
reproducible?








Test 1 Test 2 Difference Difference2
Result
6.2 5.1 1.1 1.21
7.0 7.8 0.8 0.64
8.1 3.9 4.2 17.64
7.5 5.5 2.0 4.0




Duplicate standard deviation ¼√(½ 4.7)
¼1.553
Proportional duplicate standard deviation %





A good reproducibility is between 10 and 20 %. In the above example repro-
ducibility is, thus, almost good.
6 Conclusion
In the current chapter two methods for validation of diagnostic methods with
continuous data easily performed with the help of a pocket calculator are described.
Many more methods exists. For accuracy assessments paired t-tests, Bland-Altman
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plots and the complex linear regession models of Passing-Bablok and Deming are
available. For reliability repeatability coefficients and intraclass correlations are
possible (see underneath “Note” section). These method is generally more labori-
ous, particularly, with large samples, but available through S-plus, Analyse-it, EP
Evaluator, and MedCalc and other software programs.
7 Note
More background, theoretical and mathematical information of validity assess-
ments of diagnostic tests with continuous outcomes is given in Statistics applied
to clinical studies 5th edition, the Chaps. 45 and 50, Springer Heidelberg Germany,
2012, from the same authors.
7 Note 149
Chapter 27
Robust Tests for Imperfect Data
1 General Purpose
Robust tests are wonderful for imperfect data, because they often produce signif-
icant results, when standard tests don’t. They may be able to handle major outliers
in data files without largely changing the overall test results.
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3 Primary Scientific Question
With data imperfect due to major outliers, can robust tests provide significant
effects, if traditional tests don’t.
4 Data Example
Frailty score-improvements after physiotherapy of 33 patients are measured in a









1 8.00 11 1.00
2 8.00 11 1.00
3 8.00 7 1.00
4 4.00 7 1.00
5 4.00 7 1.00
6 4.00 7 1.00
7 4.00 7 1.00
8 1.00 4 1.00 1.00
9 0.00 3 0.00 0.00
10 0.00 3 0.00 0.00
11 0.00 3 0.00 0.00
12 1.00 2 1.00 1.00
13 1.00 2 1.00 1.00
14 2.00 1 2.00 2.00
15 2.00 1 2.00 2.00
16 2.00 1 2.00 2.00
17 3.00 median 3.00 3.00
18 3.00 0 3.00 3.00
19 3.00 0 3.00 3.00
20 3.00 0 3.00 3.00
21 4.00 1 4.00 4.00
22 4.00 1 4.00 4.00
23 4.00 1 4.00 4.00
24 4.00 1 4.00 4.00
25 5.00 2 5.00 5.00
26 5.00 2 5.00 5.00
27 5.00 2 5.00
28 5.00 2 5.00
29 6.00 3 5.00
30 6.00 3 5.00
31 6.00 3 5.00
32 7.00 4 5.00
33 8.00 5 5.00
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The data suggest the presence of some central tendency: the values 3.00 and 5.00
are observed more frequently than the rest. However, the one sample t-test shows a
mean difference from zero of 1.45 scores with a p-value of 0.067. Thus, not
statistically significant.
5 T-Test for Medians and Median Absolute
Deviations (MADs)





mean after replacing outcome 1st patient with 0.00 1.697
mean after replacing outcome first 3 patients with 0.00 2.182
median 3.000
MAD 2.500
mean of the Winsorized data 1.364
standard deviation of the Winsorized data 3.880
MAD¼median absolute deviation¼ the median value of the sorted deviations
from the median of a data file.
If the mean does not accurately reflect the central tendency of the data e.g. in
case of outliers (highly unusual values), then the median (value in the middle) or the
mode (value most frequently observed) may be a better alternative to summarizing
the data and making predictions from them.
Median ¼ 3:00
The above example shows in the third column the deviations from the median, and
the table gives the median of the deviations from median (MAD¼median absolute
deviation).
MAD ¼ 2:50
If we assume, that the data, though imperfect, are from a normal distribution, then the
standard deviation of this normal distribution can be approximated from the equation
standard deviationmedian ¼ 1:426 MAD ¼ 3:565
standard errormedian ¼ 3:565=√n ¼ 3:565=√33 ¼ 0:6206
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A t-test is, subsequently, performed, and produces a very significant effect: phys-
iotherapy is really helpful.
t ¼ median=standard errormedian ¼ 3:00=0:6206 ¼ 4:834:
The underneath t-table is used for determining the p-value. For 32 (¼33 1)
degrees of freedom, and a t-value >3.646 means a p-value of <0.001 (two-tail).
The t-table has a left-end column giving degrees of freedom ( sample sizes), and
two top rows with p-values (areas under the curve¼ p – values), one-tail meaning
that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees of
154 27 Robust Tests for Imperfect Data
freedom, are equal to z-values (Chap. 36). The t-values are to be understood as mean
results of studies, but not expressed in mmol/l, kilograms, but in so-called SEM-units
(Standard error of the mean units), that are obtained by dividing your mean result by
its own standard error. With many degrees of freedom (large samples) the curve will
be a little bit narrower, and more in agreement with nature.
6 T-Test for Winsorized Variances
The terminology comes from Winsor’s principle: all observed distributions are
Gaussian in the middle. First, we have to trim the data, e.g., by 20 % on either
side (see data file, fourth column). Then, we have to fill up their trimmed values
with Winsorized scores, which are the smallest and largest untrimmed scores (data
file, fifth column). The mean is, then, calculated, as well as the standard deviation
and standard error, and a t-test is performed for null hypothesis testing.
Winsorized mean ¼ 1.364
Winsorized standard deviation ¼ 3.880
Winsorized standard error ¼ 3.880 / √n
¼ 3.880 / √ 33
¼ 0.675
t-test
t ¼Winsorized mean / Winsorized standard error
t ¼ 2.021
With 32 (¼331) degrees of freedom and a t-value> 2.2042 means a
p-value< 0.05 (two-sided).
p-value < 0:05
7 Mood’s Test (One Sample Wilcoxon’s Test)
8.00 8.00 8.00 4.00 4.00 4.00 1.00 0.00 0.00 0.00 1.00 . . ..
8.00 8.00 8.00 6.00 6.00 6.00 4.50 4.00 4.00 4.00 3.50
8.00 8.00 6.00 6.00 6.00 4.50 4.00 4.00 4.00 3.50
8.00 6.00 6.00 6.00 4.50 4.00 4.00 4.00 3.50
4.00 4.00 4.00 2.50 2.00 2.00 2.00 1.50
4.00 4.00 2.50 2.00 2.00 2.00 1.50
4.00 2.50 2.00 2.00 2.00 1.50
1.00 0.50 0.50 0.50 0.00
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The Mood’s test is, sometimes, called the one sample Wilcoxon’s test. The
above table shows how it works. Paired averages [(vertical value + horizontal
value)/2] are calculated. If the data are equally distributed around an average of
0, then we will have half of the average being positive, half negative.
We observe 1122 paired averages,
1122/2¼ 561 should be positive,
349 positive paired averages are found.
A chi-square test is performed
chi-square value¼ (Observed  expected numbers)2/Expected
numbers
chi-square value¼ (349–561)2 / 349¼ 128.729
p< 0.001 with 1 degree of freedom
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values. It




df 0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
(continued)
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Two-tailed P-value
df 0.10 0.05 0.01 0.001
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
8 Conclusion
The above three robust tests produced p-values of <0.001, <0.05, and <0.001,
while the one sample t-test was not statistically significant. Robust tests are
wonderful for imperfect data, because they often produce significant results,
when standard tests don’t.
9 Note
More background, theoretical and mathematical information of robust tests is given




Non-linear Modeling on a Pocket Calculator
1 General Purpose
Non-linear relationships in clinical research are often linear after logarithmic trans-
formations. Odds ratios, log likelihood ratios, Markov models and many regression
models are models that make use of it. An example with real data is given. We have
to add that logarithmic transformation is not always successful, and that alternative
methods are available like Box Cox transformation, and computationally intensive
methods like spline and Loess modeling (see Chap. 24. In: Statistics Applied to
Clinical Studies, Springer New York, 5th edition, 2012, and Chap. 14 of SPSS for
Starters Part 2, Springer New York, 2012, both from the same authors). However,
these methods generally require statistical software and can not be executed on a
pocket calculator. This chapter assesses simply logarithmic transformation of the
outcome variable for linearization of survival data.
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3 Primary Scientific Question
Can logarithmic transformation of survival data linearize survival patterns.
4 Data Example








0 2 4 6 8 10 12 14 16
Time (months)
numbers alive
The underneath figure shows the natural logarithms of these survivals. It can be
observed that logarithmic transformation of the numbers of patients alive readily
produces a close to linear pattern.







0 2 4 6 8 10 12 14 16
Time (months)
The equation of the above regression line of the data y¼ a + bx with
a¼ intercept and b¼ regression coefficient can be calculated from a pocket
calculator.
5 Calculation of Linear Regression Parameters
from a Pocket Calculator
Some pocket calculators offer linear regression. An example is given (see also
Chap. 8).
x-values y-values






Electronic Calculator (see Chap. 1) can be used for the purpose.
Press:
on. . ..mode. . ..3. . ..1. . ..10. . ., . . ..1003. . ..M+ . . ..15. . .., . . .. 1005. . .. M+ . . ...
etc. . ...M+....shift....s-var....►....►....1.....a is given. . ..shift....s-var ....►....►
....2.....b is given. . .. shift....s-var....►....►....3.....r is given. . ..
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Interpretation of a, b and r.: a is the intercept of the best fit regression line with
equation y¼ a + bx; b is the regression coefficient, otherwise called direction
coefficient of the regression line; r is Pearson’s correlation coefficient, it runs
from 1 to +1, 0 means no relationships between x and y, 1 and +1 mean a
very strong negative and positive relationship respectively.
6 Conclusion
Non-linear relationships in clinical research are often linear after logarithmic trans-
formations. Odds ratios, log likelihood ratios, Markov models and many regression
models are models that make use of it. An example with real data is given. We have
to add that logarithmic transformation is not always successful, and that alternative
methods are available. However, these alternative methods, generally, require
statistical software, and can not be executed on a pocket calculator.
7 Note
More background, theoretical and mathematical information is given in Statistics
Applied to Clinical Studies, Springer New York, 5th edition, Chap. 24, 2012, and
SPSS for Starters Part 2, Springer New York, 2012, Chap. 14, both from the same
authors.
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Chapter 29
Fuzzy Modeling for Imprecise
and Incomplete Data
1 General Purpose
Fuzzy modeling is a methodology that works with partial truths: it can answer
questions to which the answers are “yes” and “no” at different times or partly “yes”
and “no” at the same time. It can be used to match any type of data, particularly
incomplete and imprecise data, and it is able to improve precision of such data. It
can be applied with any type of statistical distribution and it is, particularly, suitable
for uncommon and unexpected non linear relationships. This chapter assesses the
use of fuzzy modeling of clinical data.
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3 Primary Scientific Question
Is fuzzy modeling able to provide improved precision of imprecise clinical data.
4 Fuzzy Terms
4.1 Universal Space
Defined range of input values, defined range of output values.
4.2 Fuzzy Memberships
The universal spaces are divided into equally sized parts called membership
functions
4.3 Linguistic Membership Names
Each fuzzy membership is given a name, otherwise called linguistic term.
4.4 Triangular Fuzzy Sets
A common way of drawing the membership function with on the x-axis the input
values, on the y-axis the membership grade for each input value.
4.5 Fuzzy Plots
Graphs summarizing the fuzzy memberships of (for example) the input values.
4.6 Linguistic Rules
The relationships between the fuzzy memberships of the input data and those of the
output data (the method of calculation is shown in the underneath examples).
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5 Data Example 1
Underneath are the quantal pharmacodynamic effects of different induction dos-
ages of thiopental on numbers of responding subjects.
Input values output values fuzzy-modeled output











The effects of different induction dosages of thiopental on numbers of
responding subjects are in the above table, left two columns. The right column
gives the fuzzy-modeled output. The figures below show that the un-modeled curve
(upper curve) fits the data less well than does the modeled (lower curve).
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We fuzzy-model the input and output relationships (figures below).
First of all, we create linguistic rules for the input and output data.
For that purpose we divide the universal space of the input variable into fuzzy
memberships with linguistic membership names:
input-zero, -small, -medium, -big, -superbig.
Then we do the same for the output variable:
output-zero, -small, -medium, -big.







































The above figure shows that input-zero consists of the values 1 and 1.5.
The value 1 (100 % membership) has 4 as outcome value (100 % membership of
output-zero).
The value 1.5 (50 % membership) has 5 as outcome value (75 % membership of
output-zero, 25 % of output-small).
The input-zero produces 100%x100%+50%x75%¼ 137.5 % membership to
output-zero, and 50% 25%¼ 12.5 % membership to output-small, and so, out-
put-zero is the most important output contributor here, and we forget about the
small contribution of output-small.
Input-small is more complex, it consists of the values 1.5, and 2.0, and 2.5.
The value 1.5 (50 % membership) has 5 as outcome value (75 % membership of
output-zero, 25 % membership of output-small).
The value 2.0 (100 % membership) has 6 as outcome value (50 % membership of
outcome-zero, and 50 % membership of output-small).
The value 2.5 (50 % membership) has 9 as outcome value (75 % membership of
output-small and 25 % of output-medium).
The input-small produces 50 % 75 %+100 % 50 %¼ 87.5 % membership to
output-zero, 50 % 25 %+100 % 50 %+50 % 75 %¼ 100 % membership to
output-small, and 50 % 25 %¼ 12.5 % membership to output-medium. And so, the
output-small is the most important contributor here, and we forget about the other two.




We are, particularly interested in the modeling capacity of fuzzy logic in order to
improve the precision of pharmacodynamic modeling.
The modeled output value of input value 1 is found as follows.
Value 1 is 100 % member of input-zero, meaning that according to the above
linguistic rules it is also associated with a 100 % membership of output-zero
corresponding with a value of 4.
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Value 1.5 is 50 % member of input-zero and 50 % input-small. This means it is
50 % associated with the output-zero and –small corresponding with values of
50 % (4 + 8)¼ 6.
For all of the input values modeled output values can be found in this way. The
table of the current section, right column shows the results.
6 Data Example 2
In the underneath example the fuzzy-modeled output has been given. Try and
fuzzy-model the data for yourself. Time-response effect of single oral dose of
120mg propranolol on peripheral arterial flow.
Input values output values fuzzy-modeled output
Hours after oral Administra-
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Pharmacodynamic relationship between the time after oral administration of
120 mg of propranolol (x-axis, hours) and absolute change in fore arm flow (y-axis,
ml/100 ml tissue/min) are in the above graphs. The un-modeled curve (upper curve)
fits the data slightly less well than does the modeled (lower curve).
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7 Conclusion
Fuzzy modeling is a methodology that works with partial truths: it can answer
questions to which the answers are “yes” and “no” at different times or partly “yes”
and “no” at the same time. This chapter assesses the use of fuzzy modeling of
clinical data. The examples given show that the fuzzy models better fit the data than
do the un-modeled data. The figures were drawn with SPSS module regression
(curve estimation).
8 Note
More background, theoretical and mathematical information of fuzzy modeling is
given in Statistics applied to clinical studies 5th edition, Chap. 59, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 30
Bhattacharya Modeling for Unmasking
Hidden Gaussian Curves
1 General Purpose
Bhattacharya modeling can be used for unmasking Gaussian curves in the data. It
should with the help of log transformed frequency scores of data histograms enable
to identify Gaussian subsets in the data. It can also be applied to produce a better
Gaussian fit to a data file than the usual mean and standard deviation does. This
chapter assesses how it can be used to identify Gaussian data subsets, and provide
models better fitting the data, than the traditional methods do.
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3 Primary Scientific Question
Can Bhattacharya modeling be applied for determining normal values of diagnostic
















The above graph gives an example of the frequency distributions of vascular lab
scores of a population of 787 patients at risk of peripheral vascular disease. The
continuous Gaussian curves are calculated from the mean standard deviation, the
interrupted Gaussian curves from Bhattacharya modeling. The pattern of the his-
togram is suggestive of certain subsets in this population. The underneath table left
two columns give the scores and frequencies. The frequencies are log (logarithmic)
transformed (third column) (see also 27 and 43), and, then, the differences between
two subsequent log transformed scores are calculated (fourth column).
Score frequency log delta log
2 1 0.000 0.000
4 5 0.699 0.699
6 13 1.114 0.415
8 25 1.398 0.284
10 37 1.568 0.170
12 41 1.613 0.045
14 43 1.633 0.020
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16 50 1.699 0.018
18 48 1.681 0.111
20 37 1.570 0.021
22 39 1.591 0.117
24 51 1.708 0.000
26 51 1.708 0.009
28 50 1.699 0.027
30 47 1.672 0.049
32 42 1.623 0.146
34 30 1.477 0.176
36 28 1.447 0.030
38 16 1.204 0.243
40 20 1.301 0.097
42 28 1.447 0.146
44 26 1.415 0.032
46 25 1.398 0.017
48 17 1.230 0.168
50 10 1.000 0.230
52 6 0.778 0.222
The underneath graph shows the plot of the scores against the delta log terms.
Three straight lines are identified. The equations of these lines can be calculated
(using linear regression) or extrapolated from the graph below.
1. y¼ 0.944 0.078 x
2. y¼ 0.692 0.026 x
3. y¼ 2.166 0.048 x
The characteristics of the corresponding Gaussian curves can be calculated as
follows.
1. mean¼0.944/0.078¼ 12.10, standard deviation¼ 1/0.078¼ 12.82
2. mean¼0.692/0.026¼ 26.62, standard deviation¼ 1/0.026¼ 38.46
3. mean¼2.166/0.048¼ 45.13, standard deviation¼ 1/0.048¼ 20.83.
In the underneath graph the above three Gaussian curves as given are drawn as
interrupted curves. Here the scores from the above graph have been plotted against
the delta log terms as calculated from the frequencies from the above graph.
















We conclude that Bhattacharya modeling with the help of log transformed fre-
quency scores of data histograms enables to identify Gaussian subsets in the data. It
can also be applied to produce a better Gaussian fit to a data file than the usual mean
and standard deviation does (Chapter 59. In: Statistics Applied to Clinical Studies,
Springer New York, 5th edition, 2012, from the same authors).
6 Note
More background, theoretical and mathematical information of Bhattacharya
modeling is given in the Statistics applied to clinical studies 5th edition, Chap. 26
and 59, Springer Heidelberg Germany, 2012, from the same authors.
174 30 Bhattacharya Modeling for Unmasking Hidden Gaussian Curves
Chapter 31
Item Response Modeling Instead of Classical
Linear Analysis of Questionnaires
1 General Purpose
Item response modeling is used for analyzing psychometric data, quality of life
data, and can even be used analyzing diagnostic tests. It may provide better
precision than does the classical linear analysis. This chapter assesses how it works.
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3 Primary Scientific Question
Are item response models more sensitive than classical linear methods for making
predictions from psychological/QOL questionnaires, and diagnostic tests.
4 Example
One of the estimators of quality of life (QOL) is “feeling happy”. Five yes/no
questions indicate increasing levels of daily happiness: (1) 0 hours happy,
(2) 6 hours happy, (3) 12 hours happy, (4) 18 hours happy, (5) 24 hours happy.
Usually, with five yes/no questions in a domain the individual result is given in the
form of a score, here, e.g., a score from 0 to 5 dependent on the number of positive
answers given per person. However, with many questionnaires different questions
represent different levels of difficulty or different levels of benefit etc. This can be
included in the analysis using item response modeling.




Response pattern (1¼ yes, 2¼ no)






































The above table shows how 5 questions can be used to produce 32 different
answer patterns. The above graph figure shows a histogram of the answer patterns
with the type of pattern on the x-axis and “how often” n the y-axis. A Gaussian like
distribution frequency is observed. A score around 15 is observed most frequently,
and can be interpreted as the mean score of the study. Low scores indicate little
QOL. High scores indicate high QOL. Underneath the areas under the curve
(AUCs) of the histogram is also given. The larger the AUCs, which run from
0.004 to 1.000 (0.4–100 %), the better the QOL.
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Response pattern AUC (area under the curve)





















25 271 ¼1.000 (¼100 %)
Item response models are more sensitive than classical linear methods for
making predictions from psychological/QOL questionnaires, and diagnostic tests.
The above example shows that instead of a 6 point score running from 0 to 5 in the
classical score, the item response model enabled to provide 32 scores, running from
a QOL of 0.4 % to one of 100 %. A condition for item response modeling to be
successfully applied is, of course, that the data should somewhat fit the Gaussian
distribution.
5 Conclusion
Item response models are more sensitive than classical linear methods for making
predictions from psychological/QOL questionnaires, and diagnostic tests.
Item response modeling is not in SPSS, but the LTA-2 software program of
Uebersax is a free software program for the purpose. It works with the areas under
the curve of statistically modeled best fit Gaussian curves of the data rather than a
histogram of the data, but, otherwise, it is similar to the pocket calculator method.
178 31 Item Response Modeling Instead of Classical Linear Analysis of Questionnaires
6 Note
More background, theoretical and mathematical information of item response
modeling is given in Statistics applied to clinical studies 5th edition, Chap. 39,
Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 32
Meta-analysis of Continuous Data
1 General Purpose
Meta-analyses can be defined as systematic reviews with pooled data. Because the
separate studies in a meta-analysis have different sample sizes for the overall results
a weighted average has to be calculated. Heterogeneity in a meta-analysis means
that the differences in the results between the studies are larger than could happen
by chance. The calculation of the overall result and the test for heterogeneity is
demonstrated underneath.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How do we assess pooled results of multiple studies, how do we assess heteroge-
neity between the studies.
4 Data Example, Pooling
A meta-analysis of the difference in systolic blood pressures (mm Hg) between
patients treated with potassium and those with placebo. Diff¼ difference in systolic








23 7.0 3.1 0.104 0.728 5.096
2. Siani 1987 37 14.0 4.0 0.063 0.875 12.348
3. Svetkey 1987 101 6.4 1.9 0.272 1.773 11.346
4. Krishna 1989 10 5.5 3.8 0.069 0.380 2.087
5. Obel 1989 48 41.0 2.6 0.148 6.065 248.788
6. Patki 1990 37 12.1 2.6 0.148 1.791 21.669
7. Fotherby 1992 18 10.0 3.8 0.069 0.693 6.900
8. Brancati 1996 87 6.9 1.2 0.694 4.792 33.041
9. Gu 2001 150 5.0 1.4 0.510 2.551 12.750
10. Sarkkinen 2011 45 11.3 4.8 0.043 0.490 5.091
+
2.125 20.138 359.516
Pooled difference ¼ 20.138/2.125 ¼ 9.48 mm Hg
Chi-square value for pooled data ¼ (20.138)2 / 2.125 ¼ 206.91
According to the chi-square table the p-value for 1 degree of freedom¼<0.001
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values.
Chi-squared distribution
Two-tailed P-value
df 0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
(continued)
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Two-tailed P-value
df 0.10 0.05 0.01 0.001
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
5 Data Example, Assessing Heterogeneity
The above example will now be assessed for heterogeneity.
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Heterogeneity of this meta-analysis is tested by the fixed effect model.
Heterogeneity chi-square value ¼ 359.516-206.91
¼ 152.6,
With 9 degrees of freedom the p –value
¼ <0.001.
Although the meta-analysis shows a significantly lower systolic blood pressure
in patients with potassium treatment than those with placebo, this result has a
limited meaning, since the studies are significantly heterogeneous. For heterogene-
ity testing it is tested whether there is a greater inequalities between the results of
the separate trials than is compatible with the play of chance. Additional tests for
heterogeneity testing are available (Cleophas and Zwinderman, Meta-analysis. In:
Statistics Applied to Clinical Studies, Springer New York, 2012, 5th edition, pp
365–388). However, when there is heterogeneity, a careful investigation of its
potential cause is often more important than a lot of additional statistical tests.
6 Conclusion
Meta-analyses are systematic reviews of multiple published studies with pooled
data. Because the separate studies have different sample sizes a weighted average
has to be calculated. Heterogeneity in a meta-analysis means that the differences in
the results between the studies are larger than could happen by chance. With a
significant heterogeneity the meaning of the pooled data is generally little.
Additional tests for heterogeneity testing are available in Statistics Applied to
Clinical Studies 5th edition, Chaps 32–34, Springer New York, 2012). However,
with significant heterogeneity in a meta-analysis, a careful investigation of its
potential cause is more important than lots of statistical tests.
7 Note
More background, theoretical and mathematical information of meta-analysis given
in Statistics applied to clinical studies 5th edition, Chaps. 32–34, Springer Heidel-
berg Germany, 2012, from the same authors.
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Chapter 33
Goodness of Fit Tests for Identifying
Nonnormal Data
1 General Purpose
Goodness of fit for assessing normal distribution of a data file is an important
requirement for normal and t-distributed tests to be sensitive for statistical testing
the data. Data files that lack goodness of fit can be analyzed using distribution free
methods, like Monte Carlo modeling and neural network modeling (SPSS for
Starters, Part 2 from the same authors, Chaps. 18 and 19, Springer New York,
2012, from the same authors).
The chi-square and the Kolmogorov-Smirnov goodness of fit tests are pretty
much similar, but one uses the differences between all observed and expected
observations, while the other uses the single largest difference between observed
and expected observations, and, so, results may not be identical. One test may,
however, very well be used as a complementary test or contrast test to the other.
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3 Primary Scientific Question
Can goodness of fit tests adequately identify nonnormal/non-t-distributed data.






-0.84 -0.25 0.25  0.84 Z
With the help of the t-table the areas under the curve (AUCs) of 5 intervals of the
null-hypothesis of a normal frequency distribution can be computed. The cut-off
results (z-values) for the 5 intervals with an AUC of 20 % are 0.84, 0.25, 0.25,
and 0.84 (AUC¼ area under the curve). These cut-off results can, subsequently, be
used for chi-square goodness of fit testing. A data example is given.
In random not-too-small populations body-weights follow a normal distribution.
Is this also true for the body-weights of 50 patients treated with a weight reducing
compound?
Individual weight (kgs)
85 57 60 81 89 63 52 65 77 64
89 86 90 60 57 61 95 78 66 92
50 56 95 60 82 55 61 81 61 53
63 75 50 98 63 77 50 62 79 69
76 66 97 67 54 93 70 80 67 73
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As the area under the curve (AUC) of a normal distribution curve is divided into
5 equiprobable intervals of 20 % each, we will expect approximately 10 patients per
interval. From the data a mean and standard error (SE) of 71 and 15 kg are
calculated. In order to compute the numbers of patients of our example in each
interval, we will use the underneath equation.
z ¼ standardized result ¼ unstandardized resultmean result
SE
For example for the cut-off value of 0.84 the unstandardized result of 58.40 kg
can be computed.
0.84¼ (unstandardized result 71)/15
unstandardized results¼ (158.84) + 71¼58.40 kg.
All of the unstandardized results (kgs) are given underneath:
1.... 58.40. . . 67.25. . . 74.25. . . 83.60. . . 1
As they are equiprobable,
As they are equiprobable,
we expect per interval: 10 pts      │ 10 pts    │ 10 pts      │ 10 pts   │ 10pts 
We do, however, observe
the following numbers: 10 pts      │  16 pts    │ 3 pts      │ 10 pts  │ 11pts
The chi-square value is calculated according to
X observed number expected numberð Þ2
expected number
¼ 8:6
This chi-square table is given underneath. It has an upper row with areas under the
curve, a left-end column with degrees of freedom, and a whole lot of chi-square
values.
4 Chi-Square Goodness of Fit Test, Data Example 187
The chi-square value of 8.6 means that for the given degrees of freedom of
5–1¼ 4 (there are 5 different intervals) the null-hypothesis of no-difference-
between-observed-and-expected can not be rejected. However, our p-value
is<0.10, and, so, there is a trend of a difference. The data may not be entirely
normal, as expected. This may be due to lack of randomness.
188 33 Goodness of Fit Tests for Identifying Nonnormal Data
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With the help of the t-table the areas under the curve (AUCs) of again 5 intervals of
the null-hypothesis of a normal frequency distribution can be computed. The cut-off
results (z-values) for the 5 intervals are calculated to be 2.25, 0.75, 0.75, and
2.25. The corresponding AUCs are given in the above graph (AUC¼ area under the
curve).
In random not-too-small populations plasma cholesterol levels follow a normal
distribution. Is this also true for the plasma cholesterol levels of the underneath
patients treated with a cholesterol reducing compound? A data sample of
750 patients is given.
Cholesterol (mmol/l) <4.01 4.01–5.87 5.87–7.73 7.73–9.59 >9.59
Numbers of pts 13 158 437 122 20
The cut-off results for the 5 intervals must be standardized to find the expected
normal distribution for these data according to
z ¼ standardized cut-off result ¼ unstandardized resultmean result
SE
With a calculated mean (SE) of 6.80 (1.24) we must compute the unstandardized
results corresponding with the z-values 2.25, 0.75, 0.75 and 2.25. For example,
with z¼2.25, the unstandardized z-value is calculated.
2.25 ¼ (unstandardized result 6.80)/1.24
unstandardized result
¼ (1.242.25) + 6.80¼ 4.01 mmol/l.
Similarly all unstandardized z-values are computed.
With 750 cholesterol-values in total the expected frequencies of cholesterol-
values in the subsequent intervals are
12.2 750¼ 9.2
21.4 750¼ 160.8




The observed and expected frequencies are, then, listed cumulatively
(cumul¼ cumulative):







13 13 0.0173 9.2 9.1 0.0122 0.0051
158 171 0.2280 160.98 170.0 0.2266 0.0014
437 608 0.8107 410.1 580.1 0.7734 0.0373
122 730 0.9733 160.8 740.9 0.9878 0.0145
20 750 1.000 9.2 750 1.000 0.0000
According to the Kolmogorov-Smirnov table below, the largest cumulative
difference between observed and expected should be smaller than 1.36 /
√n¼ 1.36 / ffiffiffiffiffiffiffi750p ¼ 0.0497, while we find 0.0373. This means that these data are
well normally distributed.
Level of statistical significance for maximum difference between cumulative
observed and expected frequency (n¼ sample size)
Areas under the curve
n 0.20 0.15 0.10 0.05 0.01
1 0.900 0.925 0.950 0.975 0.995
2 0.684 0.726 0.776 0.842 0.929
3 0.565 0.597 0.642 0.708 0.828
4 0.494 0.525 0.564 0.624 0.733
5 0.446 0.474 0.510 0.565 0.669
6 0.410 0.436 0.470 0.521 0.618
7 0.381 0.405 0.438 0.486 0.577
8 0.358 0.381 0.411 0.457 0.543
9 0.339 0.360 0.388 0.432 0.514
10 0.322 0.342 0.368 0.410 0.490
11 0.307 0.326 0.352 0.391 0.468
12 0.295 0.313 0.338 0.375 0.450
13 0.284 0.302 0.325 0.361 0.463
14 0.274 0.292 0.314 0.349 0.418
15 0.266 0.283 0.304 0.338 0.404
16 0.258 0.274 0.295 0.328 0.392
17 0.250 0.266 0.286 0.318 0.381
18 0.244 0.259 0.278 0.309 0.371
19 0.237 0.252 0.272 0.301 0.363
20 0.231 0.246 0.264 0.294 0.356
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25 0.21 0.22 0.24 0.27 0.32
30 0.19 0.20 0.22 0.24 0.29
35 0.18 0.19 0.21 0.23 0.27
Over 35 1.07 1.14 1.22 1.36 1.63
√n √n √n √n √n
6 Conclusion
Goodness of fit for assessing normal distribution of a data file is an important
requirement for normal and t-distributed tests to be sensitive for statistically testing
the data. The chi-square and the Kolmogorov-Smirnov goodness of fit tests are
adequate for the purpose, and are pretty much similar, but results need not be
identical.
7 Note
More background, theoretical and mathematical information of goodness if fit
testing is given in Statistics applied to clinical studies 5th edition, Chap. 42,
Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 34
Non-parametric Tests for Three or More
Samples (Friedman and Kruskal-Wallis)
1 General Purpose
The Friedman test is used for comparing three or more repeated measures that are not
normally distributed, and is a non-parametric test, and extension of the Wilcoxon
signed rank test (Chap. 6). The Kruskal-Wallis test compares multiple groups that are
unpaired and not normally distributed, and is also a non-parametric test, and exten-
sion of the Mann–Whitney test (Chap. 7). This chapter assesses both methodologies,
that are adequate for non-normal data, but can also be used with normal data.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How do we use the Friedman and Kruskal – Wallis tests for, respectively, testing
repeated measures in one group, and single measures in multiple groups, if the
assumption of normality is doubtful.
4 Friedman Test for Paired Observations
The underneath data are paired comparisons to test effect of 2 dosages of a sleeping
drug versus placebo on hours of sleep
Hours of sleep
Patient dose 1 dose 2 placebo dose 1 dose 2 placebo
(hours) (ranks)
1 6.1 6.8 5.2 2 3 1
2 7.0 7.0 7.9 1.5 1.5 3
3. 8.2 9.0 3.9 2 3 1
4. 7.6 7.8 4.7 2 3 1
5. 6.5 6.6 5.3 2 3 1
6. 8.4 8.0 5.4 3 2 1
7. 6.9 7.3 4.2 2 3 1
8. 6.7 7.0 6.1 2 3 1
9. 7.4 7.5 3.8 2 3 1
10. 5.8 5.8 6.3 1.5 1.5 3
The data are ranked for each patient in ascending order of hours of sleep. If the
hours are equal, then an average ranknumber is given. Then, for each treatment the
squared ranksum is calculated: for dose 1 it equals (2 + 1.5 + 2 + 2 + 2 + 3 + 2 + 2 + 2
+ 1.5)2¼ 400, for dose 2 it is 676, for placebo it is 196. The following equation is
used:
chi-square ¼ 12
nk kþ 1ð Þ ranksumdose1
2 þ ranksumdose22 þ ranksumplacebo2
 
 3n kþ 1ð Þ;
where n ¼ the number of patients and k ¼ the number of treatments.
The chi-square value as calculated is 7.2. The degrees of freedom is 3 1 ¼ 2.
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values. It
shows that, for 2 degrees of freedom, a chi-square> 5.991 is required to reject the
null-hypothesis of no effect at p< 0.05.




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
4 Friedman Test for Paired Observations 195
Post-hoc subgroups analyses (using Wilcoxon’s tests) are required to find out
exactly where the difference is situated, between group 1 and 2, between group
1 and 3, or between group 2 and 3 or between two or more groups. The subject of
post-hoc testing will be further discussed in the Chaps. 18, 19, and 20.
5 Kruskal-Wallis Test for Unpaired Observations
The underneath data show three-samples of patients treated with placebo or 2 dif-
ferent NSAIDs (non steroidal anti-inflammatory drugs). The outcome variable is
the fall in plasma globulin concentration (g/l). Group 1 patients are printed in
italics, group 2 in normal standard letters, and group 3 in fat prints.































196 34 Non-parametric Tests for Three or More Samples (Friedman and Kruskal-Wallis)
Three groups of patients with rheumatoid arthritis are treated with a placebo or
one of two different NSAIDS. The fall in plasma globulin (g/l) is used to estimate
the effect of treatments. First, we will give a ranknumber to every patient dependent
on his/her magnitude of fall. If two or three patients have the same fall, they are
given an average ranknumber. Then, we calculate the sum of the ranks for the three
groups. For group 1 this amounts to 1 + 2 + 3 + 4 + 5 + 6 + 7 + 10.5 + 14 + 14¼ 66.5,
for group 2 to 175.5, group 3 to 488.5. Then we use the equation:
chi-square ¼ 12












 3 30 1ð Þ;
where the number 30 equals all values, 10 the patient number per group.
The chi-square-value equals 7744.3. This value is very large, indicating that the
null-hypothesis of no difference in the data can be rejected. In this example the
calculated chi-square value is much larger than the rejection chi-square for (3–1)
degrees of freedom and, therefore, we conclude that there is a significant difference
between the three treatments at p< 0.0001 (see the above chi-square table).
Post-hoc subgroup analyses (using Man-Whitney tests) are required to find out
exactly where the difference is situated, between group 1 and 2, between group
1 and 3, or between group 2 and 3 or between two or more groups. The subject of
post-hoc testing have been discussed in the Chaps. 18, 19, and 20.
6 Conclusion
For the analysis of efficacy data we test null-hypotheses. The t-test (Chaps. 6 and 7)
is appropriate for two parallel-groups or two paired samples. Analysis of variance
(ANOVA) (Chaps. 19 and 20) is appropriate for analyzing more than two groups /
treatments. For data that do not follow a normal frequency distribution,
non-parametric tests are available: for paired data the Wilcoxon signed rank
(Chap. 6) or Friedman tests (current chapter), for unpaired data the Mann–Whitney
test (Chap. 7) or Kruskal-Wallis tests (this chapter) are adequate.
7 Note
More background, theoretical and mathematical information of Friedman and
Kruskal-Wallis tests are given in Statistics applied to clinical studies 5th edition,





Data Spread: Standard Deviations, One
Sample Z-Test, One Sample Binomial Test
1 General Purpose
With continuous outcome data (Chap. 1), the standard deviation is generally used to
estimate the spread in a data sample. The standard deviation is, then, used for multiple
purposes like null-hypothesis testing and the computation of confidence intervals.
With binary outcome data things are different. Instead of a mean value the number of
responders is calculated as a “kind of” mean value. In a data sample with binary
outcome (yes-no outcome), the spread is estimated with the equation, √(p(1 p),
where p¼ the proportion of responders, otherwise called the (yes-data fraction versus
all data). This chapter assesses how these estimators can be used in practice for
testing null-hypotheses and confidence intervals of binary outcome data.
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3 Primary Scientific Question
How do we compute the standard deviation of a binary data set.
4 The Computation of the Proportion of Responders
and Its Standard Deviation (SD)
Why is SD of the proportion responders¼ √(p(1 p)? The proportion of responders
can be looked at as the “mean” of a yes/no data set.
Proportion¼mean of yes/no data.
For example, mean of the 6 values [1, 0, 1, 0, 0, 1] is 3/6 yes¼ 50 %¼ proportion p.
SD of continuous data ¼ √ [Σ (a a¯)2/n, where n¼ sample size.
SD of proportional data ¼ √ [p(1 p)], where p¼ proportion, e.g., 5/15
What does SD of proportion¼ √[p(1 p)] mean in practice?
We assume for example: on average 10/15 in a random population say yes to the
question, are you sometimes sleepy through the day. Then, 10/15 saying yes will be
encountered most frequently.
The chance to find answer<10/15 or >10/15 gets gradually smaller.
5 10 15
The above graph has on the x-axis the numbers of patients saying yes, and on the
y-axis the chance of finding this number. The chance of 8/15 or less is only 15 %, the
chance of 7/15 or less only 2.5 %, the chance of 5/15 or less is only 1 %. With many
samples the above graph follows a normal frequency distribution, where the equation [√
[p(1 p)] is a very good approximation of its standard deviation. This is how nature
works, and it can even be proven to be true with the one sample binomial formula
requiring a hypergeometric distribution, but this is beyond the scope of the currentwork.
5 One Sample Z-Test
Out of a sample of 100 patients only 10 patients were yes-responders. And, so, the
proportion of yes responders is 10 %¼ 0.1. For testing, whether this is significantly
different from 0 responders, a standard error of the response is required.
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The standard error (SE) can be calculated from the standard deviation according to:
SE ¼ SD/n, where n ¼ sample size.
SE ¼ √[p(1 p)]/√100
¼ √(0.1 0.9)/10
¼ 0.03
the z-value is the test statistic and equals [proportion/(its SE)]¼ 0.1/0.03¼ 3.33
The bottom row of the underneath t-table gives p-values from the z-values. With a
z-value of 3.33, the p-value, two-tail as usual, should be<0.001. This would mean that
the 10 % yes responders is significantly better than a zero response would have been.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p-values), one-tail mean-
ing that only one end of the curve, two-tail meaning that both ends are assessed
simultaneously. The t-table is, furthermore, full of t-values, that, with1 degrees of
freedom, are equal to z-values. The z-values and t-values are to be understood as
mean results of studies, but not expressed in mmol/l, kilograms, or proportions of
responders, but in so-called SEM-units (Standard error of the mean units), that are
obtained by dividing your mean result by its own standard error. For continuous
outcome data, with many degrees of freedom (large samples) the curve will be a
little bit narrower, and more in agreement with nature. For binary outcome data,
nature has determined that the curves will always be as narrow as can be, according
to the row at the bottom.
6 Computing the 95 % Confidence Intervals of a Data Set
The example is taken from the Chap. 13. What is the standard error (SE) of a study
with events in 10 % of the patients, and a sample size of 100 (n). Ten percent events
means a proportion of events of 0.1. The standard deviation (SD) of this proportion
is defined by the equation
√ [proportion (1 proportion)] ¼ √ (0.1 0.9)¼ √ 0.09¼ 0.3,
the standard error ¼ standard deviation / √n,
¼ 0.3 / 10¼ 0.03,
the 95 % confidence interval is given by
proportion given  1.960 0.03 ¼ 0.1 1.960 0.03,
¼ 0.1 0.06,
¼ between 0.04 and 0.16.
The 95 % confidence intervals can be used for multiple purposes, for example
for noninferiority testing (Chap. 15), and equivalence testing (Chap. 14).
7 Conclusion
With binary outcome data, instead of a mean value the number of responders is
calculated as a “kind of” mean value. The spread is estimated with the equation, √(p
(1 p), where p¼ the proportion of responders, otherwise called the (yes-data
fraction from all data), in a data sample. This chapter assesses how these estimators
can be used in practice for testing null-hypotheses and confidence intervals of
binary data.
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8 Note
More background, theoretical and mathematical information of standard deviations
of binary data is given in Statistics applied to clinical studies 5th edition, Chap. 3,





If, as shown in the previous chapter, multiple similar a selective samples of binary
data have a normal frequency distribution, then t-tests, like the ones for continuous
data (Chap. 7), should be OK for their analysis. Consequently, if we compare two
binary samples, for example the outcomes of two treatment modalities, then a two
sample t-test should be OK for statistical testing. The two sample t-test for binary
outcomes is called the two sample z-test. This chapter shows how it works.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is the two sample z-test adequate for comparing the differences in numbers of
responders to two different treatment modalities.
4 Data Example, Two Group Z-Test
Two groups of patients are assessed for being sleepy through the day. We wish to
estimate whether group 1 is more sleepy than group 2. The underneath cross-tab
gives the data.
Sleepiness no sleepiness
Treatment 1 (group 1) 5 (a) 10 (b)
Treatment 2 (group 2) 9 (c) 6 (d)
z ¼ difference between proportions of sleepers per group dð Þ
pooled standard error difference
z ¼ d
pooled SE




SE1 or SEM1ð Þ ¼ ffip p1 1 p1ð Þ
n1
where p1 ¼ 5=15 etc::::::::;
z¼ 1.45, not statistically significant from zero, because for a two- tail p – value
<0.05 a z-value of at least 1.96 is required. This means that no significant differ-
ence between the two groups is observed. The p-value of the z-test can be obtained
by using the bottom row of the underneath t-table.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values. The z-values and t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, or
proportions of responders, but in so-called SEM-units (Standard error of the mean
units), that are obtained by dividing your mean result by its own standard error. For
continuous outcome data, with many degrees of freedom (large samples) the curve
will be a little bit narrower, and more in agreement with nature. For binary outcome
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data, nature has determined that the curves will always be as narrow as can be,
according to the row at the bottom.
5 Single Group Z-Test
A single group z-test is also possible (see also Chap. 35). For example, in 10 patients
we have 4 responders. We question whether 4 responders is significantly more than
0 responders.
z ¼ proportion/(its SE)
SE ¼ √ [(4/10 (1 4/10))/n]
¼ √ (0.24/10)
z ¼ 0.4/√ (0.24/10)
z ¼ 0.4/0.1549
z ¼ 2.582
According to the bottom row of the t-table the p-value is <0.01. A proportion of
0.4 is, thus, significantly larger than a proportion of 0.0.
6 Conclusion
As multiple similar a selective samples of binary data have a normal frequency
distribution, the t-tests like the ones for continuous data (Chap. 7) are OK for their
analysis. Consequently, for comparing two binary samples, for example the out-
comes of two treatment modalities, two sample t-test is OK for statistical testing.
The two sample t-test for binary outcomes is called the two sample z-test. This
chapter shows how it works.
7 Note
More background, theoretical and mathematical information is given in the Statis-
tics applied to clinical studies 5th edition, Springer Heidelberg Germany, Chap. 3,
2012, from the same authors.
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Chapter 37
Phi Tests for Nominal Data
1 General Purpose
Nominal data are the simplest type of data. Unlike ordinal data (Chap. 9) and
continuous data (Chaps. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,
20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, and 34), they are assumed not to
have a stepping function. Examples are genders, age classes, family names. Of
nominal data the simplest versions are the bifurcated data (binary data, dichoto-
mous data, yes no data). Chi-square tests can be used for analysis, but they do not
provide levels of association, which may be clinically rather relevant. As an




The value of [(a d) (b c)] can be used to estimate the level of association.
In the above example the level of association is 0. The gender does not give the




In the above example the level of association equals 1 (100 %). The outcome
predicts the chance of a successful exam with 100 % certainty. Phi’s, otherwise
called Cramer’s V’s, are used to calculate the precise level of association, being
between 1 and 1, and can be easily tested for statistical significance with the help
of a chi-square test.
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2 Schematic Overview of Type of Data File










3 Primary Scientific Question
In a data sample of binary variables, what is the level of association between a
binary predictor and another binary outcome variable.
4 Data Example
In a hospital many patients tend to fall out of bed. We wish to find out whether one
department performs better than the other.
fall out of bed yes no
department 1 15(a) 20(b)
department 2 15(c) 5(d)
phi ¼ (adbc)/√ (a + b)(c + d)(a + c)(b + d) ¼
¼ (300–75)/√ (35 20 30 25) ¼
¼ 0.31
We can predict the chance of falling out of bed from the department by
0.31¼ 31 %. Knowing the department, you will be 31 % certain about the chance
of falling out of bed. Is this level of association statistically significant? this means
it 31 % significantly more than 0 %. This of course depends on the magnitude of the
samples.
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With very small samples it is hard to obtain statistical significance. The under-
neath chi-square equation is adequate for statistical testing.
chi-square ¼ phi2  n, where n¼ (a + b + c + d)
¼ 0.312 55
¼ 5.29
The underneath chi-square table shows areas under the curve in the top row, and
(df) degrees of freedom in the left-end column, and furthermore plenty of
chi-square values. The table shows, that a chi-square value of 5.29 with 1 df (degree
of freedom), ((2–1) (2–1)¼ 1) is between 3.841 and 6.635. This means that the
p-value is between 0.05 and 0.01, and, thus,< 0.05. The association is significantly




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
(continued)




0.10 0.05 0.01 0.001
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
5 Conclusion
Nominal data are the simplest type of data. Unlike ordinal data (Chap. 9) and
continuous data (Chaps. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,
20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, and 34), they have no stepping
function. Of nominal data the simplest versions are the bifurcated data (binary
data). Chi-square tests can be used for analysis (Chap. 38), but they do not provide
levels of association, which may be clinically rather relevant. Phi’s, otherwise
called Cramer’s V’s, are used to calculate the precise level of association, and can
be additionally tested for statistical significance with the help of a chi-square test.
6 Note
More background, theoretical and mathematical information of binary data is given
in Statistics applied to clinical studies 5th edition, Chap. 3, Springer Heidelberg
Germany, 2012, from the same authors.




Z-tests (Chap. 36) are OK for comparing the effects of two treatment modalities on
numbers of responders to treatment, however, pretty laborious. Phi tests (Chap. 37)
provide levels of association (or interaction) between a treatment modality and the
number of responders, but no p-values. Often, we wish to know whether our result
or the difference between two results are significantly different from zero.
Chi-square tests make use of chi-square distributions (squared normal distribu-
tions), and produce p-values for the purpose, and these p-values are pretty much
similar to those of the z-tests, but they can be obtained more easily.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
In a 2 2 interaction cross-tab of binary data, like a study of two treatment
modalities and the chance of responding or not in the outcome, is there a significant
difference between the two treatment modalities and the outcome.
4 Data Example I
The underneath table shows two groups assessed for suffering from sleepiness
through the day after being treated with two different anti-sleepiness medications.
We wish to know whether there is a significant difference between the proportions
of subjects being sleepy.
Sleepiness no sleepiness______________________________
Group 1 5(a) 10(b) 15(a + b)
Group 2 9(c) 6(d) 15(c + d)______________________________
14(a + c) 16(b + d) 30(a + b + c + d)
The chi-square pocket calculator method is used for testing these data.
χ2 ¼ ad bcð Þ
2
aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ ¼
30 90ð Þ2 30ð Þ
15 15 16 14 ¼
3600 30




The chi-square value equals 2.143. The underneath chi-square table can tell you,
whether or not the difference between the groups is statistically significant.




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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In summary, the chi-square table has an upper row with areas under the curve
(p-values), a left-end column with degrees of freedom, and a whole lot of chi-square
values.
The chi-square table has columns and rows. The upper row are the p-values. The
left-end column are the degrees of freedom (df), which are, here, largely in
agreement with the numbers of cells in a cross-tab. The simplest cross-tab has
4 cells, which means 2 2¼ 4 cells. The table has been constructed such, that we
have here (2–1) (2–1)¼ 1 degree of freedom. Look at the row with 1 degree of
freedom: a chi-square value of 2.143 is left from 2.706. Now look from here right
up at the upper row. The corresponding p-value is larger than 0.1 (10 %). There is,
thus, no significant difference in sleepiness between the two groups. The small
difference observed is due to the play of chance.
5 Data Example II
Two partnerships of internists have the intention to associate. However, in one of
the two a considerable number of internists has suffered from a burn-out.
burn out no burn out
partnership 1 3(a) 7(b) 10(a + b)
partnership 2 0(c) 10(d) 10(c + d)______________________________
3(a + c) 17(b + d) 20(a + b + c + d)
χ2 ¼ ad bcð Þ
2
aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ ¼
30 0ð Þ 2 20ð Þ
10 10 17 3 ¼
900 20
. . . . . . ::
¼ 3:529
According to the chi-square table of the previous page a p-value is found of <0.10.
This means that no significant difference is found, but a p-value between 0.05 and
0.10 is looked upon as a trend to significance. The difference may be due to some
avoidable or unavoidable cause. We should add, here, that values in a cell lower
than 5 is considered slightly inappropriate according to some, and another test like
the log likelihood ratio test (Chap. 46) is more safe.
6 Example for Practicing 1
Example 2 2 table events no events
group 1 15(a) 20(b) 35(a + b)
group 2 15(c) 5(d) 20(c + d)
30(a + c) 25(b + d) 55(a + b + c + d)
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Pocket calculator
ad bcð Þ2 aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ
¼ p¼. . .
7 Example for Practicing 2
Another example 2 2 table events no events
group 1 16(a) 26(b) 42(a + b)
group 2 5(c) 30(d) 35(c + d)
21(a + c) 56(b + d) 77(a + b + c + d)
Pocket calculator
ad bcð Þ2 aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ
¼ p¼. . .
8 Conclusion
Phi tests (previous chapter) provide levels of association (or interaction) between a
treatment modality and the number of responders, but no p-values. Often, we wish
to know whether our result is significantly different from a zero-result. Chi-square
tests make use of the chi-square distribution (squared normal distribution), and
produce p-values for the purpose. A p-value< 0.05 means that our result is better
than a zero-result with over 95 % certainty, or with less than 5 % chance of a type I
error (the chance of finding a difference where there is none). A pleasant thing
about the pocket-calculator-chi-square-test is, that it can be readily performed
during working hours by physicians, for the purpose of solving the scientific
questions of their daily life (Chaps. 58, and 59). This means no need for starting
a major statistical software program like SPSS, SAS, or R.
9 Note
More background, theoretical and mathematical information of chi-square tests is
given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer Heidel-
berg Germany, 2012, from the same authors.
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Chapter 39
Fisher Exact Tests Convenient for Small
Samples
1 General Purpose
Fisher-exact test is used as a test for the analysis of cross tabs, and as a contrast test
to the chi-square test (Chap. 38), and the z-test (Chap. 36), and, also, as a binary
outcome test for small samples, e.g., samples of n< 100. It, essentially, makes use
of faculties expressed as the sign “!”: e.g.,
[5!] indicating 5 4 3 2 1.
In the past, it was rather laborious with large data, but nowadays any pocket
calculator calculates largest faculties within seconds. E.g., using the Scientific
Calculator from the Chap. 1, you press 6 and then the 2ndF button, and the CE
button: In the display is 720, which is equal to
6!¼ 6 5 4 3 2 1¼ 720.
This chapter assesses the performance of the faculty-based Fisher exact test as
compared to the traditional distribution-based methods.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is the Fisher exact test a reliable alternative to the chi-square test and z-test.
4 Data Example
The underneath example shows two groups assessed for narcolepsia during the dag.
Sleepiness no sleepiness
____________________
Left treatment (left group) 5 (a) 10 (b)
Right treatment (right group) 9 (c) 6 (d)
Unlike the chi-square test a z-test, the Fisher test does not make use of chi-square
or normal frequency distributions to approximate the level of statistical signifi-
cance, but, instead, computes exact p-values like 0.05132 (rather than< 0.05). The
underneath computation is given.
p-value ¼ probability ¼ aþ bð Þ! cþ dð Þ! aþ cð Þ! bþ dð Þð Þ!
aþ bþ cþ dð Þ!a!b!c!d! ¼ 0.200
The chi-square value from the above data is in the previous chapter (Chap. 38),
and equals 2.143. A approximated p-value as obtained from the t-table is >0.10. A
more precise approximation can be obtained from the internet. E.g., the Quick P
Value from Chi-Square Score Calculator is helpful. The approximated p-value from
the internet¼ 0.143222. This is much larger than 0.05, but considerably smaller
than 0.200. Fisher-exact test may be OK, but it is, obviously, somewhat conserva-
tive as compared to the traditional chi-square test. This means that statistical
significance tends to be somewhat harder to obtain.
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5 Conclusion
Fisher-exact test is used as a test for the analysis of cross-tabs, and also as a contrast
test to the chi-square test (Chap. 38) and the z-test (Chap. 36). It is, particularly,
convenient for small samples, e.g., samples of n< 100.
The approximated p-value from the chi-square test and z-test tend to be smaller
than those of the Fisher-exact test. Consequently, statistical significance may be
somewhat harder to obtain with the Fisher-exact test.
6 Note
More background, theoretical and mathematical information of the Fisher-exact test
is given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer





In the Chaps. 23 and 24 confounding of continuous outcome data has been assessed.
Briefly, with confounding the treatment efficacies are better in one subgroup than
they are in the other. For binary data ( ¼ proportional data) this means that the
proportions of responders in one subgroups are better than they are in the other
subgroup. In the current chapter we will assess confounding of binary outcome data
instead of continuous outcome data.
2 Schematic Overview of Type of Data
Treatment modality outcome (binary)
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3 Primary Scientific Question
Do treatment efficacies perform better in one subgroup than in the other.
4 Data Example, Demonstrating Confounding
The numbers of responders to two different treatments is assessed in a parallel-
group study of 384 patients.
responders non-responders total proportion SE (¼√[p(1p)/n)]
males:




treat 2 14 50 64 14/
64¼ 0.22
¼ 0.05
total 50 100 150
females:
treat 1 24 10 34 0.71 ¼0.08
treat 2 120 80 200 0.60 ¼0.03
total 144 90 234
together:
treat 1 60 60 120
treat 2 134 130 264
total 194 190 384
p¼ proportion, n¼ sample size, SE¼ standard error
For the males the treatments 1 and 2 perform significantly different, because
t ¼ difference of proportions/its pooled variance ¼
(0.42 0.22)/(SEtreat 12 + SEtreat 22) ¼
0.20/0.07¼ 2.86.
With proportional data t-values are more often called z-values.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values. The z-values and t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, or
proportions of responders, but in so-called SEM-units (Standard error of the mean
units), that are obtained by dividing your mean result by its own standard error. For
continuous outcome data, with many degrees of freedom (large samples) the curve
will be a little bit narrower, and more in agreement with nature. For binary outcome
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data, nature has determined that the curves will always be as narrow as can be,
according to the row at the bottom.
A z-value of 2.86 is larger than 2.807, and, therefore, statistically significant
from zero with a two-tail p-value <0.05.
For the females the treatments 1 and 2 do not perform significantly differently,
because
z ¼ difference of proportions/its pooled variance ¼
(0.71 0.60)/(SEtreat 12 + SEtreat 22) ¼
0.11/0.09¼ 1.22.
This difference is smaller than 1.960, and therefore, not statistically significantly
better than a difference of 0.
For the combined data, the treatments 1 and 2 do not perform significantly
differently from zero, because
z ¼ difference of proportions/its pooled variance ¼
(0.50 0.51)/(SEtreat 12 + SEtreat 22) ¼
0.01/.... ¼ very small.
This difference is again not statistically significant from a difference of zero,
and, thus, the treatments do not perform significantly differently from one another.
5 Testing Confounding with a Z-Test
A weighted mean proportion is calculated, and tested (variance¼ SE2). The under-
neath differences indicate, respectively, the differences in the males and the
females.
difference=variance þ difference=variance
1= variance þ 1=variance ¼







This weighted mean proportion of 0.18 is much closer to 0.20 than to 0.11, and this
is due to the much larger sample size of females than that of the males. We will now
test the weighted mean proportion against its SE (standard error).
SE ¼ √ [1/(1/SE12 + 1/SE22)]¼ 0.044
z ¼ weighted mean/its SE¼ 0.18/0.044¼ 4.9
This z-value is larger than 3.291, and, therefore, produces a two-tail p-value of
<0.01, and, so, after adjustment for confounding between males and females, the
treatments 1 and 2 perform very significantly different from one another.
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6 Testing Confounding with a Mantel-Haenszl Test
The Mantel-Haenszl chi-square test is equivalent to the z-test.
males
observed expected variance ( n¼ 150)
36 (86 50)/150¼ 28.7 86 64 50 100/n2(n 1)¼ 8.21
females
observed expected variance ( n¼ 234)
24 (34 144)/234¼ 20.9 34 200 144 90/n2(n 1)¼ 6.91.
Chi-square¼ (28.7 20.9)2/(var 1 + var 2)¼ 7.82/15.12¼ 4.02
With 1 degree of freedom the p-value should be< 0.01 (var¼ variance).
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values.
The chi-square value of 4.02 with one degree of freedom is larger than 3.841,




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
(continued)
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7 Conclusion
Both z-test and Mantel-Haenszl chi-square test results show that after adjustment
for confounding the non-significant difference between the effects of the treatments
1 and 2 turn into significant effects with p-values of <0.01 and <0.05.
8 Note
More background, theoretical and mathematical information of confounding
assessments can be found in Statistics applied top clinical studies 5th edition,
Chap. 28, Springer Heidelberg Germany, from the same authors.
df
Two-tailed P-value
0.10 0.05 0.01 0.001
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21





In the Chap. 25 interaction of continuous outcome data has been assessed. The
efficacy of one treatment is better in one of the subgroups, and the efficacy of the
other treatment is better in the other subgroup. With interaction an overall data
analysis is pretty meaningless, and separate analyses of the subgroups must be
presented. Of course, with multiple treatments and subgroups interaction is possible
as well, but the analysis is much more complex. In the current chapter we will
demonstrate how to assess interaction of binary outcome data instead of continuous
outcome data.
2 Schematic Overview of Type of Data
Treatment modality outcome (binary)
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3 Primary Scientific Question
Does one treatment perform better in one subgroup and does the other treatment so
in the other subgroup.
4 Interaction, Example 1
We will use the example of the Chap. 40, Sect. 40.4, once more to assess the
presence of interaction between males and females on the outcome.
males females
proportion treat 1 0.42 0.71
SE 0.05 0.08





pooled SE 0.07 0.09
Differences between males and females 0.200.11¼ 0.09 with a pooled SE of
√[(0.072) + (0.092)]¼ 0.11. Z-value¼ 0.09/0.11¼ 0.82. This z-value not statisti-
cally significantly different from zero (see the underneath t-table). It means that,
although confounding of genders has been demonstrated in these data (Chap. 40),
no interaction between the genders is in the data.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values (Chap. 36). The t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms,
but in so-called SEM-units (Standard error of the mean units), that are obtained by
dividing your mean result by its own standard error. With many degrees of freedom
(large samples) the curve will be a little bit narrower, and more in agreement with
nature.
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A z-value of 0.82 is a lot smaller than 1.960, and the corresponding two-tail
p-value is, thus, > 0.05, and not significant.
5 Interaction, Example 2
The hypothesized data from the above example have been slightly changed.
responders non-responders total proportion SE¼ √[p(1–p)/n)]
males:
treat 1 36 50 86 36/86¼ 0.42 √(0.42 0.58/86)
¼0.05
treat 2 14 50 64 14/64¼ 0.22 ¼0.05
total 50 100 150
females:
treat 1 120 80 200 0.60 ¼0.03
treat 2 24 10 34 0.71 ¼0.08
total 144 90 234
p¼ proportion, n¼ sample size, SE¼ standard error
males females
proportion treat 1 0.42 0.60
SE 0.05 0.03





pooled SE 0.07 0.09
Difference in proportion between males and females 0.20 + 0.11¼ 0.31 with
a pooled SE of √[(0.072) + (0.092)]¼ 0.11. The z-value¼ 0.31/0.11¼ 2.82.
This z-value statistically larger than 1.960, the p-value is significantly different
from zero (see above t-table). It means that a significant interaction between




A two-sample t-test (or rather z-test) (see also Chap. 36) can be used to test whether
the differences in treatment efficacies of two subgroups are significantly different
from one another. The above example shows that a significant interaction between
genders can be demonstrated in such data. In the males the treatment 1 performed
better, in the females the treatment 2 did so.
7 Note
More background, theoretical and mathematical information of interaction assess-
ments can be found in Statistics applied top clinical studies 5th edition, Chap. 30,
Springer Heidelberg Germany, from the same authors.
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Chapter 42
Chi-Square Tests for Large Cross-Tabs
1 General Purpose
Chi-square tests are adequate for testing 2 2 interaction cross-tabs of two treat-
ment modalities and two numbers of responders to treatment (Chap. 38). These tests
can, however, equally well, be applied for testing larger tables.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
In a 3 2 interaction cross-tab, is there a significant difference between three
treatment modalities in numbers of responders to treatment?
4 Data Example One: 3 2 Cross-Tab
In three different treatment groups of hypertensive patients the numbers of
responders (normotensive after treatment) is assessed.
Responders
yes no total
Treatment 1 60 40 100
Treatment 2 100 120 220
Treatment 3 80 60 140
total 240 220 460
The best estimate of expectation is calculated from the above data under the null-
hypothesis, that the results are not significantly different between the groups. E.g.,
estimate expected number of responders in treatment group 1 by dividing all
responders (240) by all observations (460), and multiply by observations in treat-
ment group 1 (100). Then, this estimate (the expected numbers E) is compared with
the actually observed numbers of responders (observed numbers O). The procedure
is illustrated below for responders and, also, non-responders in the treatment
1 group.
Expected (E) OE (OE)2/E
Responders
yes no
Treatment 1 (240/460) 100 (220/460) 100 . . . . . .
Treatment 2 . . . . . . . . . . . .
Treatment 3 . . . . . . . . . . . .
The add-up sum of the above three (OE)2/E terms equal the chi-square value.
The p-value can be read from the chi-square table for 3 – 1¼ 2 degrees of freedom.
The above procedure is laborious, and a fastmethod producing the same result is
given underneath.
2402/460 ¼ 125.22
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The result equals 1.9. . .
The chi-square value ¼
1.9. . ./[(240/460) (220/460)] ¼
7.19. . .
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values. The
chi-square table shows that with 3 – 1¼ 2 degrees of freedom (second row) 7.19. . .
is between 5.991 and 9.210, and, thus, that the corresponding p-value (in the




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
(continued)
4 Data Example One: 3 2 Cross-Tab 239
df
Two-tailed P-value
0.10 0.05 0.01 0.001
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
Obviously, the three treatment modalities are significantly different from one
another. In order to find out, whether the significant effect is between the treatments
1 and 2, 2 and 3, or 1 and 3, subsequent post hoc tests must be performed using 2 2
chi-square tests (Chap. 38). Bonferroni adjustments are to be recommended
(Chap. 18).
5 Data Example Two: Theoretical Distribution
A random sample of 200 subjects was assessed for sleepiness during the day. We
have been given demographic information (theoretical distribution) about the
prevalence of sleepiness in the population from which the sample was taken. We




1.sleepy 0.24 64 64 (0.24 200)¼ 16
2.sleepy
rarely 0.60 124 124 (0.6 200)¼ 4
3.sleepy
never 0.16 12 12 (0.16 200)¼20
(OE)2/E
1.sleepy 162/(0.24 200) ¼ 5.33
2.sleepy
rarely 42/(0.60 200) ¼ 0.05
3.sleepy
never (202)/(0.16 200) ¼ 12.50
total 17.88
According to the chi-square value of 17.88 with 3 – 1¼ 2 degrees of freedom,
which is larger than 13.815, the p-value should <0.001 (see chi-square table in the
above Sect. 42.4). Many more sleepy people were in the observed population than
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expected from the theoretical distribution. And, so, they must have had some reason
for being so sleepy, that should be searched for properly.
6 Conclusion
Chi-square tests are adequate for testing 2 2 interaction cross-tabs of two treat-
ment modalities and two numbers of responders to treatment. They can, however,
equally well be applied for testing larger tables. In clinical research 2 2 tables are
far more commonly used than large tables, because clinicians are mostly interested
to find a single best treatment rather than a significant difference somewhere in
multiple treatments. After an overall assessment of a larger table, multiple
Bonferroni -adjusted subsequent 2 2 tests are required to find out this single
best treatment. You may consider to skip the overall assessment and start with
2 2 tests from the very beginning.
7 Note
More background, theoretical and mathematical information of large chi-square
tables are given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer
Heidelberg Germany, from the same authors.
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Chapter 43
Logarithmic Transformations, a Great Help
to Statistical Analyses
1 General Purpose
Non-linear relationships in clinical research are often linear after logarithmic trans-
formations. Also, logarithmic transformation normalizes skewed frequency distri-
butions and is used for the analysis of likelihood ratios. Basic knowledge of
logarithms is, therefore, convenient for a better understanding of many statistical
methods. Almost always natural logarithm (ln), otherwise called Naperian loga-
rithm, is used, i.e., logarithm to the base e. Log is logarithm to the base 10, ln is
logarithm to the base e (2.718281828). This chapter is for showing that knowledge
of logarithms is helpful for understanding many statistical methods.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is logarithmic transformation relevant for statistical modeling.
4 Theory and Basic Steps
log 10¼ 10 log 10¼ 1
log 100¼ 10 log 100¼ 2




Casio fx-825 scientific, Scientific Calculator, Texas TI-30XA, Sigma,
Commodore
Press: 100. . ..log. . ..2
Press: 2. . ..2ndf. . ..log. . .100
Electronic Calculator, Kenko KK-82MS-5
Press: 100. . ..¼ . . ..log. . ..¼ . . ..2
Press: 2. . ..¼ . . ..shift. . .log. . ..100
ln e¼ e log e¼ 1
ln e2¼ e log e2¼ 2
ln 1¼ e log 1¼ 0
antiln 1¼ 2.718. . .
antiln 2¼ 7.389. . .
antiln 0¼ 1
Casio fx-825 scientific, Scientific Calculator, Texas TI-30XA, Sigma
Press: 7.389. . ..ln. . ..2
Press: 2. . ..2ndf. . ..ln. . .7389
Electronic Calculator, Kenko KK-82MS-5
Press: 7.389. . ..¼ . . ..ln. . ..¼ . . ..2
Press: 2. . ..¼ . . ..shift. . .ln. . ..7.389
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5 Example, Markov Model
In patients with diabetes mellitus (*¼ sign of multiplication):
After 1 year 10 % has beta-cell failure, and 90 % has not.
2 90 * 90¼ 81 % has not.
3 90 * 90 * 90¼ 73 % has not.
When will 50 % have beta-cell failure?
0.9x¼ 0.5
x log 0.9¼ log 0.5
x¼ log 0.5/log 0.9¼ 6.5788 years.
6 Example, Odds Ratios
events no events
numbers of patients
group 1 15(a) 20(b) 35(a + b)
group 2 15(c) 5(d) 20(c + d)
30(a + c) 25(b + d) 55(a + b + c + d)
The odds of an event¼ the number of patients in a group with an event divided
by the number without. In group 1 the odds of an event equals¼ a/b.




lnOR ¼ ln 0.25¼1.386 (ln¼ natural logarithm)
The standard error (SE) of the above term
¼ √ (1/a + 1/b + 1/c + 1/d)
¼ √ (1/15 + 1/20 + 1/15 + 1/5)
¼ √ 0.38333
¼ 0.619
The odds ratio can be tested using the z-test.
The test-statistic ¼ z-value
¼ (ln odds ratio)/(SE ln odds ratio)
¼ 1.386/0.619
¼ 2.239
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The underneath t-table, bottom row, shows, that, if this value is smaller than
1.96 or larger than +1.96, then the odds ratio is significantly different from 1 with
a two-tail p-value< 0.05. There is, thus, a significant difference in numbers of
events between the two groups.
The left-end column of the above t-table gives degrees of freedom ( sample
sizes), two top rows with p-values (areas under the curve), and, furthermore, the
t-table is full of t-values, that, with 1 degrees of freedom, become equal to
z-values.
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7 Conclusion
We conclude that basic knowledge of logarithms is convenient for a better under-
standing of many statistical methods. Odds ratio tests (Chap. 44), log likelihood
ratio tests (Chap. 46), Markov modeling (Chap. 55), and many regression models
use logarithmic transformations.
8 Note
More background, theoretical and mathematical information of logarithmic trans-
formations is given in the Chaps. 28, 30, 44, 45, 46, 47, 48, 49, and 55.
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Chapter 44
Odds Ratios, a Short-Cut for Analyzing
Cross-Tabs
1 General Purpose
The odds ratio test is just like the chi-square test (Chap. 38) applicable for testing
cross-tabs.
The advantage of the odds ratio test is, that an odds ratio value can be calculated.
The odds ratio value is, just like the relative risk, an estimate of the chance of
having had an event in group 1 as compared to that of having had it in group 2. An
odds ratio value of 1.000 indicates no difference between the two groups. This
chapter gives examples of odds ratio analyses.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How can the odds ratio method be applied for testing interaction in a 2 2
contingency table, otherwise called 2 2 cross-tab, and for estimating relative




group 1 15(a) 20(b) 35(a + b)
group 2 15(c) 5(d) 20(c + d)
30(a + c) 25(b + d) 55(a + b + c + d)
-------------------------------
The odds of an event¼ the number of patients in a group with an event divided
by the number without. In group 1 the odds of an event equals¼ a/b.




lnOR ¼ ln 0.25¼1.386 (ln¼ natural logarithm)
The standard error (SE) of the above term
¼ √ (1/a + 1/b + 1/c + 1/d)
¼ √ (1/15 + 1/20 + 1/15 + 1/5)
¼ √ 0.38333
¼ 0.619
The odds ratio can be tested using the z-test (Chap. 36).




If this value is smaller than 2 or larger than +2 (or more precisely 1.96 and
+1.96), then the odds ratio is significantly different from 1 with two-tail p-value of
<0.05, as shown in the bottom row of the t-table of the next page. An odds ratio of
1 means that there is no difference in events between group 1 and group 2.
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The left-end column of the above t-table gives degrees of freedom ( sample
sizes), two top rows with p-values (areas under the curve), and furthermore full of
t-values, that, with1 degrees of freedom, are equal to z-values.




group 1 16(a) 26(b) 42(a + b)
group 2 5(c) 30(d) 35(c + d)
21(a + c) 56(b + d) 77(a + b + c + d)
Test with OR whether there is a significant difference between group 1 and 2.
See for procedure also example 1.
OR ¼ (16/26)/(5/30)
¼ 3.69
lnOR ¼ 1.3056 (ln¼ natural logarithm see the above example)





Because this value is larger than 2, a two-tail p-value of<0.05 is observed, 0.024
to be precise (numerous “p-calculator for z-values” sites in Google will help you
calculate a more precise p-value if required. However, the above t-table may be
sufficiently precise for your purposes.
6 Conclusion
The odds ratio test is, like the z-test (Chap. 36), and the chi-square test (Chap. 38)
applicable for testing cross-tabs. A nice thing about odds ratio tests is that, unlike
the other tests, they provide odds ratios, that can be interpreted as relative risks. E.
g., an odds ratio of 3.69 means that one group performs about 3.7 better than the
other. Odds ratio methods are easy and fast, and kind of short -cut for analyzing
cross-tabs.
7 Note
More background, theoretical and mathematical information of odds ratio tests is
given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer Heidel-
berg Germany, 2012, from the same authors.
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Chapter 45
Logodds, the Basis of Logistic Regression
1 General Purpose
Logistic regression is much similar to linear regression (see Chap. 8). The differ-
ence is the type of outcome variable, which is continuous with linear regression and
binary with logistic regression. In order for logistic regression to work, we need to
transform the binary outcome into the odds of responding, or rather the logodds of
responding. In a population
the odds of an infarction ¼ the number of patients with infarct
number of patients without:
The easiest way to understand the term odds is to think of it as though it is
the risk.
The odds or risk of an infarction is correlated with age: the older, the larger
the odds.




60 70 80 age (years) 50
odds
infarction
60 70 80 age (years)
However, if we transform the underneath linear model
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y¼ a + bx
into a loglinear model
ln odds¼ a + b (x¼ age),
then, all of a sudden, we will observe a close to linear relationship (the above right
graph). This present from heaven can be used for statistical testing. The current
chapter assesses how ln odds, often called logodds, can be used for testing studies
with binary outcome data, like numbers of responders to treatment yes or no.
2 Primary Scientific Question
How can we use logodds for modeling binary outcome data for the purpose of
making predictions from them.
3 Data Example
In a random population of subjects between 50 and 75, we register 5 year age
classes for each subject and follow them for 3 years. After that the numbers of
infarctions are counted per age class.
ageclass population size infarctions odds of infarct logodds
50–55 977 8 8/969 4.80
55–60 1010 42 42/968 3.14
60–65 999 67 67/932 2.63
65–70 990 112 112/878 2.06
70–75 1061 190 190/871 1.52
For the pocket calculation of logodds, first, compute the above odds, and, then,
press the ln button. We will also use the pocket calculator to compute the intercept
and regression coefficient of the linear regression between the age class (x-variable)
and the logodds of infarction (y-variable). This linear regression is otherwise called
logistic regression.
We will use the Electronic Calculator (see Chap. 1) for computations. First, we
will calculate the b and r values.
Command:
click ON....click MODE....press 3....press 1....press SHIFT, MODE, and again 1....
press¼ ....start entering the data.... [55, 4.80]....[60, 3.14]....[65, 2.63]. . .
[70. 2.06]. . .[75, 1.52]
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In order to obtain the a value, press: shift, S-VAR,►,►, 1, ¼ .
In order to obtain the b value, press: shift, S-VAR,►,►, 2, ¼ .
The underneath values are obtained.
a¼12.8
b¼ 0.15
logodds¼ a + b (age class)
Now, we can use the above equation for making predictions about the risk of
having an infarction in the upcoming 3 years in future subjects.
For someone 50–55 years the logodds of infarction ¼ 12.8 + 0.15 (55)
¼ 4.55
the odds of infarction ¼ 0.0106¼ 1.06 %
For someone 70–75 years the logodds of infarction ¼ 12.8 + 0.15 (75)
¼ 1.55
the odds of infarction ¼ 0.212¼ 21.2 %
The risk is pretty much similar to the odds, particularly, with small risks, and is
equal to risk¼ 1/(1 + 1/odds)
e.g., with odds ¼ 21.2 %
risk ¼ 1/(1 + 1/0.212)
¼ 0.175¼ 17.5 %.
4 Conclusion
Logistic regression is not in pocket calculators, but can be used even so if you
transform your outcome odds values into logodds values. We should add that
logistic regression is a magnificent methodology with plenty applications, most of
whom require the use of advanced statistical software. For example it can be used
not only for predictive models of age and infarction, but also for predictive models
with multiple predictors like risk factors and patient characteristics for risk man-
agement assessments. It also can be used for efficacy analysis of survival studies
and exploratory purposes. More information is given in the Chaps. 17, 19, 21, 49,
and 65, in Statistics applied to clinical studies 5th edition, Springer Heidelberg
Germany, 2012, from the same authors.
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5 Note
More background, theoretical and mathematical information of logistic regression
is given in SPSS for starters and 2nd levelers 2nd edition, Chap. 36, 37, 38, and 39,
Springer Heidelberg Germany, 2015, from the same authors.
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Chapter 46
Log Likelihood Ratio Tests for the Best
Precision
1 General Purpose
The sensitivity of the chi-square test (Chap. 38), and the odds ratio test (Chap. 44)
for testing cross-tabs is limited, and, not entirely, accurate, if the values in one or
more cells is smaller than 5. The log likelihood ratio test may be an adequate
alternative with generally better sensitivity, and, so, it must be absolutely consid-
ered. This chapter assesses how it works.
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3 Primary Scientific Question
Is the log likelihood ratio test adequate and more sensitive for testing 2 2
contingency table (cross-tabs, 2 2 interaction tables) compared to standard
methods.
4 Example 1
A group of citizens is taking a pharmaceutical company to court for misrepresenting
the danger of fatal rhabdomyolysis due to statin treatment.
Patients with rhabdomyolysis patients without
company 1 (a) 309999 (b)
citizens 4 (c) 300289 (d)
pco¼ proportion given by the pharmaceutical company¼ a/(a + b)¼ 1/310000
pci¼ proportion given by the citizens¼ c/(c + d)¼ 4/300293
We make use of the z-test (Chap. 36) for testing log likelihood ratios.
As it can be shown that 2 log likelihood ratio equals z2, we can test the
significance of difference between the two proportions.
Log likelihood ratio ¼ 4 log 1=310000
4=300293 þ 300289 log 11=3100001 4=300293
¼ 2.641199
2 log likelihood ratio ¼ 22.641199
¼ 5.2824 (p< 0.05, because z> 2).
¼ z 2
A z – value larger than 2 (actually 1.960, see bottom row of underneath t-table
for all z-values) means a significant difference in your data. Here the z-value equals
√ 5.2824¼ 2.29834. The “p-calculator for z-values” in Google tells you that a more
precise p – value¼ 0.0215, anyway much smaller than 0.05.
We should note here that both the odds ratio test and chi-square test produced a
non-significant result of these data (p> 0.05). Indeed, the log likelihood ratio test is
much more sensitive than the other tests for the same data, which might once in a
while be a blessing for desperate investigators.
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The above t-table gives in the left-end column degrees of freedom (df), (
sample sizes), two top rows with p-values (areas under the curve), and furthermore
plenty t-values, that, with 1 degrees of freedom, have become equal to z-values.
We should emphasize, that, instead of the above t-table, the one-degree-of-free-
dom-row of the chi-square table can be used, because this row produces z2 – values.
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values. The
one-degree-of-freedom-row of the chi-square table has values equal to the squared
values of the bottom row of the t-table.




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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5 Example 2
Two group of 15 patients at risk for arrhythmias were assessed for the development
of torsade de points after calcium channel blockers treatment
Patients with torsade de points patients without
Calcium channel blocker 1 5 10
Calcium channel blocker 2 9 6
The proportion of patients with event from calcium channel blocker 1 is 5/15,
from blocker 2 it is 9/15.
Log likelihood ratio ¼ 9 log 5=15
9=15þ 6 log 15=1519=15
¼ 2.25
2 log likelihood ratio ¼ 4.50
¼ z2
z – value ¼ √ 4.50¼ 2.1213
p – value <0.05, because z> 2.
The traditional chi-square test of these data was non-significant (p> 0.05),
(Chap. 38). You can check for yourself, that, with the odds ratio test (Chap. 44),
this will be equally so.
6 Example 3
Two groups of patients with stage IV New York Heart Association heart failure
were assessed for clinical admission while on two beta-blockers.
Patients with clinical admission patients without
Beta blocker 1 77 62
Beta blocker 2 103 46
The proportion of patients with event while on beta blocker 1 is 77/139, while on
beta blocker 2 it is 103/149.
Log likelihood ratio ¼ 103 log 77=139
103=149þ 46 log 177=1391103=149
¼ 5.882
2 log likelihood ratio ¼ 11.766
¼ z 2
z – value ¼ √ 11.766¼ 3.43016
p – value <0.002, because z> 3.090 (see the above t-table).
Both the odds ratio test and chi-square test were also significant. However, at
lower levels of significance, both p-values 0.01< p< 0.05.
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7 Conclusion
The sensitivity of the traditional tests for testing cross-tabs is limited, and, not
entirely, accurate, with cells smaller than 5. The log likelihood ratio test is an
adequate alternative with generally better sensitivity. It is lovely to use it, if your
traditional test can not reject the null hypothesis of your study with a p-value a bit
larger than 0.05. Your chance is big, that the current test will produce a p-value just
under 0.05.
8 Note
More background, theoretical and mathematical information of log likelihood ratio
tests is given in Statistics applied to clinical studies 5th edition, Chap. 4, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 47
Hierarchical Loglinear Models for Higher
Order Cross-Tabs
1 General Purpose
The Pearson chi-square test is traditionally used for analyzing two dimensional
contingency tables, otherwise called cross-tabs or interaction matrices (Chap. 38).
It can anwer questions like: is the risk of falling out of bed different between the
departments of surgery and internal medicine (Chaps. 37 and 38). The analysis is,
however, very limited, because only the interaction between the two variables, e.g.,
(1) falling out of bed (yes, no) and (2) department (one or the other) is assessed. In
contrast, in an observational data set we may be interested in the effects of the two
variables separately:
1. is there a significant difference between the numbers of patients falling out of
bed and the patients who don’t (the main effect of variable 1),
2. is there a difference between the numbers of patients being in one department
and those being in the other (the main effect of variable 2).
The Pearson test is unable to answer such questions. Hierarchical loglinear
modeling is a pretty novel methodology adequate for the purpose, but not yet
widely available. In SPSS versions 16–23 it is not in the menu, but only accessible
through syntax commands.
In order to simultaneously analyze, in a 2 2 cross tab, the effects of the main
variable in addtion to their interaction, ANOVA (analysis of variance) might be
considered. In ANOVA with two predictor factors and one outcome, outcome
observations are often modeled as a linear combination of:
1 the grand mean
2 the main effect of the first predictor
3 the main effect of the second predictor
4 the interaction effect of the first and the second predictor.
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However, ANOVA requires continuous outcome variables and contingency
tables consist of counted data (numbers of responders, numbers of yes answers),
like numbers of patients falling out of bed. With cell-counts data, like interaction
matrices, traditional ANOVA is impossible, because the outcome-observations
must be modeled as the product of the above 4 effects, rather than their linear
add-up sum. The trick is to transform the multiplicative model into a linear model
using
logarithmic transformation (ln¼ natural logarithm is always used).
Outcome¼ 1*2*3*4 (*¼ symbol of multiplication)
Log outcome¼ log 1 + log 2 + log 3 + log 4
2 Schematic Overview of Type of Data File
Treatment modality Outcome









3 Primary Scientific Question
Can hierarchical loglinear modeling simultaneously assess the effects of the main
variables in addition to their interaction?
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4 Data Example
A simple 2 2 contingency table is given with two treatment groups as row
variable and the presence of sleeplessness as column variable. A loglinear analysis
is given underneath. Loglikelihood ratio tests are used for the computations (see
also the Chap. 46).
column 1 2
row 1 50 150 200
2 90 60 150
140 210 350
All counts have to be logarithmically transformed (ln 50¼ 3.912 etc.).
column 1 2
row 1 3.912 5.011 5.298
2 4.500 4.049 5.011
4.942 5.347 5.848
4.1 First Order Effects
Is there a significant main effect of the column variable (is the number of sleepy
people significantly different from that of non-sleepy people). Expected log fre-
quencies log(350/2)¼ 5.165. The loglikelihood ratio (LLR) chi-square test is used
for testing.
In this test 2 loglikelihood ratio should be larger than z2¼ 22¼ 4 in order to
obtain statistical significance at a p< 0.05 level, and z2¼ one-degree-of-freedom
chi-square value as explained in the Chap. 46).
2 LLRcolumn ¼2 * (140*(4.9425.165) + 210*(5.3475.165))
¼140.0,
*¼ symbol of multiplication.
The underneath chi-square table has an upper row with areas under the curve
(p-values), a left-end column with degrees of freedom (df), and, furthermore, a
whole lot of chi-square values.




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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A chi-square value of 140, one degree of freedom, means that p is much<0.001.
Is there a significant main effect of the row variable (is the numbers of treatments
in group 1 significantly different from that of group 2). Expected log frequencies ¼
log (350/2)¼ 5.165.
2 LLRrow ¼2 * (200*(5.2985.165) + 150*(5.0115.165))
¼7.0,
A chi-square value of 7.0 and 1df, means that p< 0.01.
4.2 Second Order Effects
Is there a significant interaction between the row and column variable. The
loglikelihood ratio (LLR) chi-square test is again used for testing.
2 LLRcolumn x row ¼2 * [(200*(5.2985.165) + 150*(5.0115.165)
+140*(4.9425.165) + 210 *(5.3475.165)]
¼21.0,
1 df, p< 0.001.
The traditional Pearson chi-square test for “row x column” is similarly very
significant, although with a larger chi-square value. We will use the pocket calcu-
lator method (Chap. 38).
Pearson chi-squarecolumn x row
¼ [(50*60 90*150)2 * 350]/(140*210*150*200)
¼43.75,
1 df, P< 0.0001.
*¼ symbol of multiplication.
The Pearson chi-square value is larger than the above second order log likeli-
hood ratio test. This is, because the former does not account first order effects. In
general, if you account more, then you will prove less.
5 Conclusion
The above example shows that logarithmic transformation of multiplicative models
for analyzing contingency tables can readily provide first and second statistics with
the help of log likelihood ratio tests. Also, in practice, higher order contingency
tables do exist. E.g, we may want to know, whether variables like ageclass, gender,
and other patient characteristics interact with the variables (1) and (2). Calculations
are, of course, increasingly complex, and a pocket calculator assessment is impos-
sible. In Chap. 52, SPSS for starters and second levelers 2nd edition, Springer
5 Conclusion 267
Heidelberg Germany, 2015, from the same authors, examples of third, and fourth
order hierarchical loglinear models are given.
6 Note
More background, theoretical and mathematical information of hierarchical log
linear models is given in SPSS for starters and second levelers 2nd edition,
Chap. 52, Springer Heidelberg Germany, 2015, from the same authors.
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Chapter 48
McNemar’s Tests for Paired Cross-Tabs
1 General Purpose
The Chaps. 36, 37, 38, 39, 44, and 46 have reviewed methods for analyzing cross-
tabs of two groups of patients, otherwise called unpaired cross-tabs. Sometimes, a
single group of subjects is assessed twice, and, then, we will obtain a cross-tab
slightly different from the traditional unpaired cross-tabs. McNemar’s test must be
applied for analyzing these kinds of data.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
In a crossover study two diagnostic devices are assessed. We wish to know whether
one performs better than the other.
4 Data Example, Chi-Square McNemar’s Test
315 subjects are tested for hypertension using both an automated device (device-1)




Device-2 + 184 54 238
 14 63 77_______________________
Total 198 117 315
Chi square McNemar ¼ 54 14ð Þ
2
54þ 14 ¼ 23:5
184 subjects scored positive with both tests and 63 scored negative with both tests.
These 247 subjects, therefore, give us no information about which of the two tests is
more likely to score positive. The information we require is entirely contained in
the 68 subjects for whom the tests did not agree (the discordant pairs).
The above equation shows how the chi-square value is calculated. The
chi-square table (given underneath) finds the appropriate p-value. Like with 2 2
unpaired cross-tabs, we will have 1 degree of freedom (df). The 1 degree of freedom
row of the chi-square table shows, that, with our result of 23.5 is a lot larger than
10.827, that the p-value will be a lot <0.001. We conclude, that the two devices




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
(continued)
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The above chi-square table has an upper row with areas under the curve
(p-values), a left-end column with degrees of freedom (df), and a whole lot of
chi-square values.
5 Data Example, McNemar’s Z-Test
Instead of the above chi-square McNemar’s test, also a McNemar’s z-test can be
performed, and will produce identical results. Again 184 and 63 patients need not
be taken into account. The test works as follows.
df
Two-tailed P-value
0.10 0.05 0.01 0.001
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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z ¼ 54 14ð Þ=√ 54þ 14ð Þ ¼ 4:85
A z-value> 1.960 means, that a significant difference between the two tests exists
at p< 0.05. The above z-value is a lot larger than 1.96. The underneath t-table
(bottom row) must be used for computing the p-value more precisely. A z-value of
4.85 is larger than 3.291, and, thus, the two tests are significantly from one another
at a two-tail p-value< 0.001.
The above t-table has a left-end column giving degrees of freedom ( sample
sizes), and two top rows with p-values (areas under the curve¼ p – values), one-tail
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meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values. The z-values and t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, or
proportions of responders, but in so-called SEM-units (Standard error of the mean
units), that are obtained by dividing your mean result by its own standard error. For
continuous outcome data, with many degrees of freedom (large samples) the curve
will be a little bit narrower, and more in agreement with nature. For binary outcome
data, nature has determined that the curves will always be as narrow as can be,
according to the row at the bottom.
6 Conclusion
Traditionally, 2 2 cross-tabs consist of two unpaired groups of patients. Some-
times, however, a single group is assessed twice, and, then, we will obtain a cross-
tab slightly different from the traditional unpaired cross-tabs. McNemar’s tests are
helpful for analyzing these kinds of data. Either chi-square or z statistic can be used
for testing. McNemar’s tests are appropriate for the analysis of paired binary
outcome data, like the data from diagnostic or therapeutic crossover studies.
7 Note
More background, theoretical and mathematical information of McNemar’s tests is
given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer Heidel-





The Chap. 44 has reviewed odds ratios (ORs) for analyzing cross-tabs of two
unpaired groups of patients. Sometimes a single group is assessed twice, and,
then, we will obtain a cross-tab slightly different from the traditional unpaired
cross-tabs. McNemar’s test must be applied for analyzing these kind of data
(Chap. 48). Just like the odds ratios obtained from unpaired cross-tabs, odds ratios
can be obtained from paired cross-tabs. It gives an estimate, in a crossover study of
two treatments or two diagnostic tests, of, how much better one is than the other.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
In a crossover study two diagnostic devices are assessed. We wish to know not only,
whether one performs better than the other, but also, how much better.
4 Data Example
Just like with the usual unpaired cross-tabs (Chap. 44), odds ratios can be calculated
from crossover data with a single group of patients tested twice instead of two
groups tested once. So far, we assessed two groups, and one treatment. Now, two
antihypertensive treatments will be assessed in a single group of patients.
OR¼ odds ratio, SE¼ standard error, and ln¼ natural logarithm.
normotension with drug 1
yes no
normotension yes (a) 65 (b) 28
with drug 2 no (c) 12 (d) 34























This would mean that one treatment is about 2.33 times better than the other.










lnOR 2 SE ¼ 0.847 0.690
¼ between 0.157 and 1.537,
Turn the ln numbers into real numbers by the anti-ln button (the invert button, on
many calculators, called the 2ndF button) of your pocket calculator.
¼ between 1.16 and 4.65
¼ significantly different from 1.0.
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The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values. The z-values and t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, or
proportions of responders, but in so-called SEM-units (Standard error of the mean
units), that are obtained by dividing your mean result by its own standard error. For
continuous outcome data, with many degrees of freedom (large samples) the curve
will be a little bit narrower, and more in agreement with nature. For binary outcome
data, nature has determined that the curves will always be as narrow as can be,
according to the row at the bottom.
4 Data Example 277
The bottom row of the above t-table shows that this z-value is 2.455, and, thus,
larger than 2.326. This means that the corresponding p-value of <0.02. The two
drugs, thus, produce significantly different results at p< 0.02.
We may, additionally, conclude that one drug is about 2.33 times better than the
other.
5 Conclusion
Odds ratios (ORs) are for analyzing cross-tabs of two unpaired groups of patients.
McNemar’s odds ratios are for analyzing unpaired cross-tabs obtained from
crossover data with binary outcome values. Just like the traditional odds ratios
they give an estimate of how much better one treatment or one diagnostic device is
than the other.
6 Note
More background, theoretical and mathematical information of McNemar’s odds
ratio testing is given in Statistics applied to clinical studies 5th edition, Chap. 3,
Springer Heidelberg Germany, 2012, from the same authors.




Power can be described as statistical conclusive force. It can be defined as the
chance of finding a difference where there is one. Other chances are the chance of
finding no difference where there is one (type II error) and the chance of finding a
difference where there is none (type I) error. The result of a study with binary
outcome data is often expressed in the form of the proportion of the responders or
positive tests out of all patients/all tests, and its standard deviation (SD) or standard
error (SE). With the proportion getting larger and the standard error getting smaller,
the study obtains increasing power. This chapter is to show how to compute a
study’s statistical power from its main results.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
What is the power of a study with its proportion of responders and its standard error
given.
4 Data Example
Only 4 out of 10 patients were responders to antihypertensive treatment. Is this
result statistically significant. In other words is four responders significantly more
than 0 responders?
The proportion responders¼ 4/10¼ 0.4
The standard error of this proportion (SE) ¼ √ (p (1p)/n)
with p¼ proportion and n¼ sample size
¼ √ (0.4 0.6/10)
¼ √ (0.24/10)
¼ 0.1549




This t-value, often called z-value with binary outcomes, is larger than 1.960 and,
this means, that we can conclude that 4 out of 10 is significantly more than 0 out of
10 at p< 0.05 (see underneath t-table).
What is the power of this test? The equation below has to be applied.
Power ¼ 1 prob z < t t1 
t ¼ the t-value of your results¼ 2.582
t1 ¼ the t – value, that matches a p-value of 0.05¼ 1.960;
t ¼ 2.582; t1¼ 1.960; t t1¼ 0.622; this value is close to 0.674;
prob (z< t t1) ¼ beta¼ type II error¼ close to 0.25, maybe 0.30
1-beta¼ power ¼ close to 0.70¼ close to 70 %.
A power of 70 % is not very much. We have a chance of a type II error of 30 %.
It, actually means, that, next time you perform the study, you will have about 30 %
chance of an unsignificant result.
Explanation of the above calculation is given in the next few lines. The t-table on
the next page is needed for the purpose. For binary outcome data only the bottom
row is needed. The t-values are often, simply, called z-values here. The t t1 value
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of 0.622 is close to 0.674. Look right up at the top rows for finding beta (type II
error¼ the chance of finding no difference where there is one). We have two top
rows here, one for one-tail testing one for two-tail testing. Power is always tested
one-tail. Null-hypothesis testing is mostly tested two-tail. In the t-table, we are a bit
left from 0.25 (25 %), maybe 0.30 (30 %). This would be a pretty adequate estimate
of the type II error, otherwise called beta of this small study. The power equals
(100 % – beta)¼ close to 100 – 30 %¼ 70 %.
The t-table has a left-end column giving degrees of freedom ( sample sizes),
and two top rows with p-values (areas under the curve¼ p – values), one-tail
meaning that only one end of the curve, two-tail meaning that both ends are
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assessed simultaneously. The t-table is, furthermore, full of t-values, that, with1
degrees of freedom, are equal to z-values. The z-values and t-values are to be
understood as mean results of studies, but not expressed in mmol/l, kilograms, or
proportions of responders, but in so-called SEM-units (Standard error of the mean
units), that are obtained by dividing your mean result by its own standard error. For
continuous outcome data, with many degrees of freedom (large samples) the curve
will be a little bit narrower, and more in agreement with nature. For binary outcome
data, nature has determined that the curves will always be as narrow as can be,
according to the row at the bottom.
5 Conclusion
Power can be defined as the chance of finding a difference, where there is one. It is
equal to 1 minus the type II error (¼ 1 β). A study result with binary outcome data
is often expressed in the form of proportion of responders and its standard deviation
(SD) or standard error (SE). With this proportion getting larger and the standard
error getting smaller, the study will obtain increasing power. This chapter shows,
how to compute a study’s statistical power from its proportion responders and
standard error. We recommend to read Chap. 11 for a better understanding of the
reasoning of the procedure in the current chapter.
6 Note
More background, theoretical and mathematical information of power assessments
is given in Statistics applied to clinical studies 5th edition, Chap. 6, Springer
Heidelberg Germany, 2012, from the same authors.




Just like with continuous outcome data (Chap. 12), with binary outcome data an
essential part of the study protocol is the assessment of the question, how many
subject need to be studied in order to answer the studies’ objectives. This chapter
provides equations that can be used for the purpose.
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3 Primary Scientific Question
What sample size do we need in order to produce a study with a statistically
significant result?
4 Data Example, Binary Data, Power 80 %
What is the required sample size of a study in which you expect an event in 10 % of
the patients and wish to have a power of 80 %.
10 % events means a proportion of events of 0.1.
The standard deviation (SD) of this proportion is defined by the equation
√ [proportion (1 proportion)] ¼
√ (0.1 0.9).
The suitable formula is given.
Required sample size ¼ power index SD2/proportie2
¼ 7.8 (0.1 0.9)/0.12
¼ 7.8 9¼ 71.
We conclude that with 10 % events you will need about 71 patients in order to
obtain a significant number of events for a power of 80 % in your study.
5 Data Example, Binary Data, Power 80 %, Two Groups
What is the required sample size of a study of two groups in which you expect
A difference in events between the two groups of 10 %, and in which you wish to
have a power of 80 %.
10 % difference in events means a difference in proportions of events of 0.10.
Let us assume that in Group one 10 % will have an event and in Group two 20 %.
The standard deviations per group can be calculated.
For group 1: SD¼ √ [proportion (1 proportion)] ¼ √ (0.1 0.9)¼ 0.3
For group 2: SD¼ √ [proportion (1 proportion)] ¼ √ (0.2 0.8)¼ 0.4
The pooled standard deviation of both groups ¼ √ (SD12 + SD22)
¼ √ (0.32 + 0.42)
¼ √ 0.25¼ 0.5
The adequate equation is underneath.
Required sample size ¼ power index (pooled SD)2/(difference in proportions)2
¼ 7.8 0.52/0.12
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¼ 7.8 25
¼ 195.
Obviously, with a difference of 10 % events between two groups we will need
about 195 patients per group in order to demonstrate a significant difference with a
power of 80 %.
6 Conclusion
The assessment of the sample size required to adequately answer a study’s objec-
tives is an essential part of the study protocol. This is true both for studies with
continuous (Chap. 12), and those with binary outcome data (the current chapter).
Equations are given for studies with binary outcome data.
7 Note
More background, theoretical and mathematical information of sample size assess-
ments is given in Statistics applied to clinical studies 5th edition, Chap. 6, Springer





Sensitivity and specificity are measures of diagnostic accuracy of qualitative
diagnostic tests, and are obtained from data samples. Just like averages, they are
estimates and come with certain amounts of uncertainty. The STARDS (Standards
for Reporting Diagnostic Accuracy) working party recommends to include mea-
sures of uncertainty in any evaluation of a diagnostic test. This chapter assesses how
accuracy measures for qualitative diagnostic tests can be tested for uncertainty.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How do we assess accuracy measures for qualitative diagnostic tests can be tested
for uncertainty.
4 Estimating Uncertainty of Sensitivity and Specificity
For the calculation of the standard errors (SEs) of sensitivity, specificity and
overall-validity we make use of the Gaussian curve assumption in the data.
Definitive diagnosis (n)
Yes No
Result diagnostic test Yes a b
No c d
Sensitivity¼ a/(a + c)¼ proportion true positives
Specificity¼ d/(b + d)¼ proportion true negatives
1specificity¼ b/(b + d)
Proportion of patients with a definitive diagnosis¼ (a + c)/(a + b + c + d)
Overall validity¼ (a + d)/(a + b + c + d)
In order to make predictions from these estimates of validity their standard
deviations / errors are required. The standard deviation / error (SD/ SE) of a
proportion can be calculated.
SD ¼ √ p(1 p) where p¼ proportion.
SE ¼ √ [p(1 p)/n] where n¼ sample size
where p equals a/(a + c) for the sensitivity. Using the above equations de standard
errors can be readily obtained.
SE sensitivity ¼ √ ac/(a + c)3
SE specificity ¼ √ db/(d + b)3
SE 1specificity ¼ √ db/(d + b)3
SE proportion of patients with a definitive diagnosis ¼ √ (a + b)(c + d)/(a + b + c + d)3
5 Example 1
Two hundred patients are evaluated the determine the sensitivity/specificity of
B-type Natriuretic Peptide (BNP) for making a diagnosis of heart failure.
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Heart failure (n)
Yes No
Result diagnostic test positive 70 (a) 35 (b)
negative 30 (c) 65 (d)
The sensitivity (a/(a + c)) and specificity (d/(b + d)) are calculated to be 0.70 and
0.65 respectively (70 and 65 %). In order for these estimates to be significantly
larger than 50 % their 95 % confidence interval should not cross the 50 % boundary.
The standard errors are calculated using the above equations. For sensitivity the
standard error is 0.0458, for specificity 0.0477. Under the assumption of Gaussian
curve distributions in the data the 95 % confidence intervals of the sensitivity and
specificity can be calculated according to:
95 % confidence interval of the sensitivity ¼ 0.70 1.96 0.0458
“ “ “ specificity ¼ 0.65 1.96 0.0477.
This means that the 95 % confidence interval of the sensitivity is between 61 %
and 79 %, for specificity it is between 56 % and 74 %. These results do not cross the
50 % boundary and fall, thus, entirely within the boundary of validity. The
diagnostic test can be accepted as being valid.
6 Example 2
Dimer tests have been widely used as screening tests for lung embolias.
Lung embolia (n)
Yes No
Dimer test Positive 2 (a) 18 (b)
Negative 1 (c) 182 (d)
The sensitivity (a/(a + c)) and specificity (d/(b + d)) are calculated to be 0.666
and 0.911 respectively (67 and 91 %). In order for these estimates to be significantly
larger than 50 % the 95 % confidence interval of them should again not cross the
50 % boundary.
The standard errors, as calculated according to the above equations, are for
sensitivity 0.272, for specificity 0.040. Under the assumption of Gaussian curve
distributions the 95 % confidence intervals of the sensitivity and specificity are
calculated according to:
95 % confidence interval of the sensitivity ¼ 0.67 1.96 0.272
“ “ “ specificity ¼ 0.91 1.96 0.040.
The 95 % confidence interval of the sensitivity is between 0.14 and 1.20 (14 and
120 %). The 95 % confidence interval of the specificity can be similarly calculated,
and is between 0.87 and 0.95 (87 and 95 %). The interval for the sensitivity is very
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wide and does not at all fall within the boundaries of 0.5–1.0 (50–100 %). Validity
of this test is, therefore, not really demonstrated. The appropriate conclusion of this
evaluation should be: based on this evaluation the diagnostic cannot be accepted as
being valid in spite of a sensitivity and specificity of respectively 67 and 91 %.
7 Conclusion
Sensitivity and specificity are measures of diagnostic accuracy of qualitative
diagnostic tests. Just like averages they are estimates and come with certain
amounts of uncertainty. This chapter assesses how accuracy measures for qualita-
tive diagnostic tests can be tested for uncertainty.
8 Note
More background, theoretical and mathematical information of accuracy assess-
ments of qualitative diagnostic tests is given in Statistics applied to clinical studies
5th edition, Chaps. 46 and 47, Springer Heidelberg Germany, 2012, from the same
authors.




The reproducibility, otherwise called reliability, of continuous data can be esti-
mated with duplicate standard deviations (Chap. 26). With binary data Cohen’s
kappas are used for the purpose. Reliability assessment of diagnostic procedures is
an important part of the validity assessment of scientific research. The current
chapter shows how it works.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How can binary outcome data from a diagnostic test be tested for reproducibility,
otherwise called reliability.
4 Example
Positive (pos) or negative (neg) laboratory tests of 30 patients are assessed. All





2nd timepos 10 5 15
neg 4 11 15
____________________
14 16 30
If the test is not reproducible at all, then we will find twice the same result in
50 % of the patients, and a different result the second time in the other 50 % of the
patients.
Overall 30 tests have been carried out twice.
We observe 10 times 2 positive and
11 times 2 negative.
And, thus, twice the same is found in
21 patients which is considerable more than in half of the cases, which should
have been 15 times.
Minimal indicates the number of duplicate observations if reproducibility were







A kappa-value of 0.0 means that reproducibility is very poor.
A kappa of 1.0 would have meant excellent reproducibility.
In our example we observed a kappa of 0.4, which means reproducibility is very
moderate.
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5 Conclusion
The reproducibility, otherwise called reliability, of continuous data can be esti-
mated with duplicate standard deviations. With binary data Cohen’s kappas are
adequate for the purpose. Reliability assessment of diagnostic procedures is an
important part of the validity assessment of scientific research.
6 Note
More background, theoretical and mathematical information of reliability assess-
ments of binary diagnostic tests is given in Statistics applied to clinical studies 5th





Statistics is not good at detecting manipulated data. However, tests for randomness
is possible. For example, the chi-square goodness of fit and the Kolmogorov
Smirnov test are examples (Chap. 33). Data may, of course, be unrandom due to
extreme inclusion criteria or inadequate data cleaning. But data fudging is another
possibility. This chapter assesses the use of the final digits of the pattern of the
numerical results of your study as a possible method for detecting unrandom or
fudged data.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How can the final digits of results of the study results show unrandomnes in
your data.
4 Data Example
In a statin trial 96 risk ratios (RR’s) were the main results of the study. Often 9 or
1 were observed as final digits: for example risk ratios like 0.99 or 0.89 or 1.01 or
1.011. The accuracy of these risk ratios were checked according to the underneath
procedure.





0 24 9.6 21.6
1 39 9.6 90.0
2 3 9.6 4.5
3 0 9.6 9.6
4 0 9.6 9.6
5 0 9.6 9.6
6 0 9.6 9.6
7 1 9.6 7.7
8 2 9.6 6.0
9 27 9.6 31.5
Total 96 96.0 199.7
The above differences between observed and expected frequencies were tested
with the multiple groups chi-square test (see also Chap. 42). With
Σ observed expectedð Þ2=expected ¼ 199:7, and 10  1
¼ 9 degrees of freedom;
the difference between observed and expected was much larger than could happen
by chance.
The underneath chi-square table has an upper row with areas under the curve
(p-values), a left-end column with degrees of freedom (df), and a whole lot of
chi-square values. It shows that, with 10 – 1¼ 9 degrees of freedom, our p-value
will be<0.001, if the chi-square value is>27.877. Our chi-square value was 199.7.




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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And, so, the probability <0.001 that such a large chi-square value would occur
by chance, and a chance finding can, thus, be rejected. We can conclude here, that
the frequency distribution of final digits were not random. The validity of this trial
is in jeopardy.
5 Conclusion
Statistics is not good at detecting manipulated data. But, the final digits of the
pattern of the numerical results of your study as a possible method for detecting
unrandom or fudged data.
6 Note
More background, theoretical and mathematical information of data unrandomness
is given in Statistics applied to clinical studies 5th edition, Chaps. 42 and
43, Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 55
Markov modeling for Predicting Outside
the Range of Observations
1 General Purpose
Regression models are only valid within the range of the x-values observed in the
data. Markov modeling goes one step further, and aims at predicting outside the
range of x-values. Like with Cox regression it assumes an exponential-pattern in the
data which may be a strong assumption for complex human beings. This chapter
gives examples.
2 Schematic Overview of Type of Data File
Outcome binary Predictor binary Predictor binary Predictor binary
. . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
. . . .
© Springer International Publishing Switzerland 2016
T.J. Cleophas, A.H. Zwinderman, Clinical Data Analysis on a Pocket Calculator,
DOI 10.1007/978-3-319-27104-0_55
299
3 Primary Scientific Question
Can Markov modeling adequately be used for making predictions outside the range
of observations.
4 Example 1
In patients with diabetes mellitus type II, sulfonureas are highly efficacious, but
they will, eventually, induce beta-cell failure. Beta-cell failure is defined as a
fasting plasma glucose >7.0 mmol/l. The question is, does the severity of diabetes
and/or the potency of the sulfonurea-compound influence the induction of beta-cell
failure? This was studied in 500 patients with diabetes type II.
at time 0 year 0/500 patients had beta-cell failure
at time 1 year 50/500 patients (¼ 10 % ) had beta-cell failure.
As after 1 year 90 % had no beta-cell failure, it is appropriate according to the
Markow model to extrapolate:
after 2 years 90 % 90 % ¼ 81 % no beta-cell failure
after 3 years 90 % 90 % 90 % ¼ 73 % no beta-cell failure
after 6.58 years ¼ 50 % no beta-cell failure.
The calculation uses logarithmic transformation. We will use the example from
the Chap. 43. In patients with diabetes mellitus (*¼ sign of multiplication):
After 1 year 10 % has beta-cell failure, and 90 % has not.
2 90 * 90¼ 81 % has not.
3 90 * 90 * 90¼ 73 % has not.
When will 50 % have beta-cell failure?
0.9x¼ 0.5
x log 0.9¼ log 0.5
x¼ log 0.5/log 0.9¼ 6.5788 years.
For computation command in the Scientific Calculator the following.
Press 0.5....press log....press button....press (....press 0.9....press log....press)....
press¼ .
The outcome displays 6.578813. . .
It will take around 6.6 years, before 50 % has beta-cell failure.
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5 Example 2
A second question was, does the severity of diabetes mellitus type II influence
induction of beta-cell failure. A cut-off level for severity often applied is a fasting
plasma glucose> 10 mmol/l. According to the Markov modeling approach the
question can be answered as follows:
250 patients had fasting plasma glucose< 10 mmol/l at diagnosis (Group-1)
250 patients had fasting plasma glucose> 10 mmol/l at diagnosis (Group-2)
If after 1 year sulfonureas (su) treatment, 10/250 of the patients from Group 1
had b-cell failure, and 40/250 of the patients from Group-2, which is significantly
different with an odds ratio of 0.22 ( p< 0.01, see Chap. 44 if you wish to check the
statistical test of this odds ratio).
(240/250)x¼ 0.5
x¼ log 0.5/log (24/25)
x¼ 16.9797..
(210/250)x¼ 0.5
x¼ log 0.5/log (21/25)
x¼ 3.9755..
The commands can be given as shown in the above section.
We conclude that:
in Group-1 it takes 17 years before 50 % of the patients develop beta-cell failure,
in Group-2 it takes 4 years before 50 % of the patients develop beta-cell failure.
6 Example 3
The next question is, does potency of su-compound influence induction of b-cell
failure?
250 patients started on amaryl (potent sulfonurea) at diagnosis (Group-A)
250 patients started on artosin (non-potent sulfonurea) at diagnosis (Group-B)
If after 1 year 25/250 of Group-A had beta-cell failure, and 25/250 of the group-
B, it is appropriate according to the Markov model to conclude that a non-potent
does not prevent beta-cell failure.
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7 Conclusion
Regression models are only valid within the range of the x-values observed in the
data. Markov modeling goes one step further, and aims at predicting outside the
range of x-values. Like with Cox regression it assumes an exponential-pattern.
Markov modeling, although its use is very common in long-term observational
studies remains highly speculative, because nature does not routinely follow math-
ematical models.
8 Note
More background, theoretical and mathematical information of is given in Statistics
applied to clinical studies 5th edition, Chap. 17, Springer Heidelberg Germany,
2012, and Machine learning in medicine a complete overview, Chap. 55, Springer
Heidelberg Germany, 2015, both from the same authors.
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Chapter 56
Binary Partitioning for CART (Classification
and Regression Tree) Methods
1 General Purpose
Binary partitioning is used to determine the best fit decision cut-off levels for a data
set with false positive and false negative patients. It serves a purpose similar to that
of the receiver operating characteristic (ROC) curve method (Cleophas and
Zwinderman, SPSS for starters and second levelers, Chap. 46, Springer,
New York, 2015), but, unlike ROC curves, it is adjusted for the magnitude of the
samples, and therefore more precise. A hypothesized example is given in the
underneath graph.
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The above histogram gives a patients’ sample assessed for peripheral vascular
disease; “a” summarizes the patients with a positive test and the presence of
disease, “b” the patients with a negative test and the absence of disease, “c” and
“d” are the false positive and false negative patients respectively. With binary
partitioning, otherwise called the entropy method or CART (classification and
regression tree) method, the entire sample of patients is called the parent node,
which can, subsequently, be repeatedly split, partitioned if you will, into binary
internal nodes. Mostly, internal nodes contain false positive or false negative
patients, and are, thus, somewhat impure. The magnitude of their impurity is
assessed. This chapter shows how it works.
2 Schematic Overview of Type of Data File










3 Primary Scientific Question
Can binary partitioning provide adequate cut-off levels for false positive and false
negative patients of a qualitative diagnostic test.
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4 Binary Partitioning, the Analysis
With binary partitioning, otherwise called the entropy method or CART (classifi-
cation and regression tree) method, the entire sample of patients (above graph) is
called the parent node, which can, subsequently, be repeatedly split into binary
internal nodes. Mostly, internal nodes contain false positive or negative patients,
and are, thus, impure. The magnitude of their impurity is assessed by the log
likelihood method (see also Chap. 46). Impurity equals the maximum log likelihood
of the y-axis-variable by assuming that the x-axis-variable follows a Gaussian (i.e.,
binomial) distribution and is expressed in units, sometimes called bits (a short-cut
for “binary digits”). All this sounds rather complex, but it works smoothly.
The x – axis variable for the right node¼ xr¼ a / (a + b),
for the left node¼ xl¼ d / (d + c).
If the impurity equals 1.0 bits, then it is maximal, if it equals 0.0, then it is
minimal.
Impurity node either right or left¼x ln x (1 x) ln (1 x),
where ln means natural logarithm.
The impurities of the right and left node are calculated separately. Then, a
weighted overall impurity of each cut-off level situation is calculated according
to (*¼ sign of multiplication):
Weighted impurity cut-off ¼
[(a + b)/(a + b + c + d) * impurity-right-node] +
[(d + c)/(a + b + c + d) * impurity-left-node].
Underneath, an overview is given of the calculated impurities at the different
cut-off levels. The cut-off percentage of 27 gives the smallest weighted impurity,
and is, thus, the best fit predictor for the presence of peripheral vascular disease.
Cut-off impurity right node impurity left node impurity weighted
22 % 0.5137 0.0000 0.3180
23 % 0.4392 0.0559 0.3063
24 % 0.4053 0.0982 0.2766
25 % 0.3468 0.1352 0.2711
26 % 0.1988 0.1688 0.1897
27 % 0.1352 0.2268 0.1830
28 % 0.0559 0.3025 0.1850
29 % 0.0559 0.3850 0.2375
30 % 0.0000 0.4690 0.2748
From the above calculation it can be concluded that a cut-off of 27 % is the best
fit decision cut-off level with fewest false positive and fewest false negative
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patients. The result was slightly different from that of the ROC curve analysis,
which produced a cut-off level of 26 %.
5 Conclusion
Binary partitioning is used to determine the best fit decision cut-off levels for a data
set with false positive and false negative patients. It serves a purpose similar to that
of the receiver operating characteristic (ROC) curve method., but, unlike ROC
curves, it is adjusted for the magnitude of the samples, and therefore more precise.
This chapter shows that the method works very well.
6 Note
More background, theoretical and mathematical information of binary partitioning
is given in Statistics applied to clinical studies 5th edition, Chap. 53, Springer
Heidelberg Germany, 2012, from the same authors.
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Chapter 57
Meta-analysis of Binary Data
1 General Purpose
Meta-analyses can be defined as systematic reviews with pooled data. Because the
separate studies in a meta-analysis have different sample sizes for the overall
results, a weighted average has to be calculated. Heterogeneity in a meta-analysis
means, that the differences in the results between the studies are larger than could
happen by chance. The calculation of the overall result and the test for heteroge-
neity is demonstrated in the current chapter.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
How do we assess pooled results of multiple studies, how do we assess heteroge-
neity between the studies.
4 Data Example, Pooling
The underneath data show the results of 7 studies assessing chance of death and







95 % ci z-value p
1.Monteiro
2003
6/29 11/24 70 0.45 0.15–1.40 1.38 1.69
2.Nathou
2006
3/173 20/365 561 0.32 0.09–1.08 1.84 0.066
3.Meier
2007
36/190 197/389 812 0.37 0.25–0.56 4.87 0.0001
4.Sorajja
2007
7/112 15/184 318 0.77 0.30–1.94 0.56 0.576
5.Regieli
2009
7/254 16/600 879 1.03 0.42–2.54 +0.07 0.944
6.Desch
2010
5/64 34/132 235 0.30 0.11–0.81 2.38 0.018
7.Steg 2010 246/1676 42/209 2173 0.73 0.51–1.04 1.72 0.085
In order to meta-analyze these data, the following calculations are required.
OR¼ odds ratio, lnOR¼ the natural logarithm of the odds ratio, var¼ variance.
OR lnOR var 1/var lnOR/var (lnOR)2//var
1.Monteiro 2003 0.45 0.795 0.3337 2.997 2.382 1.894
2.Nathou 2006 0.32 1.150 0.3919 2.882 2.935 3.375
3.Meier 2007 0.37 0.983 0.04069 24.576 24.158 23.748
4.Sorajja 2007 0.77 0.266 0.2239 4.466 1.188 0.3160
5.Regieli 2009 1.03 1.194 0.2526 3.959 4.727 5.644
6.Desch 2010 0.30 0.032 0.2110 4.739 0.152 0.005
7.Stege 2010 0.73 0.314 0.0333 30.03 9.429 2.961
+
73.319 44.667 37.943
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The pooled odds ratio is calculated from antiln of (44.667/73.319)
¼ 0.54
(see Chap. 43 for the antiln (anti-logaritm) calculation).
The chi-square value for pooled data ¼ (44.667)2 / 73.319¼ 27.2117
According to the underneath chi-square table for a chi-square value>10.827 and
1 degree of freedom, the p-value
¼ <0.001
The underneath chi-square table has an upper row with areas under the curve, a




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
(continued)
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5 Data Example, Assessing Heterogeneity
The above data will now be assessed for heterogeneity. Heterogeneity of this meta-
analysis is tested by the fixed effect model.
Heterogeneity chi-square value ¼ 37.943-27.2117
¼10.7317
With 6 degrees of freedom a chi-square value >10.645 the p – value
¼ 0.05< p< 0.10
Although the meta-analysis shows a significantly lower risk in patients with
collaterals than in those without, this result has a limited meaning, since there is a
trend to heterogeneity in these studies. For heterogeneity testing it is tested whether
the differences between the results of the separate trials are greater than compatible
with the play of chance. Additional tests for heterogeneity testing are available
(Cleophas and Zwinderman, Meta-analysis. In: Statistics Applied to Clinical Stud-
ies, Springer New York, 2012, 5th edition, pp 365–388). When there is heteroge-
neity in a meta-analysis, a careful investigation of its potential cause is often more
important than a lot of additional statistical tests.
6 Conclusion
Meta-analyses are systematic reviews of multiple published studies with pooled
data. Because the separate studies have different sample sizes a weighted average
has to be calculated. Heterogeneity in a meta-analysis means that the differences in
the results between the studies are larger than could happen by chance. With a
significant heterogeneity the meaning of the pooled data is generally little.
df
Two-tailed P-value
0.10 0.05 0.01 0.001
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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Additional tests for heterogeneity testing are available in Statistics Applied to
Clinical Studies 5th edition, Chaps 32–34, Springer New York, 2012). With
heterogeneity in a meta-analysis, a careful investigation of its potential cause is
important.
7 Note
More background, theoretical and mathematical information of meta-analysis given
in Statistics applied to clinical studies 5th edition, Chaps. 32–34, Springer Heidelberg
Germany, 2012, from the same authors.
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Chapter 58
Physicians’ Daily Life and the Scientific
Method
1 General Purpose
We assumed the numbers of unanswered questions in the physicians’ daily life
would be large. But just to get of impression, one of the authors of this work
(TC) recorded all of the unanswered answers he asked himself during a single busy
day. Excluding the questions with uncertain but generally accepted answers, he
included 9 questions.
During the hospital rounds 8.00–12.00 h.
1. Do I continue, stop or change antibiotics with fever relapse after 7 days
treatment?
2. Do I prescribe a secondary prevention of a venous thrombosis for 3, 6 months or
permanently?
3. Should I stop anticoagulant treatment or continue with a hemorrhagic compli-
cation in a patient with an acute lung embolia?
4. Is the rise in falling out of bed lately real or due to chance?
5. Do I perform a liver biopsy or wait and see with liver function disturbance
without obvious cause?
During the outpatient clinic 13.00–17.00 h.
6. Do I prescribe aspirin, hydroxy-carbamide or wait and see in a patient with a
thrombocytosis of 800 1012 /l over 6 months?
7. Are fundic gland polyps much more common in females than in males?
During the staff meeting 17.00–18.00 h
8. Is the large number of physicians with burn out due to chance or the result of a
local problem?
9. Is the rise in patients’ letters of complaints a chance effect or a real effect to
worry about?
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Many of the above questions did not qualify for a simple statistical assessment,
but others did. The actual assessments, that were very clarifying for our purposes,
are given underneath.
2 Schematic Overview of Type of Data File










3 Primary Scientific Question
Does event analysis in different hospital departments and other patient subgroups
provide valuable information for making predictions about health risks and other
patient risks.
4 Example 1, Falling Out of Bed
If more patients fall out of bed than expected, a hospital department will put much
energy in finding the cause and providing better prevention. If, however, the scores
tend to rise, another approach is to first assess whether or not the rise is due to
chance, because daily life is full of variations. To do so the numbers of events
observed is compared the numbers of event in a sister department. The pocket
calculator method is a straightforward method for that purpose.
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Patients with fall out of bed patients without
department 1 16 (a) 26 (b) 42 (a + b)
department 2 5 (c) 30 (d) 35 (c + d)
21 (a + c) 56 (b + d) 77 (a + b + c + d)
Pocket calculator method:
chi-square ¼ ad bcð Þ
2
aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ ¼ 5.456.
If the chi-square value (see also Chap. 38, and the underneath chi-square table) is
larger than 3.841, then a statistically significant difference between the two depart-
ments will be accepted at p< 0.05. This would mean that in this example, indeed,
the difference is larger than could be expected by chance and that a further
examination of the measures to prevent fall out of bed is warranted.
The underneath chi-square table has an upper row with areas under the curve, a




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
(continued)




0.10 0.05 0.01 0.001
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
5 Example 2, Evaluation of Fundic Gland Polyps
A physician has the impression that fundic gland polyps are more common in
females than it is in males. Instead of reporting this subjective finding, he decides
to follow the next two months every patient in his program.
patients with fundic gland polyps patients without
females 15 (a) 20 (b) 35 (a + b)
males 15 (c) 5 (d) 20 (c + d)
30 (a + c) 25 (b + d) 55 (a + b + c + d)
Pocket calculator method:
chi-square ¼ ad bcð Þ
2
aþ bþ cþ dð Þ
abð Þ cþ dð Þ bþ dð Þ aþ cð Þ ¼ 5.304
The calculated chi-square value is again larger than 3.841. The difference
between males and females is significant at p< 0.05. We can be for about 95 %
sure that the difference between the genders is real and not due to chance. The
physician can report to his colleagues that the difference in genders is to be taken
into account in future work-ups.
6 Example 3, Physicians with a Burn-Out
Two partnerships of specialists have the intention to associate. However, during
meetings, it was communicated that in one of the two partnerships there were three
specialists with burn-out. The meeting decided not to consider this as chance
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finding, but requested a statistical analysis of this finding under the assumption that
unknown factors in partnership 1 may place these specialists at an increased risk of
a burn-out.
physicians with burn out without burn out
partnership 1 3 (a) 7 (b) 10 (a + b)
partnership 2 0 (c) 10 (d) 10 (c + d)
__________
3 (a + c) 17(b + d) 20 (a + b + c + d)
pocket calculator method
chi-square ¼ adbcð Þ
2
aþbþcþdð Þ
aþbð Þ cþdð Þ bþdð Þ aþcð Þ ¼




The chi-square value was between 2.706 and 3.841. This means that no signif-
icant difference between the two partnerships exists, but there is a trend to a
difference at p< 0.10. This was communicated back to the meeting and it was
decided to disregard the trend. Ten years later no further case of burn-out had been
observed.
7 Example 4, Patients’ Letters of Complaints
In a hospital the number of patients’ letters of complaints was twice the number in
the period before. The management was deeply worried and issued an in-depth
analysis of possible causes. One junior manager recommended that prior to this
laborious exercise it might be wise to first test whether the increase might be due to
chance rather than a real effect.




year 2006 10 (a) 1000 (b) 1010 (a + b)
year 2005 5 (c) 1000 (d) 1005 (c + d)
____________
15 (a + c) 2000 (b + d) 2015 (a + b + c
+ d)
chi-square ¼ ad bcð Þ
2
aþ bþ cþ dð Þ
aþ bð Þ cþ dð Þ bþ dð Þ aþ cð Þ = 1.64
The chi-square was smaller than 2.706, and so the difference could not be
ascribed to any effect to worry about but rather to chance. No further analysis of
the differences between 2006 and 2005 were performed.
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8 Conclusion
There are, of course, many questions in physicians’ daily life that are less straight-
forward and cannot be readily answered at the workplace with a pocket calculator.
E.g., the effects of subgroups and other covariates in a patient group will require
t-tests, analyses of variance, likelihood ratio tests, and regression models. Fortu-
nately, in the past 15 years user-friendly statistical software and self-assessment
programs have been developed that can help answering complex questions. The
complementary titles of this book, entitled Statistics applied to clinical studies 5th
edition, machine in medicine a complete overview, and SPSS for starters and
second levels, Springer Heidelberg Germany, 2012–2015, from the same authors,
are helpful for the purpose.
So far, few physicians have followed the scientific method for answering
practical questions they, simply, do not know the answer to. The scientific method
can be summarized in a nutshell: reformulate your question into a hypothesis, and
try and test this hypothesis against control observations.
9 Note
More background, theoretical and mathematical information of the scientific
method during daily life is given in Statistics applied to clinical studies 5th edition,
Chap. 60, Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 59
Incident Analysis and the Scientific Method
1 General Purpose
The PRISMA (Prevention and Recovery System for Monitoring and Analysis) –, CIA
(Critical Incident Analysis) –, CIT (Critical Incident Technique) –, TRIPOD (tripod-
theory based method) – methods are modern approaches to incident – analysis. It is
unclearwhy the scientificmethod has been systematically ignored in incident – analysis.
As example the case of a fatal hemorrhage in a hospital during an observational period
of one year was used. In case of a fatal hemorrhage the physician in charge of the
analysis will first make an inventory of how many fatal hemorrhages of the same kind
have occurred in the period of one year. The number seems to be no less than ten. The
question is, is this number larger than could happen by chance. This chapter assesses the
use of z-tests and chi-square tests for answering the question of chance findings.
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3 Primary Scientific Question
In clinical facilities medical events are an important criterion of quality of care, and
careful analysis is non plus ultra. Can simple statistical tests be helpful for that
purpose.
4 Data Example, Test 1
As example the case of a fatal hemorrhage in a hospital during an observational
period of one year was used. In case of a fatal hemorrhage the physician in charge of
the analysis will first make an inventory of howmany fatal hemorrhages of the same
kind have occurred in the period of one year. The number seems to be ten.
The null - hypothesis is that 0 hemorrhages will occur per year, and the question
is whether 10 is significantly more than 0. A one – sample – z - test is used.
z ¼ (mean number)/(standard error) ¼ 10/√10 ¼ 3.16.
z – value is larger than 3.080 (see underneath t-table).
p – value is < 0.002.
The number 10 is, thus, much larger than a number that could occur by accident.
Here an avoidable error could very well be responsible. However, a null - hypoth-
esis of 0 hemorrhages is probably not correct, because a year without fatal hemor-
rhages, actually, never happens. Therefore, we will compare the number of fatal
hemorrhages in the given year with that of the year before. There were five fatal
hemorrhages then. The z - test produces the following result (see underneath
t-table).
T-Table
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The left-end column of the above t-table gives degrees of freedom ( sample
sizes), two top rows with p-values (areas under the curve), and the t-table is,
furthermore, full of t-values, that, with 1 degrees of freedom, become equal to
z-values.
z ¼ (10 – 5)/√ (10 + 5) ¼ 1.29
p – value ¼ not significant, because z is <1.96.
We can, however, question whether both years are representative for a longer
period of time. Epidemiological data have established that an incident-reduction of
70% is possible with optimal quality health care. We test whether 10 is significantly
different from (10 - (70%) x 10) ¼ 3. The z-test shows the following.
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z ¼ (10–3)/√(10+3) ¼ 1.94
p-value ¼ 0.05 < p < 0.10
It means, that here also no significant effect has been demonstrated. A more
sensitive mode of testing will be obtained, if we take into account the entire number
of admissions per year. In the given hospital there were 10,000 admissions in either
of the two years. A chi-square test can now be performed.
5 Data Example, Test 2
A chi-square test can now be performed according to the 2 x 2 contingency table in
the underneath table.
With one degree of freedom this value ought to have been at least 3.84 in order to
demonstrate whether a significant difference is in the data (chi-square table). And,
so, again there is no significant difference between the two years.
Rates of fatal hemorrhages in a hospital during two subsequent year of obser-
vation. According to the chi - square statistic < 3.84 the difference in rates is not
significant
Year 1    Year 2
Number fatal hemorrhages              10 5
Number control patients              9990     9995
Chi - square = (10 x 9995 + 5 x 9990)2 (20000) =    1.62
10 x 9990 x 5 x 9995
The underneath chi-square table has an upper row with areas under the curve, a




0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
(continued)
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6 Data Example, Test 3
Finally, a log – likelihood – ratio - test will be performed, a test which falls into the
category of exact - tests, and is, generally, still somewhat more sensitive (see also
Chap. 46). The result is in the table below. It is close to 3.84, but still somewhat
smaller.
Log likelihood ratio test of the data is below. Also this test is not significant with
a chi-square value smaller than 3.84
df
Two-tailed P-value
0.10 0.05 0.01 0.001
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
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¼ 3.468200 5.008856 ¼ 1.540656
Chi - square ¼ 2 log likelihood ratio ¼ 3.0813
log ¼ natural logarithm
Also the above test shows no significant difference between the frequencies of
deadly fatal hemorrhages in the two years of observation.
7 Data Example, Test 4
The analyst in charge takes the decision to perform one last test, making use of
epidemiological data that have shown that with optimal health care quality in a
facility similar to ours we may accept with 95% confidence that the number of fatal
hemorrhages will remain below 20 per 10,000 admissions. With 10 deadly bleed-
ings the 95% confidence interval can be calculated to be 5–18 (calculated from the
Internet “Confidence interval calculator for proportions”, http://faculty.vassar.edu).
This result is under 20. Also from this analysis it can be concluded that a profound
research of the fatal hemorrhages is not warranted. The number of hemorrhages
falls under the boundary of optimal quality care.
8 Conclusion
The scientific method is often defined as an evaluation of clinical data based on
appropriate statistical tests, rather than a description of the cases and their summa-
ries. The above example explains that the scientific method can be helpful in giving
a clue to which incidents are based on randomness and which are not so.
Many incident analysis software programs provide systematic approaches to the
explanation of a single incident at the workplace. Few such software programs have
followed the scientific method for assessing causal relationships between factors
and the resulting incident. The scientific method is in a nutshell: reformulate your
question into a hypothesis and try and test this hypothesis against control
observations.
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9 Note
More background, theoretical and mathematical information of incident analysis
and the scientific method is given in Statistics applied to clinical studies 5th edition,
Chap. 61, Springer Heidelberg Germany, 2012, from the same authors.
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Chapter 60
Cochran Q-Test for Large Paired Cross-Tabs
1 General Purpose
To analyze samples of more than 2 pairs of data, e.g., 3, 4 pairs, etc., McNemar’s
test (Chap. 48 and 49) can not be applied. For that purpose Cochran’s test or logistic
regression analysis is adequate (Chap. 45). The current chapter assesses how the
Cochran’s test works.
2 Schematic Overview of Type of Data File
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3 Primary Scientific Question
Is the Cochran Q-test able to tell the differences between three or more paired
observations of yes / no responders to three or more different treatments.
4 Cochran Q-Test for a Study with Three Paired Binary
Observations per Patient
The underneath table shows three paired observations in each single patient. The
paired property of these observations has to be taken into account because of the,
generally, positive correlation between paired observations. Cochran’s Q test is
appropriate for that purpose.
Responders and non-responders to three different treatments.
(treat¼ treatment, 1¼ responder, 0¼ non-responder)
Patient treat1 treat2 treat3
1 1 0 0
2 0 0 1
3 0 0 1
4 0 0 1
5 0 0 1
6 1 0 0
7 1 0 0
8 1 0 0
9 1 0 0
10 0 0 1
11 0 0 1
12 0 0 1+________________________
5 0 7
Grans mean columns
¼ 5 þ 0 þ 7ð Þ=3 ¼ 12=3 ¼ 4







columns2 ¼ 5 4ð Þ2 þ 0 4ð Þ2 þ 7 4ð Þ2 ¼ 1þ 16þ 9
¼ 26
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∑ rows ¼
for row 1 (number treatments) (number responders)¼ 3 1 ¼ 2
for row 2 ¼ 2
for row 3 ¼ 2
for row 4 ¼ 2
for row 5 ¼ 2
for row 6 ¼ 2
for row 7 ¼ 2
for row 8 ¼ 2
for row 9 ¼ 2
for row 10 ¼ 2
for row 11 ¼ 2
for row 12 ¼ 2+
¼ 24
Chi-square¼ 6 26/24¼ 6.5
With 3 treatments we have (3 – 1) degrees of freedom.
The underneath chi-square table has an upper row with areas under the curve, a
left-end column with degrees of freedom, and a whole lot of chi-square values. It
show that for 2 degrees of freedom, a chi-square value>5.991 means that p< 0.05.




df 0.10 0.05 0.01 0.001
1 2.706 3.841 6.635 10.827
2 4.605 5.991 9.210 13.815
3 6.251 7.851 11.345 16.266
4 7.779 9.488 13.277 18.466
5 9.236 11.070 15.086 20.515
6 10.645 12.592 16.812 22.457
7 12.017 14.067 18.475 24.321
8 13.362 15.507 20.090 26.124
9 14.684 16.919 21.666 27.877
10 15.987 18.307 23.209 29.588
11 17.275 19.675 24.725 31.264
12 18.549 21.026 26.217 32.909
13 19.812 22.362 27.688 34.527
14 21.064 23.685 29.141 36.124
15 22.307 24.996 30.578 37.698
16 23.542 26.296 32.000 39.252
17 24.769 27.587 33.409 40.791
18 25.989 28.869 34.805 42.312
(continued)
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Two-tailed P-value
df 0.10 0.05 0.01 0.001
19 27.204 30.144 36.191 43.819
20 28.412 31.410 37.566 45.314
21 29.615 32.671 38.932 46.796
22 30.813 33.924 40.289 48.268
23 32.007 35.172 41.638 49.728
24 33.196 36.415 42.980 51.179
25 34.382 37.652 44.314 52.619
26 35.536 38.885 45.642 54.051
27 36.741 40.113 46.963 55.475
28 37.916 41.337 48.278 56.892
29 39.087 42.557 49.588 58.301
30 40.256 43.773 50.892 59.702
40 51.805 55.758 63.691 73.403
50 63.167 67.505 76.154 86.660
60 74.397 79.082 88.379 99.608
70 85.527 90.531 100.43 112.32
80 96.578 101.88 112.33 124.84
90 107.57 113.15 124.12 137.21
100 118.50 124.34 135.81 149.45
Mc Nemar tests (Chaps. 48 and 49) must be performed to find out, where the
differences are: between treatments 1 and 2, 2 and 3, and/or 1 and 3. Adjustment for
multiple testing is also required (Chap.18).
5 Conclusion
To analyze samples of more than 2 pairs of yes-no data, e.g., 3, 4 paired columns,
McNemar’s test can not be applied. For that purpose Cochran’s test or logistic
regression analysis is adequate. The current chapter assesses how the Cochran test
works. Like with paired analysis of variance (Chap. 20), Post hoc analyses, and
adjustment for multiple testing are required.
6 Note
More background, theoretical and mathematical information of Cochran Q-test is
given in Statistics applied to clinical studies 5th edition, Chap. 3, Springer Heidel-
berg Germany, 2012, from the same authors.
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